{"meta":{"query_hash":"7ee8ea7c73fd","filters":{"venue":"Human Psychopharmacology Clinical and Experimental"},"cohort_total":104,"direct_labels_cover":1,"predictions_cover":104,"exported":104,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7ee8ea7c73fd","api":"https://metacan.xera.ac/api/v1/cohort?venue=Human+Psychopharmacology+Clinical+and+Experimental"},"results":[{"id":"W1481698373","doi":"10.1002/hup.1199","title":"Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetine","year":2011,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Treatment of Major Depression","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Alberta","funders":"Eli Lilly Australia","keywords":"Duloxetine; Anxiety; Hamilton Anxiety Rating Scale; Mood; Population; Psychology; Hamd; Depression (economics); Rating scale; Internal medicine; Psychiatry; Physical therapy; Medicine","score_opus":0.03702081680045414,"score_gpt":0.3827842841808541,"score_spread":0.3457634673803999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1481698373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987025,0.0007852492,0.000032905325,0.000046116747,0.000023880464,0.000080456564,0.00013319807,0.0000056843783,0.000189873],"genre_scores_gemma":[0.9989334,0.0001918075,0.00011865137,0.000119547294,0.000044219258,0.00008639153,0.00040061606,9.453885e-7,0.00010438542],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991391,0.00040707737,0.00008967641,0.00011225759,0.00012857883,0.00012328403],"domain_scores_gemma":[0.99896276,0.00031880153,0.0003285192,0.00005025231,0.00007394478,0.00026561806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016344197,0.00044053298,0.0015462936,0.00029160487,0.00029178898,0.00058847835,0.00039377337,0.00058640336,0.0012420387],"category_scores_gemma":[0.0020854343,0.00024498237,0.0010106527,0.0002642749,0.00031315663,0.00027660665,0.00024799496,0.0005639499,0.00013891124],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40345255,0.00796562,0.4864348,0.0008557545,0.0074857087,0.00033488186,0.00027958263,0.0012966484,0.0068232166,0.000072792216,0.0013070904,0.083691314],"study_design_scores_gemma":[0.09279319,0.1224198,0.77860105,0.00009794477,0.0020029095,0.00044405565,0.00014722321,0.0017462933,0.0008089431,0.00008885603,0.0008155034,0.000034269502],"about_ca_topic_score_codex":0.0009006467,"about_ca_topic_score_gemma":0.0022939197,"teacher_disagreement_score":0.0016344197,"about_ca_system_score_codex":0.00049718027,"about_ca_system_score_gemma":0.0004457312,"threshold_uncertainty_score":0.008643746},"labels":[],"label_agreement":null},{"id":"W1499518160","doi":"10.1002/hup.2233","title":"Association study of <i>GRIK1</i> gene polymorphisms in schizophrenia: case–control and family‐based studies","year":2012,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; AstraZeneca; Eli Lilly and Company; American Foundation for Suicide Prevention","keywords":"Single-nucleotide polymorphism; Schizophrenia (object-oriented programming); Haplotype; Dorsolateral prefrontal cortex; Genetic association; Case-control study; Genetics; Glutamatergic; DISC1; Linkage disequilibrium; Association (psychology); Gene; Prefrontal cortex; Glutamate receptor; Biology; Medicine; Allele; Internal medicine; Psychology; Neuroscience; Genotype; Psychiatry; Receptor; Cognition","score_opus":0.13824270185541165,"score_gpt":0.47621105967673233,"score_spread":0.3379683578213207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1499518160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984674,0.00045605758,0.00056217023,0.000043527838,0.00001058125,0.000016126187,0.00018329854,0.00001344794,0.00024728166],"genre_scores_gemma":[0.9991192,0.0001275319,0.00046943597,0.000023546792,0.000012454667,0.000014876618,0.00016589952,0.0000060484704,0.000060984705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840456,0.0006433388,0.00015854079,0.0005376919,0.00016683874,0.00008901631],"domain_scores_gemma":[0.99684995,0.0012665875,0.0010116479,0.00038929144,0.00020086551,0.00028167802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022491247,0.0006498258,0.0005900664,0.0010406764,0.0008267447,0.00045595437,0.00061037764,0.0006352209,0.0033179214],"category_scores_gemma":[0.005352816,0.00032995892,0.0006451602,0.0012850381,0.00063184265,0.00029615074,0.00040272393,0.00048769318,0.00032037706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019423141,0.00025753243,0.98288417,0.00007020577,0.0013670474,0.0014264367,0.00032483262,0.00022009395,0.0062093884,0.00014565203,0.00028244054,0.0048698345],"study_design_scores_gemma":[0.00024598156,0.0008813275,0.98939383,0.000027820315,0.0010145855,0.0053462354,0.00015476653,0.00073382905,0.0013033521,0.00023544092,0.00063916954,0.000023715436],"about_ca_topic_score_codex":0.002395983,"about_ca_topic_score_gemma":0.0015745786,"teacher_disagreement_score":0.0033179214,"about_ca_system_score_codex":0.0002866537,"about_ca_system_score_gemma":0.0002488844,"threshold_uncertainty_score":0.011894643},"labels":[],"label_agreement":null},{"id":"W1501567039","doi":"10.1002/hup.2394","title":"Evaluation of the safety, pharmacodynamic, and pharmacokinetic effects following oral coadministration of immediate‐release morphine with ethanol in healthy male participants","year":2014,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Pharmacology; Morphine; Ethanol; Medicine; Chemistry","score_opus":0.056784689675123935,"score_gpt":0.4447436207714164,"score_spread":0.3879589310962924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1501567039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994475,0.0002292696,0.00016910004,0.000008473835,0.000003675287,0.000050660245,0.000018648243,0.0000031712698,0.000069415466],"genre_scores_gemma":[0.99887735,0.00017041714,0.0006193442,0.000023720639,0.000014845511,0.000048304846,0.00003929906,0.000001943389,0.00020477106],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99947506,0.00022377579,0.000036761896,0.00007430499,0.00015407264,0.00003596384],"domain_scores_gemma":[0.99906284,0.00023587256,0.00041119943,0.00005419484,0.00011643901,0.00011934042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009837764,0.00040900992,0.0004995993,0.00014720336,0.00021773679,0.00023338095,0.00022075113,0.00028089652,0.001361745],"category_scores_gemma":[0.0013148229,0.00022631565,0.0002567466,0.000100219084,0.00027154502,0.00021461153,0.00023958975,0.00029378454,0.00015060158],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19860713,0.014572674,0.31907463,0.0011689977,0.0014805009,0.0010883824,0.0009278947,0.0006276103,0.33845824,0.00006522298,0.00019398048,0.12373475],"study_design_scores_gemma":[0.0034279355,0.4192881,0.5206789,0.000036371395,0.000890013,0.0015967786,0.00040620717,0.0011387978,0.051283322,0.000027834334,0.0011911513,0.0000345911],"about_ca_topic_score_codex":0.00031716024,"about_ca_topic_score_gemma":0.0006195646,"teacher_disagreement_score":0.001361745,"about_ca_system_score_codex":0.00016637033,"about_ca_system_score_gemma":0.00030029152,"threshold_uncertainty_score":0.0052027702},"labels":[],"label_agreement":null},{"id":"W1521700621","doi":"10.1002/hup.2418","title":"Modulation of auditory deviance detection by acute nicotine is baseline and deviant dependent in healthy nonsmokers: a mismatch negativity study","year":2014,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuroscience and Music Perception","field":"Neuroscience","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Mismatch negativity; Nicotine; Psychology; Nicotinic agonist; Auditory cortex; Audiology; Stimulus (psychology); Nicotinic acetylcholine receptor; Cognition; Neuroscience; Electroencephalography; Medicine; Cognitive psychology; Internal medicine; Receptor","score_opus":0.05457024941184346,"score_gpt":0.42269098333835525,"score_spread":0.3681207339265118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1521700621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997037,0.000032023338,0.000103366394,0.0000062939334,0.0000032809915,0.000023073773,0.000017552462,0.000001932476,0.00010865307],"genre_scores_gemma":[0.9994073,0.000035678346,0.00017804246,0.000026177324,0.000008490059,0.000030176674,0.000046375575,0.0000027337999,0.00026511913],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998299,0.000035144614,0.000016009499,0.000054347303,0.000043010667,0.000021641194],"domain_scores_gemma":[0.9996512,0.00009212282,0.00005168943,0.000041750056,0.00003791896,0.00012530696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003678628,0.00025851562,0.000361634,0.00018831418,0.00022843544,0.00016749871,0.00018336097,0.0004142614,0.0025334733],"category_scores_gemma":[0.0007419481,0.00019657923,0.00017504217,0.000069833,0.0003980087,0.00018915387,0.00026657394,0.00033234563,0.000221635],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036382582,0.006991667,0.06747714,0.00018687193,0.00018850021,0.0004175359,0.0005986766,0.000084007246,0.8712677,0.000094665695,0.000113502145,0.016197162],"study_design_scores_gemma":[0.00076660275,0.02260064,0.94778496,0.000005352827,0.0001259601,0.00089556637,0.00021792926,0.00055772706,0.026476761,0.00014046491,0.0004127104,0.0000152294115],"about_ca_topic_score_codex":0.0006515662,"about_ca_topic_score_gemma":0.0012160479,"teacher_disagreement_score":0.0025334733,"about_ca_system_score_codex":0.00011494346,"about_ca_system_score_gemma":0.000119596756,"threshold_uncertainty_score":0.008475304},"labels":[],"label_agreement":null},{"id":"W1558149471","doi":"10.1002/hup.2294","title":"Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression","year":2013,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Treatment of Major Depression","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Agomelatine; Antidepressant; Depression (economics); Anxiety; Psychology; Psychiatry; Medicine; Clinical psychology; Psychotherapist","score_opus":0.038699610096068586,"score_gpt":0.41239357314812736,"score_spread":0.37369396305205876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1558149471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6190974,0.37480307,0.00070954644,0.0011960221,0.00022471766,0.0002251266,0.000434136,0.00006685017,0.0032430028],"genre_scores_gemma":[0.95358175,0.04362481,0.0010519511,0.0005956345,0.00021239299,0.00007035052,0.00031038685,0.0000047476074,0.0005480057],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99978834,0.00008198246,0.000044481625,0.000030385512,0.00004322723,0.000011535273],"domain_scores_gemma":[0.9997025,0.000117739364,0.00011539668,0.000014467631,0.00002663795,0.00002313871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008171277,0.0002388444,0.0007245813,0.00024623377,0.000097752025,0.0002778015,0.00039314583,0.00043711122,0.0012997766],"category_scores_gemma":[0.0009039282,0.0001271412,0.00061441545,0.00018605094,0.00018252525,0.0002511638,0.00013815775,0.0004665109,0.00015155697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06604203,0.0029634996,0.012850923,0.016455874,0.010533857,0.00059563626,0.00015501231,0.00087610947,0.11379048,0.00042235764,0.0022106904,0.7731036],"study_design_scores_gemma":[0.12012368,0.2905495,0.4278297,0.0040342463,0.026694683,0.010061479,0.00030079708,0.0032186618,0.053762015,0.0013158552,0.061953373,0.00015598064],"about_ca_topic_score_codex":0.00032391417,"about_ca_topic_score_gemma":0.0015718746,"teacher_disagreement_score":0.0012997766,"about_ca_system_score_codex":0.00028818025,"about_ca_system_score_gemma":0.00021631314,"threshold_uncertainty_score":0.004348159},"labels":[],"label_agreement":null},{"id":"W1571005844","doi":"10.1002/hup.2413","title":"Is environmental temperature related to renal symptoms, serum lithium levels, and other laboratory test results in current lithium users?","year":2014,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Victoria Hospital; Ontario Shores Centre for Mental Health Sciences; University of Toronto; McGill University","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Lithium (medication); Nephrogenic diabetes insipidus; Urine osmolality; Mood; Urine specific gravity; Renal function; Medicine; Bipolar disorder; Internal medicine; Endocrinology; Diabetes insipidus; Urine; Psychiatry","score_opus":0.030003125700162513,"score_gpt":0.3886337448856706,"score_spread":0.3586306191855081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1571005844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874663,0.00065795303,0.000050600636,0.00008264389,0.000006415192,0.000004197239,0.00009289085,0.000002258969,0.00035639975],"genre_scores_gemma":[0.99971896,0.00012257912,0.00003394,0.000024981506,0.0000092649125,0.000002287879,0.000049062783,7.708764e-7,0.00003813834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953485,0.0001858497,0.00007040261,0.000058975864,0.00008365182,0.0000663277],"domain_scores_gemma":[0.9974679,0.0005519649,0.0015523317,0.00008417547,0.00015712496,0.0001866179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000575507,0.00013564865,0.00032556555,0.0005786857,0.00028105002,0.0004749496,0.00021870807,0.0004224817,0.001965507],"category_scores_gemma":[0.0037942016,0.00017628784,0.00035563132,0.00076468906,0.00038425543,0.00037213342,0.00022011051,0.00040509118,0.00021025565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010816447,0.000021857462,0.99889094,0.000008896607,0.00003088331,0.000026802067,0.00003492746,0.000011294367,0.00008101399,0.0000038544304,0.000026188014,0.00075518794],"study_design_scores_gemma":[0.0000023455793,0.00007540605,0.9995427,0.000005198856,0.000015421441,0.00015689823,0.00008058049,0.000054536853,0.00002621755,0.000009426767,0.000029779063,0.0000015864993],"about_ca_topic_score_codex":0.002894698,"about_ca_topic_score_gemma":0.003802057,"teacher_disagreement_score":0.002894698,"about_ca_system_score_codex":0.00022609676,"about_ca_system_score_gemma":0.00020234985,"threshold_uncertainty_score":0.006575227},"labels":[],"label_agreement":null},{"id":"W1578387912","doi":"10.1002/hup.2325","title":"The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder","year":2013,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"START Clinic; University of Toronto; University Health Network","funders":"","keywords":"Internal medicine; Bipolar disorder; Resistin; Medicine; Body mass index; Adjunctive treatment; Clinical endpoint; Adiponectin; Major depressive disorder; Metabolic syndrome; Gastroenterology; Endocrinology; Randomized controlled trial; Obesity; Insulin resistance; Lithium (medication)","score_opus":0.009754570716360532,"score_gpt":0.33546367876504635,"score_spread":0.3257091080486858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1578387912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972498,0.002038863,0.000033284145,0.00006552571,0.000016538543,0.000037795413,0.00006958552,0.0000074793575,0.00048117628],"genre_scores_gemma":[0.9982132,0.0008594447,0.00023410616,0.00014577393,0.000030623352,0.00003367435,0.00012551814,0.0000013019759,0.00035649998],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99986637,0.000050172395,0.000021145466,0.000017888597,0.000027862736,0.000016582459],"domain_scores_gemma":[0.99967074,0.00007184073,0.000117821095,0.000011790275,0.00002531162,0.00010254012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033866178,0.00031352259,0.0006411078,0.00016666723,0.00018574519,0.0002102356,0.00014259056,0.0003266534,0.0013000235],"category_scores_gemma":[0.00066942925,0.00014162401,0.0002970698,0.00016815432,0.000134327,0.00018619647,0.00013025868,0.00049981865,0.00016796107],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25029814,0.018446404,0.3366896,0.000982166,0.0015477154,0.0007432276,0.00040594596,0.0006488007,0.07400885,0.000068956375,0.0014381061,0.31472206],"study_design_scores_gemma":[0.008885353,0.13141093,0.852693,0.00007508257,0.00046607404,0.0006028652,0.00014660608,0.00058895984,0.0036722375,0.00002995261,0.0014146769,0.000014302508],"about_ca_topic_score_codex":0.0007650305,"about_ca_topic_score_gemma":0.0032775328,"teacher_disagreement_score":0.0013000235,"about_ca_system_score_codex":0.00021235761,"about_ca_system_score_gemma":0.00016685583,"threshold_uncertainty_score":0.004349053},"labels":[],"label_agreement":null},{"id":"W1608528568","doi":"10.1002/hup.2326","title":"Patterns of atypical antipsychotic therapy use in adults with bipolar I disorder in the USA","year":2013,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Discontinuation; Bipolar disorder; Antipsychotic; Concomitant; Medicine; Bipolar I disorder; Internal medicine; Persistence (discontinuity); Psychiatry; Pediatrics; Schizophrenia (object-oriented programming); Mood; Mania","score_opus":0.04820522135731387,"score_gpt":0.39684679873718615,"score_spread":0.3486415773798723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608528568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986777,0.000305991,0.00004008454,0.000081025755,0.0000032179678,0.000006469446,0.00050913024,0.0000031275545,0.0003733321],"genre_scores_gemma":[0.9991703,0.00016231036,0.0000731378,0.00005431772,0.000005599912,0.000006396515,0.00045042933,9.578904e-7,0.000076566444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958473,0.00010009295,0.000089039546,0.000066550754,0.00010444452,0.000055054355],"domain_scores_gemma":[0.9987502,0.00013501957,0.0008292703,0.000026275604,0.00013729579,0.00012195489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004398421,0.00011181824,0.00017082276,0.000757712,0.00024516348,0.0004242506,0.00019105458,0.00029166994,0.0008211988],"category_scores_gemma":[0.0013787413,0.000121045356,0.00025290958,0.000997131,0.00013053944,0.00025916813,0.0002623426,0.000295138,0.00011871641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018945539,0.000016735794,0.9985795,0.000005309819,0.000021181726,0.00002015596,0.00004473229,0.0000142657,0.000054736312,0.0000039471342,0.000088946945,0.0011315063],"study_design_scores_gemma":[0.0000015914095,0.000022536937,0.9995716,0.0000054155125,0.00000722728,0.000098487435,0.00011603649,0.000068752954,0.000018754452,0.0000031268094,0.000085254745,0.0000012797192],"about_ca_topic_score_codex":0.017625084,"about_ca_topic_score_gemma":0.030792622,"teacher_disagreement_score":0.017625084,"about_ca_system_score_codex":0.00040363122,"about_ca_system_score_gemma":0.00035447083,"threshold_uncertainty_score":0.035045028},"labels":[],"label_agreement":null},{"id":"W1622313911","doi":"10.1002/hup.2383","title":"Positive perception of pharmacogenetic testing for psychotropic medications","year":2014,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; Centre for Addiction and Mental Health; Western University","funders":"Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; University of Toronto","keywords":"Pharmacogenetics; Medicine; Perception; Psychology; Pharmacology; Biology; Genetics; Neuroscience; Genotype; Gene","score_opus":0.1763177381488729,"score_gpt":0.5428489992395906,"score_spread":0.36653126109071776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1622313911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947813,0.00021496434,0.00015895617,0.001757141,0.000045357752,0.00002348464,0.00003029291,0.0000056650083,0.002982858],"genre_scores_gemma":[0.9983956,0.00022412455,0.00009384819,0.0006403654,0.000025096293,0.0000074437576,0.000015540763,0.0000016768919,0.00059632864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969216,0.0011695906,0.00018301286,0.00014718376,0.0012082973,0.00037032497],"domain_scores_gemma":[0.98201585,0.0059799035,0.005783448,0.00043174584,0.0023053482,0.0034836286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053707184,0.00022171428,0.00021776232,0.0005359327,0.0011543592,0.001331516,0.00032384225,0.0008403238,0.0042624483],"category_scores_gemma":[0.0144236935,0.00016494744,0.00032965516,0.00028220084,0.0023066993,0.0005321872,0.0011239889,0.0013507316,0.00026432503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003465055,0.00029677668,0.9267254,0.00021810687,0.00006757421,0.0008787142,0.03625686,0.00018837559,0.004682314,0.00041512234,0.0022898389,0.027634392],"study_design_scores_gemma":[0.00004703725,0.0009849898,0.91024333,0.00027415153,0.00007805468,0.0017742849,0.07442382,0.0005825098,0.0010241847,0.00031410833,0.010178861,0.00007469248],"about_ca_topic_score_codex":0.013398207,"about_ca_topic_score_gemma":0.011884208,"teacher_disagreement_score":0.013398207,"about_ca_system_score_codex":0.0016019066,"about_ca_system_score_gemma":0.0016706374,"threshold_uncertainty_score":0.028403401},"labels":[],"label_agreement":null},{"id":"W1749705612","doi":"10.1002/hup.2477","title":"Detecting a signal in the noise: monitoring the global spread of novel psychoactive substances using media and other open‐source information","year":2015,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Forensic Toxicology and Drug Analysis","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University; Canadian Centre on Substance Use and Addiction","funders":"Health Canada; Government of Canada; Public Health Agency; Public Health Agency of Canada","keywords":"Law enforcement; Public health; Relevance (law); Enforcement; Agency (philosophy); Psychoactive substance; Computer security; Computer science; Psychology; Medicine; Internet privacy; Political science; Psychiatry; Sociology; Law","score_opus":0.2633703388882517,"score_gpt":0.5339977098763229,"score_spread":0.2706273709880712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1749705612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971467,0.0014184662,0.007759471,0.0013093619,0.000075652715,0.0005200227,0.0039970563,0.00016868277,0.013284293],"genre_scores_gemma":[0.98115057,0.0010821198,0.01494949,0.00031690957,0.00014179264,0.00016064684,0.0014309103,0.00002363675,0.0007439084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996027,0.0017968647,0.00035430992,0.00045840789,0.0011998517,0.00016362722],"domain_scores_gemma":[0.9606036,0.016541231,0.015145959,0.0016068496,0.005588333,0.00051404774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006787225,0.0004992725,0.00024889057,0.0071757166,0.0004104187,0.001943692,0.00064495916,0.0005156413,0.0009969453],"category_scores_gemma":[0.030213201,0.00020393853,0.0002669572,0.0043750317,0.0007510977,0.002760589,0.0017915905,0.00044772646,0.00028807312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034288075,0.00017002357,0.86975324,0.00067874725,0.00018441405,0.00029735867,0.0032359455,0.0009706124,0.0049487073,0.0005977158,0.0012235617,0.11759691],"study_design_scores_gemma":[0.00004066242,0.0007194123,0.95596683,0.0005187673,0.00026845466,0.00038097944,0.011284141,0.005850178,0.013045181,0.0009659987,0.010886276,0.000073158226],"about_ca_topic_score_codex":0.008561928,"about_ca_topic_score_gemma":0.012958042,"teacher_disagreement_score":0.008561928,"about_ca_system_score_codex":0.0006850296,"about_ca_system_score_gemma":0.0009569625,"threshold_uncertainty_score":0.035894692},"labels":[],"label_agreement":null},{"id":"W1894568551","doi":"10.1002/hup.1243","title":"The effects of agomelatine on sexual function in depressed patients and healthy volunteers","year":2011,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Fowler Kennedy Sport Medicine Clinic; University Health Network","funders":"","keywords":"Agomelatine; Sexual function; Psychology; Internal medicine; Medicine; Clinical psychology; Antidepressant","score_opus":0.09401394231628969,"score_gpt":0.46807398319986937,"score_spread":0.3740600408835797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1894568551","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958319,0.00323059,0.000032751785,0.000031907348,0.000008996567,0.00002428867,0.000114670365,0.0000034985344,0.0007213953],"genre_scores_gemma":[0.99855584,0.0009516107,0.0000805192,0.00006805546,0.000015126138,0.000014597723,0.00015451368,8.228689e-7,0.00015906885],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964523,0.00019150226,0.00004055532,0.000030292316,0.00006514871,0.000027266451],"domain_scores_gemma":[0.9993161,0.00029922108,0.00019031316,0.00002896268,0.000055364642,0.000110013054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066118245,0.0001924852,0.00032486234,0.0003319827,0.00015461174,0.00022815769,0.00012750665,0.0002633106,0.0009570076],"category_scores_gemma":[0.0016706884,0.00011563384,0.0003219174,0.00020957775,0.00014149296,0.00013879949,0.00015867328,0.00021492093,0.0001736789],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022861848,0.0014797394,0.8820556,0.0005640583,0.00091277715,0.0008893075,0.0005174061,0.00016495818,0.01105818,0.000041845975,0.0004724548,0.078981794],"study_design_scores_gemma":[0.00039271734,0.010006154,0.9866942,0.000025491208,0.00017364713,0.0011708395,0.00012691313,0.00011714398,0.00076232065,0.00001538577,0.0005083376,0.000006786841],"about_ca_topic_score_codex":0.00055165385,"about_ca_topic_score_gemma":0.0008987298,"teacher_disagreement_score":0.0009570076,"about_ca_system_score_codex":0.00016691342,"about_ca_system_score_gemma":0.000096174655,"threshold_uncertainty_score":0.0034967065},"labels":[],"label_agreement":null},{"id":"W1933977529","doi":"10.1002/hup.2243","title":"Effects of anxiolytic treatment on potentiated startle during aversive image anticipation","year":2012,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse; National Institute of Mental Health","keywords":"Anticipation (artificial intelligence); Psychology; Anxiety; Anxiolytic; Aversive Stimulus; Functional magnetic resonance imaging; Arousal; Audiology; Neuroscience; Developmental psychology; Medicine; Psychiatry","score_opus":0.05165671553649838,"score_gpt":0.4510372539875754,"score_spread":0.399380538451077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1933977529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984127,0.00047039718,0.00011143791,0.00005092141,0.000016415506,0.000041669155,0.00011663155,0.000025674779,0.0007540738],"genre_scores_gemma":[0.998451,0.0005008043,0.00024327055,0.000047502614,0.000027411847,0.000041373998,0.00012659248,0.000004724872,0.0005574498],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998846,0.000044201846,0.000011053033,0.000012691004,0.000021403479,0.000025912665],"domain_scores_gemma":[0.9995977,0.00016576795,0.00010140934,0.000031151387,0.00002841868,0.00007562503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019153464,0.00036856576,0.0005274344,0.00020496137,0.000115447314,0.0002138584,0.00017158006,0.00027175012,0.0035796799],"category_scores_gemma":[0.00094214414,0.0001428396,0.00015939905,0.0001269918,0.00023479667,0.00014140231,0.0001407001,0.0006989221,0.0002386616],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09393196,0.006324087,0.0022474602,0.00052488135,0.00031304185,0.00021064254,0.00022251935,0.00044867824,0.8390777,0.00014187502,0.00034795768,0.056209106],"study_design_scores_gemma":[0.014206754,0.37247577,0.16697308,0.0001303477,0.0007417351,0.0010696662,0.00032709772,0.0027443809,0.43777347,0.00029242717,0.0032012216,0.00006401939],"about_ca_topic_score_codex":0.00041493945,"about_ca_topic_score_gemma":0.0008353907,"teacher_disagreement_score":0.0035796799,"about_ca_system_score_codex":0.00014432314,"about_ca_system_score_gemma":0.00017101572,"threshold_uncertainty_score":0.011975229},"labels":[],"label_agreement":null},{"id":"W1937837739","doi":"10.1002/hup.1219","title":"Genetic interactions in the adrenergic system genes: analysis of antipsychotic‐induced weight gain","year":2011,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Adrenergic; Adrenergic receptor; Receptor; Biology; Weight gain; Monoamine oxidase A; Antipsychotic; Endocrinology; Monoamine oxidase; Phenotype; Internal medicine; Gene; Genetics; Pharmacology; Medicine; Schizophrenia (object-oriented programming); Enzyme; Serotonin; Body weight; Biochemistry; Psychiatry","score_opus":0.16291012432290258,"score_gpt":0.44180190072836045,"score_spread":0.27889177640545787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937837739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996891,0.00006658729,0.0000928239,0.00000804911,0.0000015036762,0.0000030094684,0.000058648355,0.0000021022302,0.00007815877],"genre_scores_gemma":[0.99968743,0.000026129834,0.00012700746,0.0000058690584,0.000001840485,0.0000039506244,0.000076157,0.0000015632676,0.00007009652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974304,0.00008177026,0.000029053861,0.00005873868,0.000059847516,0.000027507222],"domain_scores_gemma":[0.99924785,0.00020626826,0.00035931548,0.00004588495,0.000036199843,0.00010454185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030402432,0.00032765928,0.00021666384,0.00070692546,0.00027432884,0.00020438993,0.00019151821,0.00024243917,0.0022970254],"category_scores_gemma":[0.00081123447,0.000116756906,0.00032358392,0.0005748659,0.0002495214,0.00009879352,0.00027411108,0.00032519858,0.00016071199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048423055,0.00006568834,0.9882465,0.000016139817,0.00012527368,0.00039104468,0.00007394278,0.00006481745,0.008190276,0.00002823319,0.00002846464,0.0022852405],"study_design_scores_gemma":[0.0000075374496,0.0001505186,0.9983088,0.0000022647246,0.000036806818,0.00076538377,0.000040763083,0.0001626822,0.00045071315,0.00002312038,0.000049255646,0.0000021099372],"about_ca_topic_score_codex":0.0008599677,"about_ca_topic_score_gemma":0.0011142216,"teacher_disagreement_score":0.0022970254,"about_ca_system_score_codex":0.0001384735,"about_ca_system_score_gemma":0.00014740632,"threshold_uncertainty_score":0.0076842904},"labels":[],"label_agreement":null},{"id":"W1949474745","doi":"10.1002/hup.2258","title":"Methylphenidate‐mediated reduction in prefrontal hemodynamic responses to working memory task: a functional near‐infrared spectroscopy study","year":2012,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Placebo; Functional near-infrared spectroscopy; Prefrontal cortex; Crossover study; Methylphenidate; Working memory; Cognition; Anesthesia; Audiology; Psychology; Elementary cognitive task; Effects of sleep deprivation on cognitive performance; Medicine; Internal medicine; Cardiology; Neuroscience; Psychiatry; Attention deficit hyperactivity disorder; Pathology","score_opus":0.06063489954899019,"score_gpt":0.4540011986362789,"score_spread":0.3933662990872887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1949474745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993548,0.00019342864,0.00014443544,0.000017466233,0.0000059060603,0.000025974427,0.00005429615,0.000003243574,0.00020039358],"genre_scores_gemma":[0.99864894,0.00023358312,0.0002636821,0.000052862557,0.000014710752,0.000045724,0.00014865214,0.0000024805274,0.00058924634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999429,0.000013059503,0.0000036593165,0.000012831751,0.000017648994,0.000009854633],"domain_scores_gemma":[0.99986434,0.000027037851,0.000037689573,0.000018480217,0.000018002282,0.000034518118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023937924,0.00054700463,0.00029932513,0.00008311798,0.00016445496,0.000122598,0.00017092688,0.00030663869,0.0019430298],"category_scores_gemma":[0.0003530811,0.0001476532,0.00014697797,0.000060535313,0.00029896517,0.00014887794,0.00015817599,0.00040402848,0.0001803216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06580538,0.0068345154,0.032540377,0.00044371976,0.0005126471,0.00074129825,0.00039972828,0.00018100892,0.84733284,0.00008413602,0.00030571528,0.04481869],"study_design_scores_gemma":[0.0021914917,0.04386421,0.8386387,0.000020621477,0.00039254746,0.0013604803,0.00021112908,0.00069683994,0.11094111,0.00010432407,0.0015610938,0.000017439756],"about_ca_topic_score_codex":0.0013943127,"about_ca_topic_score_gemma":0.0016667069,"teacher_disagreement_score":0.0019430298,"about_ca_system_score_codex":0.00014584811,"about_ca_system_score_gemma":0.00022975676,"threshold_uncertainty_score":0.0065000653},"labels":[],"label_agreement":null},{"id":"W1953092902","doi":"10.1002/hup.2421","title":"A review on schizophrenia and relapse—a quest for user‐friendly psychopharmacotherapy","year":2014,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Schizophrenia (object-oriented programming); User Friendly; Psychiatry; Psychology; Medicine; Psychotherapist; Computer science; Operating system","score_opus":0.1041482483956502,"score_gpt":0.5287976079021227,"score_spread":0.42464935950647253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1953092902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039894257,0.99947566,0.000028345652,0.00016286722,0.00008013919,0.0000029273049,0.000008873835,0.0000022152835,0.00019898564],"genre_scores_gemma":[0.000299594,0.99936754,0.00007773126,0.00011493239,0.000051700245,0.00000386396,0.000009059888,5.5819993e-7,0.00007518712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994406,0.00017185159,0.00014281207,0.00005875564,0.00015592328,0.000029974435],"domain_scores_gemma":[0.9988186,0.0008144363,0.00015801289,0.000024637473,0.00014554732,0.000038832408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009781063,0.0008102302,0.0018364324,0.002706632,0.00030163408,0.0012145321,0.000967892,0.0012088519,0.0038829674],"category_scores_gemma":[0.0022453996,0.0003535577,0.0011492502,0.0033518935,0.00043317722,0.0012503917,0.0006113569,0.0014893152,0.0007535966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011459649,0.00006749918,0.0001659556,0.15783276,0.0005124581,0.00020092429,0.00016132116,0.0003051673,0.00072620733,0.0030637137,0.034700893,0.80214864],"study_design_scores_gemma":[0.00005129836,0.00013360714,0.001617581,0.089007616,0.0011967053,0.0014468677,0.00016170998,0.00010014483,0.00025499842,0.0022182122,0.90377957,0.00003170731],"about_ca_topic_score_codex":0.0019318443,"about_ca_topic_score_gemma":0.0033383488,"teacher_disagreement_score":0.0038829674,"about_ca_system_score_codex":0.00084935816,"about_ca_system_score_gemma":0.0024276862,"threshold_uncertainty_score":0.012989819},"labels":[],"label_agreement":null},{"id":"W1970434963","doi":"10.1002/hup.530","title":"Donepezil in a chronic drug user—a potential treatment?","year":2003,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Donepezil; Dysexecutive syndrome; Psychology; Neuropsychology; MDMA; Wechsler Adult Intelligence Scale; Clinical psychology; Cognition; Neuropsychological test; Psychiatry; Cognitive psychology; Developmental psychology; Medicine; Dementia; Internal medicine","score_opus":0.06629194327758388,"score_gpt":0.43210154173832144,"score_spread":0.3658095984607376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970434963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98241097,0.0088351825,0.00026171774,0.0033055036,0.00014269911,0.00003349204,0.000091927315,0.000021858235,0.004896699],"genre_scores_gemma":[0.99512094,0.0025646703,0.00024957806,0.00084106415,0.00014345681,0.000012097263,0.000042145668,0.0000017478858,0.0010243885],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9998852,0.000045012162,0.000011058723,0.000012357881,0.000020585756,0.000025660564],"domain_scores_gemma":[0.999754,0.000056926183,0.000060018046,0.000013088902,0.00003039444,0.000085491214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002530157,0.0001764555,0.00045898993,0.00024334398,0.00064353686,0.00045536712,0.00021916103,0.0012795872,0.0024765145],"category_scores_gemma":[0.00084813207,0.00010896734,0.00026107454,0.0002511281,0.00028196952,0.00046046078,0.0001785743,0.00039810225,0.00029862532],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008349549,0.003163975,0.63592184,0.0011155533,0.00026500894,0.06940519,0.0015037359,0.00017500353,0.03485311,0.0013819522,0.0052027004,0.23866247],"study_design_scores_gemma":[0.0013345041,0.01871021,0.8146583,0.00034527987,0.000769111,0.12490025,0.0045788065,0.0016384191,0.007681288,0.0019296699,0.023382366,0.0000718313],"about_ca_topic_score_codex":0.0016669022,"about_ca_topic_score_gemma":0.009175785,"teacher_disagreement_score":0.0024765145,"about_ca_system_score_codex":0.0002812666,"about_ca_system_score_gemma":0.00035954872,"threshold_uncertainty_score":0.008284748},"labels":[],"label_agreement":null},{"id":"W1971912227","doi":"10.1002/hup.226","title":"Self‐report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance","year":2000,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and related disorders","field":"Psychology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"","keywords":"Association (psychology); Sleep disorder; Disturbance (geology); Sleep (system call); Psychology; Clinical psychology; Sample (material); Psychiatry; Medicine; Audiology; Cognition; Psychotherapist; Computer science; Biology","score_opus":0.017569865354006897,"score_gpt":0.36063283140744673,"score_spread":0.34306296605343983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971912227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9998387,0.000034698493,0.000011380046,0.000011837009,0.000001438576,0.000004119124,0.00002946826,6.822124e-7,0.00006753294],"genre_scores_gemma":[0.9996854,0.00004493022,0.000031290907,0.000023192924,0.000005795301,0.0000073124684,0.00010157253,5.1026745e-7,0.00010000218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997285,0.00006256797,0.00004207149,0.00003877878,0.0000762853,0.00005183031],"domain_scores_gemma":[0.99905163,0.00017526426,0.00039829387,0.00005078188,0.00012082311,0.0002033512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000400424,0.00021741378,0.00039555857,0.0008422233,0.0005620029,0.0005243191,0.00020966287,0.00035014324,0.0013375252],"category_scores_gemma":[0.0026343851,0.00030535532,0.0002061876,0.00046141804,0.0003922223,0.0003661994,0.00046785554,0.00046737748,0.00019849282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009825903,0.00008562111,0.99739134,0.0000114564355,0.00002381443,0.000118704236,0.00053874915,0.00001065094,0.00039909192,0.00000540267,0.00006549853,0.0012514426],"study_design_scores_gemma":[0.00000712002,0.00022668685,0.99875736,0.0000023438258,0.000008492131,0.00038535034,0.00048774536,0.00003706145,0.000031012456,0.0000065443614,0.000048283568,0.0000018670756],"about_ca_topic_score_codex":0.0033889522,"about_ca_topic_score_gemma":0.004173953,"teacher_disagreement_score":0.0033889522,"about_ca_system_score_codex":0.00018102361,"about_ca_system_score_gemma":0.0001822962,"threshold_uncertainty_score":0.0067384243},"labels":[],"label_agreement":null},{"id":"W1973189506","doi":"10.1002/hup.665","title":"Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation","year":2005,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Dextroamphetamine; Lithium (medication); Placebo; Psychology; Neuroscience; Pharmacology; Anesthesia; Medicine; Psychiatry; Amphetamine; Pathology","score_opus":0.0868604780322,"score_gpt":0.46082887580146226,"score_spread":0.3739683977692623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973189506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978065,0.0010916326,0.00027771082,0.00009396821,0.000013061761,0.00005719437,0.00011836017,0.000049563165,0.00049199583],"genre_scores_gemma":[0.996111,0.00070583285,0.0009082108,0.00009481127,0.000020862537,0.00009755334,0.00029256084,0.000007914993,0.0017612525],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999943,0.000013448523,0.000008760097,0.000010575101,0.000011475848,0.000012855061],"domain_scores_gemma":[0.99985266,0.000020586695,0.00005459436,0.000013921634,0.0000141773935,0.000044094002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008435307,0.00028688143,0.00044738004,0.00014079767,0.00012174859,0.0001599284,0.00023424077,0.0003706925,0.0021757176],"category_scores_gemma":[0.00030291767,0.00014473384,0.000174306,0.00008510967,0.0002757748,0.00018131762,0.00015753777,0.00047577426,0.0003152493],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032150377,0.0018369737,0.0018257175,0.0002728818,0.00009633524,0.00011741682,0.00011522532,0.00008155362,0.93238133,0.000056938596,0.00023219151,0.030833004],"study_design_scores_gemma":[0.007866045,0.10144912,0.08510855,0.000069056296,0.00029065553,0.0008740326,0.00017902823,0.0016012086,0.79797536,0.00015669735,0.0043983734,0.000031895044],"about_ca_topic_score_codex":0.0006197294,"about_ca_topic_score_gemma":0.0019990145,"teacher_disagreement_score":0.0021757176,"about_ca_system_score_codex":0.00017562011,"about_ca_system_score_gemma":0.00028821983,"threshold_uncertainty_score":0.007278502},"labels":[],"label_agreement":null},{"id":"W1979260280","doi":"10.1002/hup.676","title":"A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis","year":2005,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; The Scarborough Hospital","funders":"","keywords":"Galantamine; Donepezil; Meta-analysis; Cognition; Disease; Alzheimer's disease; Psychology; Dementia; Medicine; Intervention (counseling); Psychiatry; Pharmacology; Internal medicine","score_opus":0.3437238473383894,"score_gpt":0.5819603609728178,"score_spread":0.23823651363442838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979260280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008918823,0.9894587,0.000529183,0.000117902724,0.00016260648,0.0003192114,0.00018899361,0.000021194084,0.00028345553],"genre_scores_gemma":[0.15684485,0.83880126,0.0023608513,0.0004096141,0.0001646023,0.00070867623,0.00035409592,0.000015951953,0.00034012762],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9956565,0.0024522783,0.0009350779,0.00035776568,0.00048153315,0.00011694222],"domain_scores_gemma":[0.9942781,0.0042041778,0.0007734281,0.00015002355,0.00047340797,0.000120880366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007535057,0.0026014105,0.016444173,0.004382307,0.00049598113,0.0020183905,0.0015632333,0.0018049997,0.0024368763],"category_scores_gemma":[0.014253987,0.0011265111,0.021143673,0.0041861203,0.0004368573,0.0011648934,0.0008439992,0.0011835137,0.00020454005],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012338183,0.00009534698,0.0015305268,0.37419716,0.58003765,0.00029188115,0.0001140797,0.00092536194,0.00080028194,0.00019423164,0.00059399067,0.028881352],"study_design_scores_gemma":[0.0033678263,0.00087320444,0.0022488795,0.0139438305,0.9766342,0.00017297776,0.000055395416,0.00022540338,0.0003040606,0.00017500526,0.0019765678,0.0000227065],"about_ca_topic_score_codex":0.0040772646,"about_ca_topic_score_gemma":0.012148205,"teacher_disagreement_score":0.016444173,"about_ca_system_score_codex":0.0019211163,"about_ca_system_score_gemma":0.0023247523,"threshold_uncertainty_score":0.03984964},"labels":[],"label_agreement":null},{"id":"W1982900708","doi":"10.1002/hup.480","title":"Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers","year":2003,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Amphetamine; Mania; Stimulant; Placebo; Metabolite; Internal medicine; Endocrinology; Crossover study; Plasma concentration; Psychology; Pharmacology; Medicine; Dopamine; Bipolar disorder; Lithium (medication)","score_opus":0.17859813782405698,"score_gpt":0.45509106250014364,"score_spread":0.27649292467608666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982900708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992471,0.00029693486,0.00007887907,0.000008215165,0.0000050314407,0.000024209374,0.000057271158,0.000005525651,0.00027698418],"genre_scores_gemma":[0.9993507,0.00012178315,0.00012444475,0.000025383566,0.000008874884,0.00002655554,0.000098519595,0.0000016710453,0.00024203515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975544,0.00008575435,0.000022898805,0.000059266647,0.000044234253,0.0000323923],"domain_scores_gemma":[0.9994091,0.00016885698,0.00015597027,0.00004103608,0.00004853175,0.0001765572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003387084,0.00031991286,0.00030697827,0.00032316032,0.00022587826,0.00029433376,0.00008086177,0.00035436472,0.0010467686],"category_scores_gemma":[0.0011656577,0.00028694214,0.00013809229,0.00015684725,0.00031282124,0.00017747468,0.00017275348,0.00036739913,0.00023175291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054980356,0.0046206047,0.7753082,0.00022133069,0.00047954873,0.001034537,0.00078900054,0.00025720074,0.1319595,0.00008630663,0.00030007132,0.029963328],"study_design_scores_gemma":[0.00028819215,0.01775626,0.97771215,0.0000043127975,0.00007471077,0.00062670314,0.00008859179,0.00018971777,0.0030085163,0.000030656152,0.00021173288,0.000008502884],"about_ca_topic_score_codex":0.00073777407,"about_ca_topic_score_gemma":0.0009243437,"teacher_disagreement_score":0.0010467686,"about_ca_system_score_codex":0.00014273477,"about_ca_system_score_gemma":0.0001244288,"threshold_uncertainty_score":0.0035018325},"labels":[],"label_agreement":null},{"id":"W1985931523","doi":"10.1002/hup.1146","title":"Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response","year":2010,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Clozapine; Schizophrenia (object-oriented programming); Neurexin; Neuroscience; Medicine; Internal medicine; Biology; Psychiatry; Receptor; Postsynaptic potential","score_opus":0.07579218702771681,"score_gpt":0.47543872277325483,"score_spread":0.399646535745538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985931523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991304,0.00032090722,0.00006631528,0.000063175314,0.000006657931,0.0000050903445,0.00013525774,0.0000042357287,0.00026797949],"genre_scores_gemma":[0.99961865,0.00007535354,0.000056651603,0.000029637564,0.0000044590756,0.0000033498081,0.00007683353,0.0000042601782,0.00013085439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991805,0.000355239,0.000105905696,0.000160628,0.00013855717,0.000059214774],"domain_scores_gemma":[0.99847347,0.00069915684,0.0005183601,0.00007916597,0.00009480349,0.00013509936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061393896,0.00037645194,0.00056734297,0.00031544743,0.0001782227,0.00037012063,0.00017150906,0.0004526972,0.0016051572],"category_scores_gemma":[0.003009323,0.00016117838,0.00045362653,0.0003575033,0.00021903547,0.00013115643,0.00012717381,0.00034149914,0.0002579956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015413313,0.0002228629,0.88978404,0.00008920865,0.0015898907,0.0013388599,0.0003847185,0.0004786468,0.07500934,0.000076102675,0.00026113397,0.01535186],"study_design_scores_gemma":[0.00006201552,0.00044898453,0.9967512,0.0000069642224,0.00020277638,0.00039152798,0.00005156337,0.00025130805,0.0016289144,0.000033884877,0.00016304842,0.000007910939],"about_ca_topic_score_codex":0.0032064768,"about_ca_topic_score_gemma":0.0050622746,"teacher_disagreement_score":0.0032064768,"about_ca_system_score_codex":0.00038489173,"about_ca_system_score_gemma":0.00022391879,"threshold_uncertainty_score":0.0063756704},"labels":[],"label_agreement":null},{"id":"W1991293593","doi":"10.1002/hup.1170","title":"The acute effect of Swedish‐style snus on cigarette craving and self‐administration in male and female smokers","year":2011,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Snus; Placebo; Lozenge; Craving; Nicotine; Medicine; Smoking cessation; Harm reduction; Randomized controlled trial; Psychology; Clinical psychology; Physical therapy; Psychiatry; Internal medicine; Smokeless tobacco; Addiction; Environmental health; Tobacco use; Public health; Population; Alternative medicine","score_opus":0.050760917946429174,"score_gpt":0.4256653895921206,"score_spread":0.3749044716456914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991293593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956125,0.00012396216,0.00006335989,0.000011204972,0.0000051697616,0.000017715394,0.000020916583,0.0000060641737,0.00019042267],"genre_scores_gemma":[0.9986784,0.00029869922,0.00030318843,0.000032627264,0.000024253604,0.000044798537,0.00006482887,0.0000034205625,0.00054979237],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983144,0.000071121314,0.000012946114,0.000021252583,0.00003642258,0.000026742187],"domain_scores_gemma":[0.9995689,0.00018300182,0.00008293546,0.00003492644,0.000027989985,0.000102236365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032877477,0.00030908268,0.00036288798,0.00014201632,0.00015795548,0.00019635164,0.00014603543,0.0002675685,0.0028878246],"category_scores_gemma":[0.0008317081,0.00022410334,0.00024472582,0.000094321025,0.0004113735,0.00015783307,0.00020570357,0.00036761322,0.00027233944],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19683023,0.024759984,0.0708217,0.0007107486,0.000390199,0.0002188338,0.001202096,0.0004734367,0.5500588,0.00018593726,0.00038088518,0.15396719],"study_design_scores_gemma":[0.0027153755,0.44075036,0.45405346,0.000060395385,0.00033928812,0.00064397056,0.0006129507,0.0016071888,0.09754211,0.00014306889,0.0014969215,0.00003485487],"about_ca_topic_score_codex":0.0004859241,"about_ca_topic_score_gemma":0.0005876533,"teacher_disagreement_score":0.0028878246,"about_ca_system_score_codex":0.000099421995,"about_ca_system_score_gemma":0.00022964767,"threshold_uncertainty_score":0.009660721},"labels":[],"label_agreement":null},{"id":"W1991510272","doi":"10.1002/hup.467","title":"Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review","year":2002,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Paroxetine; Panic disorder; Anxiety; Generalized anxiety disorder; Psychiatry; Anxiety disorder; Panic; Depression (economics); Psychology; Tolerability; Social anxiety; Adverse effect; Antidepressant; Medicine; Internal medicine","score_opus":0.22065676671635012,"score_gpt":0.5230055692913864,"score_spread":0.30234880257503627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991510272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018026869,0.9991233,0.000056531964,0.00007589107,0.000069884925,0.000010163897,0.000016206846,0.000004590442,0.00046324852],"genre_scores_gemma":[0.00068783655,0.99875224,0.0001884833,0.000071762544,0.000061337574,0.00000965125,0.00002063722,6.9506035e-7,0.00020727728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977106,0.000052066556,0.00005112177,0.00003770993,0.00007678371,0.000011330243],"domain_scores_gemma":[0.9996587,0.00017817202,0.00006803518,0.000009094606,0.00006202689,0.00002399773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005168306,0.0008020034,0.0014594891,0.0029759067,0.00022506714,0.00051280874,0.00083382445,0.0007564307,0.003726972],"category_scores_gemma":[0.00084516656,0.00021192415,0.0005058453,0.0030463312,0.00024005394,0.0009412442,0.0003306504,0.00064031914,0.0012378973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010215579,0.000090196714,0.0002832694,0.041363772,0.00017637595,0.0003488692,0.00009455942,0.00017601602,0.000799216,0.00047616556,0.019187551,0.93690175],"study_design_scores_gemma":[0.0001558438,0.00034884925,0.0069168326,0.025597246,0.0009552383,0.00682454,0.00023931157,0.00017256802,0.00059075106,0.0010664214,0.9570954,0.00003702557],"about_ca_topic_score_codex":0.0016934421,"about_ca_topic_score_gemma":0.0038614115,"teacher_disagreement_score":0.003726972,"about_ca_system_score_codex":0.00038608754,"about_ca_system_score_gemma":0.000789971,"threshold_uncertainty_score":0.012467921},"labels":[],"label_agreement":null},{"id":"W1992505607","doi":"10.1002/hup.1161","title":"Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective","year":2011,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Tardive dyskinesia; Antipsychotic; Biomarker; Schizophrenia (object-oriented programming); Prolactin; Dyskinesia; Allele; Internal medicine; Pharmacogenetics; Medicine; Endocrinology; Genotype; Psychology; Oncology; Psychiatry; Genetics; Biology; Parkinson's disease; Hormone; Gene; Disease","score_opus":0.058328678059480554,"score_gpt":0.4136569510773177,"score_spread":0.35532827301783715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992505607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8324245,0.13368094,0.0057404833,0.025796259,0.0003342581,0.00002277239,0.00030431122,0.00007773468,0.0016187407],"genre_scores_gemma":[0.9919051,0.004668267,0.001144373,0.0014224862,0.0005860988,0.000010602033,0.00004645056,0.000011679111,0.00020488283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967121,0.0021149903,0.00033616516,0.00038696686,0.00036022358,0.000089559995],"domain_scores_gemma":[0.98776835,0.007549659,0.0026848954,0.0008692389,0.0007009761,0.0004269157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011277068,0.0004967369,0.0013362997,0.0015251058,0.00030342463,0.0019339389,0.00075094594,0.0012795683,0.0006091505],"category_scores_gemma":[0.010987855,0.00035239963,0.00059464795,0.0013631001,0.0032326074,0.0018576566,0.000692781,0.0018899434,0.00013770557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023070078,0.00006884865,0.929852,0.0003800768,0.0011534351,0.0005896299,0.00074835646,0.00045946075,0.0038760866,0.0017506807,0.00088519504,0.05792916],"study_design_scores_gemma":[0.000101976846,0.0011277731,0.9787828,0.00033404346,0.00078049605,0.0022681379,0.0011395835,0.0029162948,0.0015953833,0.008623487,0.0022305346,0.00009941999],"about_ca_topic_score_codex":0.0017468759,"about_ca_topic_score_gemma":0.0014336291,"teacher_disagreement_score":0.011277068,"about_ca_system_score_codex":0.000571013,"about_ca_system_score_gemma":0.0005820126,"threshold_uncertainty_score":0.059639513},"labels":[],"label_agreement":null},{"id":"W1993289280","doi":"10.1002/hup.1111","title":"Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic‐induced weight gain in European and African‐American schizophrenia patients","year":2010,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Clozapine; Olanzapine; Risperidone; Antipsychotic; Weight gain; Haloperidol; Allele; Internal medicine; Medicine; Genotype; Schizophrenia (object-oriented programming); Oncology; Endocrinology; Genetics; Psychiatry; Biology; Gene; Dopamine; Body weight","score_opus":0.03299244179103093,"score_gpt":0.37749372504611367,"score_spread":0.3445012832550827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993289280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997936,0.00006176466,0.000024859615,0.000010174645,0.0000020410473,0.0000022128586,0.000041864576,7.061835e-7,0.00006284444],"genre_scores_gemma":[0.99968016,0.00003702391,0.00008574495,0.000013110947,0.0000041043822,0.000004685698,0.00009247203,0.000001221806,0.000081608305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999798,0.00005764783,0.00002586904,0.00005958166,0.000030789022,0.000028146962],"domain_scores_gemma":[0.9995369,0.00010367234,0.0002002018,0.000028307051,0.000030107107,0.00010084469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032864444,0.0004160348,0.00028421264,0.0005643223,0.00044091677,0.00030618586,0.0002077761,0.00047916817,0.0019271234],"category_scores_gemma":[0.0010068599,0.00022617026,0.00034980557,0.0006601989,0.00021495433,0.0001427364,0.00023331329,0.0003674375,0.00018177964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010699787,0.00008977243,0.9924716,0.000014275888,0.0001663937,0.00036337003,0.00015231056,0.000050200924,0.0040444084,0.00003253932,0.00006558972,0.0014797401],"study_design_scores_gemma":[0.000051007173,0.00026737474,0.9980876,0.0000054316197,0.00007412468,0.00082928344,0.00011263377,0.00019245135,0.00024015021,0.000030217752,0.00010552173,0.0000041582966],"about_ca_topic_score_codex":0.0015424443,"about_ca_topic_score_gemma":0.0018105514,"teacher_disagreement_score":0.0019271234,"about_ca_system_score_codex":0.00017536995,"about_ca_system_score_gemma":0.00016811922,"threshold_uncertainty_score":0.006446898},"labels":[],"label_agreement":null},{"id":"W2000906264","doi":"10.1002/hup.873","title":"The neuropsychology of ecstasy (MDMA) use: a quantitative review","year":2007,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Forensic Toxicology and Drug Analysis","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; University of Toronto","funders":"","keywords":"Ecstasy; MDMA; Neuropsychology; Psychology; Psychiatry; Cognition","score_opus":0.4500235545481315,"score_gpt":0.6435152760980752,"score_spread":0.19349172154994376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000906264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000639778,0.99871945,0.00008275821,0.00011099976,0.000020600677,0.000010280705,0.00007908782,0.0000021962614,0.00033490142],"genre_scores_gemma":[0.0032077946,0.9964675,0.00015729945,0.00003839833,0.000015225575,0.00000940387,0.000043100827,6.2999413e-7,0.000060585604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994549,0.00016562322,0.00013011698,0.000072375435,0.00016028385,0.000016733351],"domain_scores_gemma":[0.9978612,0.0013707733,0.0003655695,0.000040355466,0.0003307424,0.000031402444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013715638,0.0005652819,0.0014676885,0.004419857,0.00017692742,0.0008204788,0.00067643437,0.0003923863,0.0018132327],"category_scores_gemma":[0.00383953,0.00026512134,0.00087832066,0.006885245,0.00037500396,0.0008521155,0.00039669714,0.00031859006,0.000278371],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108362714,0.000039067836,0.0043537873,0.17042768,0.0017205798,0.0003102313,0.00027154788,0.00039407742,0.00064971944,0.0010024622,0.0074936925,0.8132287],"study_design_scores_gemma":[0.00013448497,0.0005405023,0.10533489,0.21514247,0.019943528,0.00816082,0.0017228643,0.0004543775,0.0018085536,0.0034767422,0.64313364,0.00014714946],"about_ca_topic_score_codex":0.0043184957,"about_ca_topic_score_gemma":0.008350391,"teacher_disagreement_score":0.004419857,"about_ca_system_score_codex":0.0007794611,"about_ca_system_score_gemma":0.002541464,"threshold_uncertainty_score":0.008586764},"labels":[],"label_agreement":null},{"id":"W2003064473","doi":"10.1002/hup.1084","title":"Lorazepam modulates orbitofrontal signal changes during emotional processing in catatonia","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Electroconvulsive Therapy Studies","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Lorazepam; Catatonia; Orbitofrontal cortex; Psychology; Psychomotor learning; Functional magnetic resonance imaging; Neuroscience; Prefrontal cortex; Schizophrenia (object-oriented programming); Psychiatry; Cognition","score_opus":0.03797315505347342,"score_gpt":0.42542834760681386,"score_spread":0.38745519255334043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003064473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996232,0.000101867794,0.000046342924,0.00002252916,0.0000034871139,0.000007793632,0.000012831979,0.0000037479585,0.00017818302],"genre_scores_gemma":[0.9996598,0.00007009477,0.00006956993,0.000022421953,0.000003596827,0.000007904697,0.000018749115,0.0000011635547,0.00014685736],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999471,0.000022698556,0.0000037356428,0.0000074759796,0.000008183818,0.000010790099],"domain_scores_gemma":[0.9998914,0.000026950745,0.000043095723,0.000007631647,0.000010858794,0.000019989777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011564289,0.00018522804,0.00024508656,0.00010235683,0.000116482566,0.00012832068,0.00005924955,0.00015426552,0.0010873372],"category_scores_gemma":[0.000429267,0.00007773718,0.0000957035,0.00005591104,0.00018909598,0.000080935984,0.000085110725,0.00018600357,0.00007454066],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031365722,0.00079542457,0.06842243,0.00035109572,0.00022468808,0.0011745365,0.00043788116,0.00022846746,0.8584846,0.000097865915,0.00038112843,0.0380361],"study_design_scores_gemma":[0.0014160995,0.010197726,0.9530943,0.000016206332,0.00020882073,0.0014736415,0.00020992171,0.00075519155,0.03155809,0.0000905075,0.00096662936,0.0000128349675],"about_ca_topic_score_codex":0.0008038247,"about_ca_topic_score_gemma":0.0016451565,"teacher_disagreement_score":0.0010873372,"about_ca_system_score_codex":0.00021158677,"about_ca_system_score_gemma":0.0001203642,"threshold_uncertainty_score":0.0036374927},"labels":[],"label_agreement":null},{"id":"W2003829755","doi":"10.1002/hup.317","title":"Fluvoxamine in obsessive‐compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine","year":2001,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Clomipramine; Fluvoxamine; Tolerability; Clinical Global Impression; Psychology; Adverse effect; Rating scale; Psychiatry; Internal medicine; Anesthesia; Medicine; Fluoxetine; Serotonin; Placebo","score_opus":0.039236521161719974,"score_gpt":0.4226257529002544,"score_spread":0.3833892317385344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003829755","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23895355,0.7556784,0.0008182734,0.000932885,0.00077191106,0.00046139225,0.0007501437,0.000074953154,0.001558458],"genre_scores_gemma":[0.9042264,0.09222767,0.0010480173,0.0009577598,0.00040245726,0.00019627805,0.00044353,0.000023272421,0.0004746019],"study_design_codex":"meta_analysis","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969574,0.0018141159,0.0005102763,0.00036495534,0.0002682132,0.00008496158],"domain_scores_gemma":[0.99656713,0.002318406,0.0006847655,0.00016508326,0.00015348189,0.00011113119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005420348,0.0009660858,0.0059640454,0.0013062684,0.0002751516,0.0015740516,0.000738163,0.0015177245,0.002440996],"category_scores_gemma":[0.0067932806,0.00057426345,0.012770671,0.0012072186,0.0005069364,0.0007600761,0.00035176994,0.0010687582,0.0001523642],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31558198,0.0004261893,0.0069399043,0.067403,0.5180268,0.00028192776,0.00018198814,0.0010380344,0.004498632,0.00029897815,0.001120141,0.084202506],"study_design_scores_gemma":[0.16238713,0.022061061,0.035949472,0.0038714784,0.7660512,0.000630691,0.00012862151,0.0010546716,0.0015743221,0.00058858615,0.0056061237,0.00009675945],"about_ca_topic_score_codex":0.0019080027,"about_ca_topic_score_gemma":0.0047430047,"teacher_disagreement_score":0.0059640454,"about_ca_system_score_codex":0.0008091211,"about_ca_system_score_gemma":0.0004593153,"threshold_uncertainty_score":0.02866584},"labels":[],"label_agreement":null},{"id":"W2005015693","doi":"10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j","title":"Hallucinogenic drugs attenuate the subjective response to alcohol in humans","year":2000,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Psilocybin; Hallucinogen; Lysergic acid diethylamide; Serotonergic; Alcohol; Antagonism; Psychology; Pharmacology; Alcohol addiction; Medicine; Addiction; Psychiatry; Chemistry; Receptor; Internal medicine; Serotonin","score_opus":0.07015782356166694,"score_gpt":0.47569956591512885,"score_spread":0.4055417423534619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005015693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979518,0.0007310506,0.00015243351,0.000031141346,0.000004083781,0.000006382423,0.000038285085,0.000006598061,0.0010783048],"genre_scores_gemma":[0.99851054,0.0007335161,0.00016069674,0.00003491416,0.000006797722,0.0000031462382,0.000053727686,0.0000013472749,0.0004953733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999095,0.00004471321,0.0000036667327,0.000009030667,0.000022644927,0.000010438558],"domain_scores_gemma":[0.9997943,0.000039043174,0.0000862651,0.000017657245,0.000022528418,0.00004018385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020364064,0.00014062379,0.000100816425,0.0001872062,0.00014803412,0.00019471136,0.000044819386,0.00010046183,0.0012376114],"category_scores_gemma":[0.0006749115,0.000093721676,0.000054136235,0.000051923143,0.00025696112,0.00011447333,0.00012275977,0.00014564216,0.00022945376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010182405,0.0021141567,0.43209368,0.0004419196,0.00032689408,0.0010370839,0.0037982506,0.00031875004,0.3971867,0.0006936024,0.001319921,0.15048659],"study_design_scores_gemma":[0.00008173837,0.008476975,0.97209686,0.000016476048,0.000038159156,0.0016291864,0.0008328279,0.0002150888,0.012239454,0.00021417774,0.004143432,0.000015618009],"about_ca_topic_score_codex":0.00048026725,"about_ca_topic_score_gemma":0.0007158615,"teacher_disagreement_score":0.0012376114,"about_ca_system_score_codex":0.000067243025,"about_ca_system_score_gemma":0.00006290845,"threshold_uncertainty_score":0.004140198},"labels":[],"label_agreement":null},{"id":"W2008459739","doi":"10.1002/hup.189","title":"Antidepressants in clinical practice: limitations of assessment methods and drug response","year":2001,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Treatment of Major Depression","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Clinical Practice; Drug trial; Clinical trial; Medicine; Outcome (game theory); Randomized controlled trial; Drug response; Intensive care medicine; Psychology; Drug; Psychiatry; Internal medicine; Physical therapy","score_opus":0.18107087704164163,"score_gpt":0.6059506347499309,"score_spread":0.42487975770828934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008459739","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18450928,0.20192668,0.4104098,0.10913019,0.00668857,0.028706055,0.010475861,0.0008597292,0.047293834],"genre_scores_gemma":[0.7130222,0.03333069,0.18642727,0.02996201,0.004394016,0.028438017,0.0023278676,0.00025181088,0.0018461669],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.19931841,0.6497152,0.06817408,0.012418847,0.069360696,0.0010128652],"domain_scores_gemma":[0.11816033,0.7468691,0.054609515,0.039497226,0.03945306,0.0014107113],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.5570274,0.0015019344,0.0037780707,0.0062555154,0.0017540916,0.0056353826,0.0064303475,0.0037467054,0.00204706],"category_scores_gemma":[0.786826,0.0017991515,0.0022194542,0.008356755,0.008473833,0.0061803716,0.006340838,0.0034255092,0.0009847005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002596496,0.00080675766,0.23633859,0.02490925,0.0060165636,0.00018976351,0.009034921,0.0070802243,0.00055580476,0.026569568,0.01731841,0.6685837],"study_design_scores_gemma":[0.0038616974,0.0063164686,0.59354323,0.043013684,0.0038585002,0.0024169583,0.010917477,0.034496345,0.0032163,0.1700026,0.12706676,0.0012898683],"about_ca_topic_score_codex":0.00831883,"about_ca_topic_score_gemma":0.008862919,"teacher_disagreement_score":0.5570274,"about_ca_system_score_codex":0.0059500933,"about_ca_system_score_gemma":0.007075055,"threshold_uncertainty_score":0.5462641},"labels":[],"label_agreement":null},{"id":"W2018350887","doi":"10.1002/hup.866","title":"Relationship between the cardiac response to acute intoxication and alcohol‐induced subjective effects throughout the blood alcohol concentration curve","year":2007,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McGill University; University of New Brunswick","funders":"Canadian Institutes of Health Research","keywords":"Alcohol; Stimulant; Sedative; Blood alcohol; Ethanol; Medicine; Area under the curve; Ingestion; Anesthesia; Internal medicine; Poison control; Injury prevention; Chemistry; Biochemistry; Emergency medicine","score_opus":0.16209001834767195,"score_gpt":0.5408834831316449,"score_spread":0.37879346478397297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018350887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950767,0.0000588958,0.00012208975,0.000010288869,0.0000011004926,0.000007414767,0.000028202137,0.0000024027731,0.000262008],"genre_scores_gemma":[0.99968696,0.000040465948,0.000104671795,0.000012315515,0.0000043259406,0.0000049830273,0.000050396142,0.0000011776053,0.000094736126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998832,0.00003431864,0.000011273566,0.000019788104,0.000037151487,0.000014173541],"domain_scores_gemma":[0.9977162,0.0007679727,0.0009316615,0.0001228338,0.00014926499,0.00031216245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023306628,0.00013648812,0.00010087452,0.0003367916,0.000107743675,0.00019567022,0.00007905673,0.00018260918,0.0023438637],"category_scores_gemma":[0.00190791,0.00010032867,0.00007325819,0.000120509816,0.00037274056,0.000108332446,0.00020830552,0.00029214975,0.00016828426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010898677,0.00018883099,0.961623,0.0000235314,0.000060723913,0.00014177695,0.00015382773,0.00012259246,0.031603258,0.000034310153,0.000035160865,0.004923121],"study_design_scores_gemma":[0.0000025721226,0.0002777796,0.9988525,8.3391745e-7,0.0000041454887,0.00014922948,0.000021877371,0.00007622027,0.0005836587,0.0000085157135,0.000021137346,0.000001413929],"about_ca_topic_score_codex":0.00061004935,"about_ca_topic_score_gemma":0.00074025133,"teacher_disagreement_score":0.0023438637,"about_ca_system_score_codex":0.00010716506,"about_ca_system_score_gemma":0.000085364976,"threshold_uncertainty_score":0.007840991},"labels":[],"label_agreement":null},{"id":"W2024344447","doi":"10.1002/hup.1076","title":"Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Clozapine; GPX1; Internal medicine; Oxidative stress; Schizophrenia (object-oriented programming); Glutathione peroxidase; Medicine; Antioxidant; Lipid peroxidation; Endocrinology; Psychiatry; Superoxide dismutase; Biology; Biochemistry","score_opus":0.05336549478538501,"score_gpt":0.41203768746196734,"score_spread":0.35867219267658235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024344447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99980456,0.0000436883,0.000017906676,0.000015283562,0.0000010725793,0.000001389622,0.000038706792,0.0000011857569,0.00007630195],"genre_scores_gemma":[0.999705,0.000025012887,0.000023846691,0.000012424044,0.0000023300804,0.0000027002045,0.00007036056,0.0000010507705,0.00015703373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983704,0.000041924854,0.00002434154,0.000040506853,0.000029959056,0.000026324096],"domain_scores_gemma":[0.9995022,0.00012294916,0.00020381226,0.000032460623,0.000032581986,0.00010602075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021100674,0.00030507773,0.00025391637,0.00055370195,0.00024180065,0.00027870588,0.00013049974,0.00035485727,0.0022176374],"category_scores_gemma":[0.00095129036,0.00017885445,0.00024021305,0.00029529168,0.00023773793,0.00012385975,0.00014813691,0.00027610577,0.00018844531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026833857,0.00020274469,0.961951,0.00002965526,0.00018474995,0.00083750667,0.00037307845,0.00008661683,0.029658692,0.000049618524,0.000091300564,0.0038518035],"study_design_scores_gemma":[0.00002472743,0.0002127662,0.99846005,0.0000025084787,0.00003413557,0.0006443305,0.000079878235,0.00010272799,0.00034481427,0.000033949702,0.000057146644,0.0000029299106],"about_ca_topic_score_codex":0.0028696463,"about_ca_topic_score_gemma":0.0027390525,"teacher_disagreement_score":0.0028696463,"about_ca_system_score_codex":0.00017208287,"about_ca_system_score_gemma":0.00018958125,"threshold_uncertainty_score":0.0074187517},"labels":[],"label_agreement":null},{"id":"W2028184718","doi":"10.1002/hup.868","title":"HTR2C haplotypes and antipsychotics‐induced weight gain: X‐linked multimarker analysis","year":2007,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Health Canada; National Alliance for Research on Schizophrenia and Depression","keywords":"Haplotype; Weight gain; Clozapine; Confounding; Antipsychotic; Internal medicine; Medicine; Polymorphism (computer science); Obesity; Genetics; Oncology; Gene; Body weight; Schizophrenia (object-oriented programming); Biology; Genotype; Psychiatry","score_opus":0.06937529939051093,"score_gpt":0.4694765214319927,"score_spread":0.4001012220414818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028184718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913967,0.00008321368,0.00054407533,0.0000128598585,0.0000023748382,0.000006890749,0.00012446914,0.0000061201085,0.00008026382],"genre_scores_gemma":[0.9994161,0.00001742865,0.0003237456,0.0000059118497,0.000006156286,0.00000930911,0.00013954222,0.0000031222708,0.0000786164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925464,0.0003510583,0.00006175916,0.00020402917,0.00006710033,0.00006149902],"domain_scores_gemma":[0.9981761,0.00083029753,0.0006120402,0.00017277965,0.000052171927,0.00015663696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012685021,0.00032082605,0.00041627066,0.00083244266,0.00032781644,0.00029762796,0.0003059635,0.00036675262,0.0041437973],"category_scores_gemma":[0.0015180896,0.00014414766,0.0005481894,0.00070885057,0.00022443949,0.00019044364,0.0003486606,0.00035673846,0.0002531863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023471941,0.00009977534,0.9858379,0.000018969844,0.00054165925,0.000306041,0.00008612893,0.00040816073,0.004700498,0.000062062616,0.000088626664,0.0055029676],"study_design_scores_gemma":[0.000088408065,0.0006848789,0.99459803,0.000004636918,0.00024675904,0.00086207985,0.0000562771,0.002324695,0.0008516098,0.00009354563,0.00018125959,0.000007826139],"about_ca_topic_score_codex":0.00074711716,"about_ca_topic_score_gemma":0.0007450567,"teacher_disagreement_score":0.0041437973,"about_ca_system_score_codex":0.00012731783,"about_ca_system_score_gemma":0.00015263162,"threshold_uncertainty_score":0.013862431},"labels":[],"label_agreement":null},{"id":"W2031176566","doi":"10.1002/hup.852","title":"Do formulation switches exacerbate existing medical illness? Results of an open‐label transition to orally disintegrating risperidone tablets","year":2007,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Risperidone; Medicine; Clinical Global Impression; Adverse effect; Schizophrenia (object-oriented programming); Side effect (computer science); Psychiatry; Internal medicine; Alternative medicine","score_opus":0.19966845533366856,"score_gpt":0.5499176975775033,"score_spread":0.35024924224383475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031176566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991806,0.0002522841,0.000056946188,0.000019236804,0.000011049244,0.00011128776,0.000119421435,0.000006364076,0.00024270048],"genre_scores_gemma":[0.9991053,0.00012109642,0.00014166655,0.000054036842,0.000015423897,0.00010787715,0.00024854293,0.0000024010062,0.00020366159],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99921453,0.00035940117,0.00009340591,0.00010152381,0.00011197555,0.000119114404],"domain_scores_gemma":[0.9976025,0.0011449403,0.0005577003,0.00028573975,0.00018289332,0.00022616296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014379827,0.0003087761,0.0011363854,0.00020986107,0.00022475491,0.00043996412,0.0002688394,0.00067122665,0.0020572452],"category_scores_gemma":[0.0028321338,0.00015620055,0.0011402707,0.00023316854,0.00033774477,0.0004550436,0.00025034256,0.00081707904,0.000318349],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6901693,0.04868318,0.050884087,0.0008812287,0.001560033,0.0008755759,0.0012808669,0.0012380838,0.046772465,0.00010762913,0.0011152982,0.1564323],"study_design_scores_gemma":[0.035472125,0.7261301,0.210579,0.00008312951,0.0014997406,0.0008355465,0.00055565394,0.0023266594,0.02045968,0.000104982966,0.0018876303,0.00006575753],"about_ca_topic_score_codex":0.00058185315,"about_ca_topic_score_gemma":0.0005866681,"teacher_disagreement_score":0.0020572452,"about_ca_system_score_codex":0.0003899626,"about_ca_system_score_gemma":0.000199542,"threshold_uncertainty_score":0.0076048374},"labels":[],"label_agreement":null},{"id":"W2039846441","doi":"10.1002/(sici)1099-1077(200004)15:3<199::aid-hup163>3.0.co;2-t","title":"The interaction between cytokines and neurotransmitters in depression and stress: possible mechanism of antidepressant treatments","year":2000,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Antidepressant; Mechanism (biology); Depression (economics); Animal models of depression; Psychology; Stress (linguistics); Chronic stress; Neuroscience; Pharmacology; Psychotherapist; Medicine; Hippocampus; Philosophy","score_opus":0.0501237004069989,"score_gpt":0.399544832697158,"score_spread":0.34942113229015914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039846441","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34610793,0.6043485,0.0076241908,0.013520689,0.004435254,0.00018986773,0.00074215734,0.0001049904,0.022926444],"genre_scores_gemma":[0.8494798,0.12587345,0.0025597678,0.0026661134,0.0039636292,0.00014304291,0.000275344,0.000010621256,0.015028193],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99987316,0.000050097955,0.0000128794045,0.000017151073,0.000019048726,0.000027665557],"domain_scores_gemma":[0.99981755,0.000076528995,0.000042822154,0.000013672028,0.000024724497,0.000024838435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003437364,0.00038092514,0.00064101914,0.00027887733,0.0002668239,0.0007373158,0.00045872285,0.0009804304,0.0044080056],"category_scores_gemma":[0.00033658455,0.00017976589,0.00040441263,0.00025447915,0.00045589657,0.00048704445,0.00029234088,0.0007965186,0.00045661526],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035648394,0.0014809534,0.01999454,0.0068108262,0.00062657864,0.008802721,0.0005787355,0.0015255366,0.53254974,0.036097977,0.01570959,0.3401744],"study_design_scores_gemma":[0.004824539,0.023950372,0.27918133,0.002542431,0.0033468744,0.01945328,0.0021418955,0.00709821,0.31213877,0.071974,0.27313676,0.00021156427],"about_ca_topic_score_codex":0.00041766677,"about_ca_topic_score_gemma":0.00048032653,"teacher_disagreement_score":0.0044080056,"about_ca_system_score_codex":0.00030952945,"about_ca_system_score_gemma":0.00035774772,"threshold_uncertainty_score":0.014746249},"labels":[],"label_agreement":null},{"id":"W2046097935","doi":"10.1002/hup.994","title":"St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double‐blind placebo‐controlled pilot trial","year":2008,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Placebo; Kava; Anxiety; Major depressive disorder; Beck Anxiety Inventory; Randomized controlled trial; Depression (economics); Antidepressant; Psychiatry; Double blind; Crossover study; Medicine; Hypericum; Psychology; Beck Depression Inventory; Internal medicine; Traditional medicine; Alternative medicine","score_opus":0.07076856362050964,"score_gpt":0.38460027298227434,"score_spread":0.3138317093617647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046097935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96517897,0.017048625,0.0010389849,0.0009805618,0.0010625389,0.012243484,0.00069424213,0.00014832958,0.0016042636],"genre_scores_gemma":[0.96992403,0.00873352,0.0033292207,0.0010038271,0.000848243,0.013349103,0.00043937183,0.000019883873,0.0023528286],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99867874,0.0007685047,0.00016374492,0.00014897334,0.00011773056,0.00012231048],"domain_scores_gemma":[0.9986437,0.0005958003,0.00030393607,0.000089455185,0.00009496409,0.00027207372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025948407,0.0012763056,0.0034962443,0.0007802229,0.00058692927,0.00090599025,0.0009783463,0.0026339116,0.007657279],"category_scores_gemma":[0.0031574892,0.00086253753,0.0019776018,0.00065157056,0.0014493191,0.0010071578,0.00047720113,0.0015778097,0.0007595667],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96766716,0.006337841,0.00024136034,0.003173168,0.0010211573,0.000059936552,0.00007278855,0.00012282921,0.0027562876,0.00009293873,0.0003433178,0.018111158],"study_design_scores_gemma":[0.9656105,0.033257578,0.00038949368,0.00004435883,0.0002492498,0.000017547125,0.000010898583,0.00007307984,0.00012430862,0.000027626704,0.00018963678,0.000005713633],"about_ca_topic_score_codex":0.0010731841,"about_ca_topic_score_gemma":0.002196747,"teacher_disagreement_score":0.007657279,"about_ca_system_score_codex":0.00056793384,"about_ca_system_score_gemma":0.0012653057,"threshold_uncertainty_score":0.025616169},"labels":[],"label_agreement":null},{"id":"W2046149237","doi":"10.1002/hup.1073","title":"Augmentation of atypical antipsychotics with valproic acid. An open‐label study for most difficult patients with schizophrenia","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Astellas Pharma; Asahi Kasei Pharma Corporation; GlaxoSmithKline; Dainippon Sumitomo Pharma; Pfizer","keywords":"Brief Psychiatric Rating Scale; Risperidone; Clozapine; Polypharmacy; Olanzapine; Schizophrenia (object-oriented programming); Clinical Global Impression; Medicine; Valproic Acid; Sedation; Internal medicine; Adverse effect; Global Assessment of Functioning; Positive and Negative Syndrome Scale; Psychiatry; Pediatrics; Psychosis; Anesthesia; Epilepsy","score_opus":0.08173536920673692,"score_gpt":0.4752615703145118,"score_spread":0.3935262011077749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046149237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829584,0.00056582387,0.00007763458,0.00009023771,0.00003583744,0.0005438798,0.00015869974,0.000010490117,0.00022153015],"genre_scores_gemma":[0.9960588,0.0009474263,0.00058081304,0.00021795003,0.00018139032,0.0009417255,0.00042504194,0.000006288797,0.0006405294],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992285,0.0003816097,0.00008531851,0.00009279033,0.000091757756,0.00012010825],"domain_scores_gemma":[0.99796116,0.00048280705,0.00048648886,0.00016114117,0.00011597435,0.0007924992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018334395,0.001575515,0.0019658746,0.0005758571,0.000657445,0.00077996077,0.000691733,0.0013595,0.0032737],"category_scores_gemma":[0.0017293377,0.000753383,0.0017200345,0.00037795395,0.0011096357,0.0010690872,0.00062602706,0.0021194266,0.00065195415],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74315435,0.15497231,0.015789099,0.001143464,0.0014039485,0.0006346422,0.0007228748,0.00080649205,0.023794854,0.00010123827,0.00076495763,0.056711737],"study_design_scores_gemma":[0.28741434,0.6802667,0.028228275,0.000044146145,0.00039265532,0.00033445246,0.00017610344,0.00061317306,0.0013553653,0.00009288534,0.0010282329,0.000053682135],"about_ca_topic_score_codex":0.0012020384,"about_ca_topic_score_gemma":0.002633889,"teacher_disagreement_score":0.0032737,"about_ca_system_score_codex":0.0007387759,"about_ca_system_score_gemma":0.0010048456,"threshold_uncertainty_score":0.010951579},"labels":[],"label_agreement":null},{"id":"W2052521137","doi":"10.1002/hup.932","title":"Adverse events in children and adolescents treated with antipsychotic medications","year":2008,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Antipsychotic; Odds ratio; Adverse effect; Psychiatry; Pediatrics; Retrospective cohort study; Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.03767934550095657,"score_gpt":0.41470536717201223,"score_spread":0.37702602167105564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052521137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987238,0.00041083983,0.000058053487,0.00004243365,0.000006864634,0.0000119336955,0.0004651187,0.0000024837811,0.0002784785],"genre_scores_gemma":[0.9985875,0.0004559039,0.00020607418,0.000033572163,0.000016981834,0.000015953447,0.0005598744,0.0000014288436,0.00012274121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999233,0.00017419601,0.000102194994,0.00010876836,0.00027211563,0.000109769484],"domain_scores_gemma":[0.9960861,0.00046115156,0.0027648164,0.00005918929,0.00026609577,0.00036265719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006262968,0.00020652308,0.00030998155,0.00070341816,0.00025829292,0.00034614519,0.00016551653,0.00027009365,0.0012294059],"category_scores_gemma":[0.0034325991,0.00019044944,0.00058417895,0.00056665856,0.00017383396,0.00024539756,0.00028450438,0.0005140929,0.00011319962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027148193,0.000008304965,0.99920803,0.000004558395,0.000023581744,0.00005119609,0.000016626294,0.00001186174,0.000027611977,0.0000041311673,0.0000400186,0.00057689275],"study_design_scores_gemma":[0.000005246029,0.000100538346,0.9985362,0.000012305411,0.000021774169,0.00095996633,0.00007667608,0.00005475697,0.0000558865,0.0000068580125,0.0001680138,0.0000018400054],"about_ca_topic_score_codex":0.003926742,"about_ca_topic_score_gemma":0.004813625,"teacher_disagreement_score":0.003926742,"about_ca_system_score_codex":0.00027579558,"about_ca_system_score_gemma":0.00036414943,"threshold_uncertainty_score":0.0078077912},"labels":[],"label_agreement":null},{"id":"W2058705456","doi":"10.1002/hup.883","title":"Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users","year":2007,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Methylphenidate; Medical prescription; Stimulant; Psychiatry; Prescription Drug Misuse; Medicine; Compliance (psychology); Substance misuse; Substance abuse; Attention deficit hyperactivity disorder; Psychology; Mental health; Pharmacology","score_opus":0.05042384498019385,"score_gpt":0.4307247282445931,"score_spread":0.38030088326439926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058705456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997458,0.00006265634,0.000019843415,0.000020735419,8.446325e-7,0.0000037977975,0.000060999384,0.0000015235563,0.00008387344],"genre_scores_gemma":[0.9997149,0.000053781667,0.00005418374,0.0000105520185,0.0000027534202,0.0000047807607,0.00010201929,8.745642e-7,0.00005612514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994474,0.00013980352,0.000107951055,0.00007207294,0.00016033599,0.00007239154],"domain_scores_gemma":[0.9979929,0.00043024073,0.0011026117,0.00006462153,0.00016973254,0.00023986671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005449067,0.00019422703,0.0003077692,0.0006237211,0.0003435742,0.00040241115,0.00022044593,0.00042543883,0.0011409259],"category_scores_gemma":[0.003837103,0.00027029304,0.00024003151,0.00057944324,0.00023690164,0.00040962294,0.0003846975,0.00044213227,0.00016434523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029774155,0.000024825358,0.9990282,0.0000032361497,0.000010081649,0.00002608112,0.0000739899,0.000008445356,0.00005878328,0.0000017896073,0.000017679458,0.0007172226],"study_design_scores_gemma":[0.0000021961916,0.000072010036,0.99938786,0.000002552953,0.00000499277,0.00021356615,0.00015067842,0.00010460776,0.000031167663,0.0000027977962,0.0000263525,0.0000012081075],"about_ca_topic_score_codex":0.0052438714,"about_ca_topic_score_gemma":0.007937855,"teacher_disagreement_score":0.0052438714,"about_ca_system_score_codex":0.00016867043,"about_ca_system_score_gemma":0.00024146566,"threshold_uncertainty_score":0.0104267},"labels":[],"label_agreement":null},{"id":"W2058914162","doi":"10.1002/hup.417","title":"Acute cholecystokinin effects on event‐related potentials in healthy volunteers","year":2002,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuroscience and Music Perception","field":"Neuroscience","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre; University of Ottawa","funders":"","keywords":"N100; Cholecystokinin; Placebo; Mood; Psychology; Audiology; Panic disorder; Event-related potential; Electroencephalography; Medicine; Internal medicine; Anxiety; Neuroscience; Psychiatry","score_opus":0.0659935334473063,"score_gpt":0.4351830708851802,"score_spread":0.3691895374378739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058914162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989479,0.0005031676,0.00016519793,0.00003337387,0.000016125796,0.000035377943,0.000039706985,0.000009650637,0.00024953802],"genre_scores_gemma":[0.99878937,0.0004405486,0.00027410168,0.00010111622,0.000037961858,0.00005364473,0.00009478873,0.000003440429,0.00020497107],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99984384,0.000051231793,0.000014691711,0.000036142654,0.000025728506,0.00002834625],"domain_scores_gemma":[0.9996873,0.0001111048,0.000057708003,0.000020534375,0.00002498746,0.00009841499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027677283,0.00040705068,0.00046550162,0.00013116981,0.00018522945,0.0002137377,0.000081585116,0.00036955476,0.0010571913],"category_scores_gemma":[0.0011512843,0.00020310796,0.00012868608,0.00007274042,0.00028030903,0.00018836447,0.00014851979,0.00039323056,0.00020095185],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22364412,0.0073041716,0.099942565,0.0006642863,0.00038946647,0.0028210771,0.00085829425,0.00033976624,0.5199334,0.00012106936,0.00064694346,0.14333484],"study_design_scores_gemma":[0.010684758,0.21358937,0.7396682,0.000045574972,0.00039170703,0.003383095,0.00034135216,0.0006404313,0.028032664,0.0001979881,0.0029799272,0.000045066565],"about_ca_topic_score_codex":0.00027199872,"about_ca_topic_score_gemma":0.00030808564,"teacher_disagreement_score":0.0010571913,"about_ca_system_score_codex":0.00008917543,"about_ca_system_score_gemma":0.0001292789,"threshold_uncertainty_score":0.0035366416},"labels":[],"label_agreement":null},{"id":"W2062291045","doi":"10.1002/hup.453","title":"Cognitive effects of long‐term benzodiazepine use in older adults","year":2002,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and related disorders","field":"Psychology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Benzodiazepine; Cognition; Discontinuation; Effects of sleep deprivation on cognitive performance; Audiology; Sedative; Psychology; Medicine; Affect (linguistics); Working memory; Psychiatry; Internal medicine","score_opus":0.04135031935559214,"score_gpt":0.4171162764878241,"score_spread":0.375765957132232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062291045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99934286,0.0003860531,0.00001456542,0.000023611976,0.000003012503,0.0000026900416,0.000037305654,0.0000011209785,0.00018885249],"genre_scores_gemma":[0.9996388,0.00015937796,0.000021641741,0.000029253977,0.000010057446,0.0000017149382,0.000055365887,4.088432e-7,0.000083397485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981445,0.000044812645,0.00002374022,0.000021232552,0.000059617032,0.000036271496],"domain_scores_gemma":[0.99879575,0.00020163799,0.000565408,0.000044920343,0.00017330884,0.00021889557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033783237,0.00027887226,0.00029466563,0.00042904483,0.00037035058,0.0002847068,0.00011367599,0.00023604173,0.0005552717],"category_scores_gemma":[0.0022254696,0.00013099007,0.00024984396,0.0002473175,0.00024419554,0.00024954617,0.00026994487,0.0003197198,0.00008566025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016010319,0.00029970834,0.9840147,0.00005171051,0.00014958909,0.0004201183,0.00035656575,0.000041058258,0.0019203114,0.000011901711,0.0000848301,0.011048548],"study_design_scores_gemma":[0.000010440615,0.00051422743,0.99896264,0.0000029581347,0.000027675182,0.0002568771,0.00006119145,0.000021370208,0.000083590225,0.000007498723,0.00004955571,0.0000019220186],"about_ca_topic_score_codex":0.0051056985,"about_ca_topic_score_gemma":0.010067973,"teacher_disagreement_score":0.0051056985,"about_ca_system_score_codex":0.00023919877,"about_ca_system_score_gemma":0.00016691582,"threshold_uncertainty_score":0.010151982},"labels":[],"label_agreement":null},{"id":"W2070405109","doi":"10.1002/hup.454","title":"Adverse effects of temazepam in older adults with chronic insomnia","year":2003,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and related disorders","field":"Psychology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Mental Health","keywords":"Temazepam; Insomnia; Adverse effect; Medicine; Placebo; Hypnotic; Anesthesia; Benzodiazepine; Internal medicine; Psychiatry","score_opus":0.012341032773999706,"score_gpt":0.3767591763358378,"score_spread":0.36441814356183805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070405109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963194,0.0026607523,0.0001056644,0.0000902928,0.000017061957,0.000050220588,0.00010736953,0.0000053986396,0.0006437522],"genre_scores_gemma":[0.9984621,0.0009341862,0.00022911192,0.00011466947,0.000034203422,0.000027061647,0.00008917922,8.62956e-7,0.00010870705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993956,0.00021402085,0.00011837187,0.00004491724,0.00018662566,0.00004048148],"domain_scores_gemma":[0.9969037,0.00095799484,0.0015745591,0.00006332838,0.00027403908,0.00022633045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009468826,0.00015559212,0.00047736897,0.00020355775,0.0002638431,0.00016583357,0.000084415595,0.00022998928,0.0011792463],"category_scores_gemma":[0.0030667128,0.000091565475,0.00045442441,0.00019914893,0.00015932307,0.00012664244,0.00017938133,0.00028855746,0.0000974174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011736653,0.00060739665,0.9031342,0.0008561048,0.00055181765,0.00059691496,0.00035134822,0.00020376444,0.0057881363,0.000027457821,0.0005165272,0.07562972],"study_design_scores_gemma":[0.00059483136,0.01172239,0.98326886,0.0000948579,0.00035449848,0.001812028,0.00012335269,0.00023228412,0.00083378324,0.000024506977,0.0009319123,0.0000068599065],"about_ca_topic_score_codex":0.0006392977,"about_ca_topic_score_gemma":0.0013215735,"teacher_disagreement_score":0.0011792463,"about_ca_system_score_codex":0.00021159726,"about_ca_system_score_gemma":0.00021244593,"threshold_uncertainty_score":0.0050076246},"labels":[],"label_agreement":null},{"id":"W2072357163","doi":"10.1002/hup.648","title":"Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder","year":2004,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; St. Joseph’s Healthcare Hamilton; University of Toronto; McMaster University; St. Joseph's Hospital","funders":"Pfizer","keywords":"Sertraline; Placebo; Clinical Global Impression; Psychology; Anxiety; Internal medicine; Depression (economics); Generalized anxiety disorder; Medicine; Psychiatry; Antidepressant","score_opus":0.13531036234617175,"score_gpt":0.504781174446511,"score_spread":0.3694708121003393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072357163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727124,0.0016254871,0.000059961563,0.000081561644,0.000026481057,0.000021953107,0.0001203534,0.000005000279,0.00078782975],"genre_scores_gemma":[0.9991365,0.00029934823,0.000048202408,0.00010955589,0.00003085363,0.000017046583,0.00012327841,0.0000016834613,0.00023359645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977463,0.00010642493,0.000020534855,0.000030058634,0.0000362502,0.00003213535],"domain_scores_gemma":[0.99930596,0.00021940752,0.00026477288,0.00002509875,0.000039211453,0.00014548468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045543938,0.00019676113,0.00036945436,0.00016331421,0.00008563729,0.0001734659,0.000103575214,0.00024564358,0.0026933786],"category_scores_gemma":[0.001920097,0.000098090226,0.00020570554,0.000118876356,0.00018965862,0.00014349954,0.00011701537,0.00016117808,0.00028721668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060230706,0.0022749263,0.82093364,0.0003703176,0.0005512357,0.002449331,0.0005982408,0.00046418296,0.028114166,0.00021527882,0.0019101342,0.08188786],"study_design_scores_gemma":[0.0011353906,0.0069520166,0.9876702,0.00003336365,0.00009214247,0.0023357365,0.00017617668,0.00021118714,0.0004925326,0.00008074207,0.0008072325,0.000013343301],"about_ca_topic_score_codex":0.0003129307,"about_ca_topic_score_gemma":0.0003650396,"teacher_disagreement_score":0.0026933786,"about_ca_system_score_codex":0.0001494339,"about_ca_system_score_gemma":0.00012169788,"threshold_uncertainty_score":0.009010255},"labels":[],"label_agreement":null},{"id":"W2077355116","doi":"10.1002/hup.816","title":"Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory","year":2006,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Behavioral and Psychological Studies","field":"Psychology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Institute on Drug Abuse","keywords":"Craving; Reinforcement; Nicotine; Psychology; Smoke; Anticipation (artificial intelligence); Smoking cessation; Psychological intervention; Clinical psychology; Addiction; Medicine; Social psychology; Psychiatry; Chemistry; Computer science","score_opus":0.13438987261527538,"score_gpt":0.4556974017737499,"score_spread":0.3213075291584745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077355116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997811,0.000022881446,0.000072795636,0.000009341008,0.000001419381,0.000007793727,0.000013184082,0.0000024012193,0.00008919414],"genre_scores_gemma":[0.99882776,0.00006328948,0.0006910358,0.000033006385,0.000006128482,0.000026009868,0.00005688391,0.0000035961991,0.0002924124],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997477,0.00012791905,0.000008120788,0.000039105224,0.000052650044,0.00002451099],"domain_scores_gemma":[0.99865806,0.0006181984,0.00022989589,0.0001222375,0.000055089517,0.0003164839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051832054,0.00033072606,0.0003169946,0.0001699189,0.00019170163,0.00033010144,0.00013188733,0.00032873466,0.0018797732],"category_scores_gemma":[0.002087403,0.00030410202,0.0001531436,0.00006866537,0.0005021258,0.00012259308,0.0001901207,0.0005690153,0.00014550348],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062316127,0.019412678,0.27346775,0.00013930301,0.00034025137,0.00040604165,0.0006616533,0.00093377917,0.6092023,0.00021992698,0.00030141376,0.032598812],"study_design_scores_gemma":[0.0007253642,0.055223856,0.89322096,0.000018790828,0.0001480195,0.00082521903,0.00018085144,0.004819631,0.043869693,0.00036919385,0.00054836395,0.00005004306],"about_ca_topic_score_codex":0.0012337446,"about_ca_topic_score_gemma":0.0023233183,"teacher_disagreement_score":0.0018797732,"about_ca_system_score_codex":0.00018256826,"about_ca_system_score_gemma":0.00022290742,"threshold_uncertainty_score":0.006288469},"labels":[],"label_agreement":null},{"id":"W2082771012","doi":"10.1002/hup.1135","title":"Protracted, dose‐dependent weight loss after addition of ziprasidone to a stable regimen of clozapine","year":2010,"lang":"en","type":"letter","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Ziprasidone; Olanzapine; Citation; Psychology; Medicine; Library science; Schizophrenia (object-oriented programming); Psychiatry; Computer science","score_opus":0.04178586303216055,"score_gpt":0.42338770986154084,"score_spread":0.3816018468293803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082771012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85269403,0.004704772,0.0054463744,0.09998036,0.011737811,0.00060387515,0.0012523435,0.0009212098,0.022659237],"genre_scores_gemma":[0.9428834,0.0017030534,0.0016875544,0.03376445,0.004177118,0.00011990897,0.00048797188,0.000059697253,0.015116901],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99968565,0.000066816945,0.000046162186,0.00005516314,0.000084029634,0.00006225851],"domain_scores_gemma":[0.99841917,0.0008462727,0.00024410871,0.000113421425,0.00011870876,0.0002583882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049936055,0.0009095363,0.0011414265,0.00032252877,0.0006843954,0.00050415064,0.0009990138,0.0056445873,0.0012431749],"category_scores_gemma":[0.003683045,0.00033422254,0.0013567939,0.00028108968,0.00046511908,0.00046952354,0.0002480446,0.006264465,0.0005344317],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033219755,0.0029888463,0.016593305,0.0005200932,0.0006808784,0.77305406,0.0004906274,0.001208084,0.036197033,0.0016096659,0.038635116,0.09480263],"study_design_scores_gemma":[0.014981005,0.03191837,0.30487555,0.00026738178,0.001251966,0.5163196,0.00048034583,0.016628804,0.030455386,0.004587502,0.077934064,0.0003001138],"about_ca_topic_score_codex":0.0027890112,"about_ca_topic_score_gemma":0.0069253733,"teacher_disagreement_score":0.0056445873,"about_ca_system_score_codex":0.0012504249,"about_ca_system_score_gemma":0.0006360418,"threshold_uncertainty_score":0.009072542},"labels":[],"label_agreement":null},{"id":"W2083693117","doi":"10.1002/hup.710","title":"Differential effects of chronic lithium and valproate on brain activation in healthy volunteers","year":2005,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Lithium (medication); Medicine; Neuroscience; Internal medicine; Pharmacology; Psychology","score_opus":0.026072353661381064,"score_gpt":0.4145243416145304,"score_spread":0.38845198795314934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083693117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986993,0.00068125565,0.000070955066,0.000025472911,0.000011379464,0.00006213406,0.000087694636,0.0000073500214,0.00035433762],"genre_scores_gemma":[0.9986381,0.00031988334,0.00020015899,0.00011046273,0.000032766737,0.0001366294,0.00019582518,0.0000038341873,0.00036232118],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99977964,0.00007886236,0.00002373086,0.00004411206,0.000040528565,0.000033205062],"domain_scores_gemma":[0.99968994,0.000077251585,0.00007117748,0.000019903979,0.000029984314,0.00011177495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033830616,0.00028496017,0.00059352175,0.00019021226,0.00022542407,0.00025373415,0.00011420914,0.00045082046,0.0014334087],"category_scores_gemma":[0.0006931967,0.0001510886,0.00014535344,0.000112831585,0.00040724166,0.00016227078,0.0001703186,0.00023005049,0.00023305429],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32587567,0.0071337535,0.14779939,0.0009567777,0.00050279754,0.0011720097,0.00081693,0.00014291379,0.45499745,0.00010962817,0.0007089872,0.05978367],"study_design_scores_gemma":[0.0054224343,0.09903523,0.8737385,0.000036853296,0.00024464715,0.0010434361,0.00025106192,0.00025998778,0.018525178,0.000103207516,0.0013173586,0.000022096285],"about_ca_topic_score_codex":0.0006345562,"about_ca_topic_score_gemma":0.0013418155,"teacher_disagreement_score":0.0014334087,"about_ca_system_score_codex":0.0001841849,"about_ca_system_score_gemma":0.00018677721,"threshold_uncertainty_score":0.0047951937},"labels":[],"label_agreement":null},{"id":"W2084291311","doi":"10.1002/hup.747","title":"Diazepam-induced prospective memory impairment and its relation to retrospective memory, attention, and arousal","year":2005,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Cognitive Functions and Memory","field":"Psychology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto; York University","funders":"","keywords":"Arousal; Psychology; Recall; Prospective memory; Audiology; Retrospective memory; Diazepam; Cognitive psychology; Developmental psychology; Cognition; Explicit memory; Episodic memory; Psychiatry; Neuroscience; Medicine","score_opus":0.04416885291669423,"score_gpt":0.42300482590563016,"score_spread":0.3788359729889359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084291311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99952924,0.00022103079,0.00008226537,0.000008592858,0.0000020506577,0.000007126651,0.000013800178,0.000004069079,0.0001319518],"genre_scores_gemma":[0.99956673,0.00017651654,0.0000739136,0.000011227968,0.000004378089,0.000004765578,0.000035433633,8.204922e-7,0.00012614935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999094,0.000025412874,0.00000813103,0.000009639993,0.000029276162,0.000018152066],"domain_scores_gemma":[0.9996375,0.00007953213,0.00015888983,0.000033775472,0.000024079036,0.00006626938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015749436,0.00028047292,0.00023040059,0.0002229127,0.000100403406,0.00012884005,0.00011838067,0.00015406251,0.0006919443],"category_scores_gemma":[0.00089400215,0.0001204471,0.00010807234,0.00007690885,0.00026874253,0.00014254123,0.00016395033,0.000404114,0.00009517065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034852352,0.004064571,0.1556899,0.00031609903,0.00020362518,0.0026534568,0.0003571839,0.00026990933,0.73584765,0.00016447414,0.00016032401,0.06542046],"study_design_scores_gemma":[0.0004514106,0.030261667,0.90055454,0.000013696285,0.00011265424,0.0040917895,0.00010010583,0.0004944578,0.06321937,0.00013898795,0.0005475973,0.000013729974],"about_ca_topic_score_codex":0.00032045774,"about_ca_topic_score_gemma":0.00042202865,"teacher_disagreement_score":0.0006919443,"about_ca_system_score_codex":0.00014644873,"about_ca_system_score_gemma":0.00009616071,"threshold_uncertainty_score":0.002314806},"labels":[],"label_agreement":null},{"id":"W2089644403","doi":"10.1002/hup.435","title":"Pharmacotherapy of anxious disorders","year":2002,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Panic disorder; Anxiety; Pharmacotherapy; Social anxiety; Psychiatry; Anxiety disorder; Psychology; Panic; Clinical psychology; Epidemiology; Psychotherapist; Medicine; Internal medicine","score_opus":0.16020570993694463,"score_gpt":0.5426876525794043,"score_spread":0.3824819426424597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089644403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063761265,0.9980459,0.000112894144,0.00016396907,0.00008106173,0.000014315766,0.00001627091,0.000007908902,0.0009200647],"genre_scores_gemma":[0.0042990367,0.99438727,0.0003242602,0.00034466895,0.00013861833,0.000023291648,0.000032891377,0.000001684068,0.0004483255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973696,0.000082676226,0.00004171869,0.00003640327,0.00008543278,0.00001677617],"domain_scores_gemma":[0.9998078,0.00009364096,0.000050568775,0.000008495762,0.000027783783,0.000011830165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004025963,0.00064246595,0.0013607565,0.00156508,0.00020167127,0.00043377953,0.0005332797,0.0006174245,0.0029847496],"category_scores_gemma":[0.0007195896,0.00014757889,0.0006167126,0.0011403608,0.00019593851,0.0003736323,0.00039143104,0.0007850485,0.0007379843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016516364,0.00017739947,0.0002394734,0.02348706,0.000331442,0.00023818178,0.000036836085,0.00013593196,0.0012438714,0.0005074395,0.0073328363,0.9661044],"study_design_scores_gemma":[0.001019654,0.0018069292,0.020477556,0.030926894,0.002659418,0.011878685,0.00025100546,0.0005072211,0.0040530306,0.004332174,0.9220197,0.00006773836],"about_ca_topic_score_codex":0.0006651275,"about_ca_topic_score_gemma":0.0020083466,"teacher_disagreement_score":0.0029847496,"about_ca_system_score_codex":0.00024778224,"about_ca_system_score_gemma":0.00046396552,"threshold_uncertainty_score":0.00998503},"labels":[],"label_agreement":null},{"id":"W2092531023","doi":"10.1002/hup.445","title":"Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement","year":2003,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and related disorders","field":"Psychology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Zopiclone; Library science; Medicine; Psychiatry; Insomnia","score_opus":0.11872431532709739,"score_gpt":0.49614200888124904,"score_spread":0.37741769355415167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092531023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002139518,0.990617,0.00010776984,0.0067247916,0.0010808718,0.000040894716,0.00013065484,0.0000068546037,0.0010772592],"genre_scores_gemma":[0.0023187976,0.9899418,0.00093242124,0.004638679,0.0006161724,0.00007197501,0.00017138048,0.0000043381488,0.0013044792],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9990158,0.00015757034,0.000232813,0.000104501814,0.0003880522,0.000101318896],"domain_scores_gemma":[0.9971102,0.0009936892,0.00047151127,0.00004085533,0.0011722404,0.00021147869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044242195,0.00083871314,0.0032070775,0.00253322,0.0009410044,0.0016707248,0.0033430976,0.0040690284,0.0034332045],"category_scores_gemma":[0.0035415373,0.00045659178,0.0019177244,0.0034543031,0.0012911956,0.001245161,0.0009394976,0.003547358,0.0009271619],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014521383,0.000116813135,0.00045273761,0.04521639,0.00064640807,0.00033442763,0.00015419848,0.00032953607,0.001134685,0.002864161,0.18002294,0.7672756],"study_design_scores_gemma":[0.0014942142,0.00030711095,0.0047177644,0.05571093,0.002484756,0.0007273175,0.00027963732,0.00018411489,0.000653839,0.0017079555,0.93165845,0.000073772026],"about_ca_topic_score_codex":0.09470108,"about_ca_topic_score_gemma":0.2540456,"teacher_disagreement_score":0.90529895,"about_ca_system_score_codex":0.0057161367,"about_ca_system_score_gemma":0.022808246,"threshold_uncertainty_score":0.18829972},"labels":[],"label_agreement":null},{"id":"W2093963332","doi":"10.1002/hup.1143","title":"Relative association of treatment‐emergent adverse events with quality of life of patients with schizophrenia: <i>post hoc</i> analysis from a 3‐year observational study","year":2010,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Memorial University of Newfoundland","funders":"","keywords":"Tardive dyskinesia; Adverse effect; Medicine; Observational study; Post-hoc analysis; Dyskinesia; Sexual dysfunction; Extrapyramidal symptoms; Schizophrenia (object-oriented programming); Quality of life (healthcare); Internal medicine; Antipsychotic; Association (psychology); Psychiatry; Psychology; Parkinson's disease; Disease","score_opus":0.07694083267069264,"score_gpt":0.4372907074699322,"score_spread":0.3603498747992396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093963332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979771,0.00081972784,0.00034040326,0.000035656114,0.00001837819,0.00007377001,0.0006081463,0.00000721953,0.000119636905],"genre_scores_gemma":[0.9978794,0.00015341805,0.00034856904,0.000047645095,0.000029764458,0.00014504303,0.001315309,0.0000042973684,0.0000766282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99265105,0.0047572963,0.0007541362,0.00080472184,0.0006657098,0.00036707617],"domain_scores_gemma":[0.978913,0.009844975,0.0071426104,0.0017000623,0.0013371727,0.0010621565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012846703,0.00061937066,0.0014035365,0.00073336356,0.0004944319,0.00110319,0.0006643549,0.0007953391,0.00127358],"category_scores_gemma":[0.013124928,0.0003744294,0.0072346367,0.00078016333,0.000526155,0.0006156115,0.00088485546,0.0010891686,0.00010822486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025713315,0.0003490348,0.9539325,0.00027477456,0.012932061,0.00012433818,0.00012286828,0.00070460985,0.0009854785,0.00002653399,0.00028173684,0.004552793],"study_design_scores_gemma":[0.0011046639,0.006542653,0.9865545,0.000030599414,0.003975554,0.0001295911,0.000096373384,0.0009209832,0.00033937168,0.000025956659,0.0002535321,0.000026287235],"about_ca_topic_score_codex":0.0033052973,"about_ca_topic_score_gemma":0.004158978,"teacher_disagreement_score":0.012846703,"about_ca_system_score_codex":0.00071102736,"about_ca_system_score_gemma":0.0010500291,"threshold_uncertainty_score":0.06794071},"labels":[],"label_agreement":null},{"id":"W2095301214","doi":"10.1002/hup.1086","title":"Effect of metabolic blockade on the psychoactive effects of dextromethorphan","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Dextromethorphan; Dextrorphan; Quinidine; Pharmacology; Euphoriant; Active metabolite; Pharmacokinetics; CYP2D6; Metabolite; Levorphanol; Pharmacodynamics; Drug; Medicine; Internal medicine; Cytochrome P450; Antagonist; Metabolism; Receptor; (+)-Naloxone","score_opus":0.0356026045328353,"score_gpt":0.47899230181106217,"score_spread":0.44338969727822686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095301214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984854,0.0005624657,0.00025069044,0.00004487411,0.000014811803,0.000028601567,0.000090908,0.0000140814145,0.00050823257],"genre_scores_gemma":[0.9988054,0.00027679867,0.0003313039,0.000030062532,0.000015908714,0.000019188528,0.00008161282,0.0000042585034,0.00043537322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987423,0.00004783304,0.000009036241,0.00002678803,0.000021204904,0.000020877962],"domain_scores_gemma":[0.99979335,0.00006189212,0.00006134216,0.000022437185,0.000014391084,0.000046584308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001342599,0.00031122292,0.00031330297,0.000075526994,0.00011180524,0.00013604906,0.00011132883,0.00019142346,0.00343135],"category_scores_gemma":[0.00053510076,0.000116115596,0.00015430569,0.00006605656,0.00019899842,0.00012635777,0.00011432039,0.00039306586,0.00026847798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029484114,0.000887183,0.0026552642,0.00018963906,0.00009946507,0.00015365086,0.000048326354,0.00012218193,0.9506597,0.000054206066,0.000090342364,0.015555928],"study_design_scores_gemma":[0.00390233,0.16255605,0.19085893,0.000042717398,0.0004148737,0.002111263,0.00016666517,0.0023126868,0.6336627,0.000114379625,0.0038303607,0.000027057675],"about_ca_topic_score_codex":0.0002662686,"about_ca_topic_score_gemma":0.0005854682,"teacher_disagreement_score":0.00343135,"about_ca_system_score_codex":0.00010480679,"about_ca_system_score_gemma":0.000103277474,"threshold_uncertainty_score":0.01147902},"labels":[],"label_agreement":null},{"id":"W2098344591","doi":"10.1002/hup.949","title":"Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double‐blind, placebo‐controlled studies","year":2008,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Duloxetine; Tolerability; Placebo; Internal medicine; Anxiety; Psychology; Nausea; Adverse effect; Medicine; Somatic anxiety; Generalized anxiety disorder; Randomized controlled trial; Anesthesia; Psychiatry","score_opus":0.07486002951016098,"score_gpt":0.43663988467652665,"score_spread":0.3617798551663657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098344591","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35757083,0.63188577,0.0023708486,0.00053469895,0.0005423871,0.0028267775,0.0027624017,0.00020251835,0.0013037883],"genre_scores_gemma":[0.86821604,0.123618305,0.0025432413,0.0007793559,0.0004545652,0.0021065187,0.0019298663,0.000032204447,0.00031982703],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99271554,0.0041403873,0.0016695516,0.0006382768,0.0006539752,0.0001822567],"domain_scores_gemma":[0.9908268,0.0045838016,0.0032507463,0.0004054288,0.00066834094,0.00026488674],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.010601329,0.0017361781,0.009840569,0.0018349435,0.00034256355,0.0016406884,0.00092873786,0.0016739864,0.001796982],"category_scores_gemma":[0.014416178,0.0009201259,0.011551353,0.002112218,0.0007572038,0.0006562681,0.00066511665,0.00072769524,0.0001782963],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36760157,0.00054904254,0.012320786,0.05137082,0.51010954,0.00018259839,0.00011355372,0.0011518797,0.002644261,0.000076476,0.0010004484,0.052879058],"study_design_scores_gemma":[0.28997603,0.019216226,0.04684039,0.002600538,0.63685894,0.00028837798,0.00010706294,0.0006746234,0.0008254186,0.00020272074,0.0023280235,0.00008164494],"about_ca_topic_score_codex":0.0011550555,"about_ca_topic_score_gemma":0.0025359,"teacher_disagreement_score":0.99015945,"about_ca_system_score_codex":0.00081000203,"about_ca_system_score_gemma":0.0009931797,"threshold_uncertainty_score":0.056065857},"labels":[],"label_agreement":null},{"id":"W2099385540","doi":"10.1002/hup.596","title":"Effects of modafinil on cognitive and meta‐cognitive performance","year":2004,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Defence Research and Development Canada","funders":"","keywords":"Modafinil; Psychology; Cognition; Vigilance (psychology); Effects of sleep deprivation on cognitive performance; Placebo; Mood; Sleep deprivation; Audiology; Clinical psychology; Psychiatry; Medicine; Cognitive psychology","score_opus":0.1110857118431437,"score_gpt":0.461557397347303,"score_spread":0.3504716855041593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099385540","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16922054,0.7933872,0.013791326,0.0025902523,0.002474714,0.0030910275,0.007823824,0.002121642,0.005499443],"genre_scores_gemma":[0.9202477,0.057295833,0.013457089,0.0010584557,0.0004323102,0.0028758654,0.0024617861,0.00023391971,0.0019369754],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9908999,0.0053845523,0.0013214536,0.0012476948,0.00090700865,0.00023945073],"domain_scores_gemma":[0.98604923,0.010510086,0.0016576635,0.00090852566,0.0005590558,0.00031544387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016445307,0.0037011534,0.012906918,0.0053915824,0.000810748,0.0031516715,0.0026572214,0.0018283102,0.005299685],"category_scores_gemma":[0.024557171,0.0011393549,0.03257143,0.004193362,0.00070937665,0.0017156482,0.0014213849,0.002353665,0.00047446677],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017639754,0.0000885006,0.004605107,0.03114549,0.9361034,0.00011027393,0.000106246596,0.0015041851,0.00066637713,0.00017596819,0.0007069293,0.0071477313],"study_design_scores_gemma":[0.0063139326,0.0015109719,0.012846238,0.001305013,0.96861804,0.00015495351,0.00009092625,0.0037362745,0.0006494486,0.0009857427,0.0036793754,0.00010903505],"about_ca_topic_score_codex":0.004640024,"about_ca_topic_score_gemma":0.0070966803,"teacher_disagreement_score":0.016445307,"about_ca_system_score_codex":0.001814645,"about_ca_system_score_gemma":0.001947732,"threshold_uncertainty_score":0.08697212},"labels":[],"label_agreement":null},{"id":"W2102232838","doi":"10.1002/hup.959","title":"Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open‐label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone","year":2008,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Olanzapine; Risperidone; Quetiapine; Polypharmacy; Antipsychotic; Clozapine; Medicine; Schizophrenia (object-oriented programming); Refractory (planetary science); Internal medicine; Atypical antipsychotic; Adverse effect; Psychiatry; Psychology; Pharmacology","score_opus":0.10420626554927495,"score_gpt":0.4711181981429769,"score_spread":0.3669119325937019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102232838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986412,0.0005343337,0.000112679045,0.00009743035,0.000051793497,0.00030893247,0.0000646616,0.00001012764,0.00017876913],"genre_scores_gemma":[0.9976393,0.00043337265,0.00067674613,0.00016233421,0.00015547995,0.0004567322,0.0001982066,0.0000045259135,0.0002734187],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99917245,0.00046491157,0.000102572914,0.00011326079,0.00008719923,0.00005971789],"domain_scores_gemma":[0.9984078,0.0005063108,0.00041305996,0.00012292199,0.00009394972,0.00045593033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016867948,0.0012809065,0.0018552417,0.0004502907,0.00039425018,0.00062965025,0.00052175636,0.0010337303,0.0018567682],"category_scores_gemma":[0.0025092117,0.00058355456,0.0015672335,0.00026885656,0.00072722696,0.00063864276,0.00037931692,0.0013579484,0.00030692588],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9173322,0.026428536,0.004963292,0.00044248198,0.0012552609,0.0001226744,0.00015562522,0.0005663855,0.009997214,0.000044324726,0.00020402815,0.038487993],"study_design_scores_gemma":[0.6063358,0.37781286,0.0126206,0.000025069521,0.0005265312,0.0001356774,0.000041697767,0.0011133406,0.0010222177,0.00005582609,0.00028001834,0.0000303417],"about_ca_topic_score_codex":0.0006611733,"about_ca_topic_score_gemma":0.0016798452,"teacher_disagreement_score":0.0018567682,"about_ca_system_score_codex":0.0006500831,"about_ca_system_score_gemma":0.0008385801,"threshold_uncertainty_score":0.008920729},"labels":[],"label_agreement":null},{"id":"W2104759830","doi":"10.1002/hup.1227","title":"Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent‐onset bipolar disorder","year":2011,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Bipolar disorder; Psychiatry; Psychotropic medication; Pediatrics; Comorbidity; Medical prescription; Medicaid; Lithium (medication); Mental health; Pharmacology","score_opus":0.058856367615107076,"score_gpt":0.4062285793716007,"score_spread":0.3473722117564936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104759830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908435,0.0003783843,0.000023522069,0.000055080036,0.0000044069757,0.0000032814141,0.00019887245,0.0000015414744,0.000250612],"genre_scores_gemma":[0.99909055,0.00035757376,0.00008754687,0.000022290806,0.000008747564,0.000004800049,0.00033370635,0.0000012113863,0.00009359325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997329,0.00006257099,0.00003070688,0.000047629826,0.000059898757,0.000066143606],"domain_scores_gemma":[0.9977458,0.0003123224,0.0014830716,0.000042517608,0.00013105816,0.00028520523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027290813,0.0001850298,0.00019063296,0.0006373479,0.00035391602,0.00043198015,0.00019140319,0.00029850466,0.0019591528],"category_scores_gemma":[0.0018844537,0.0002427822,0.00033716406,0.0006335655,0.00018899702,0.00025098474,0.00032447826,0.0007100594,0.00012284724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014114398,0.000009107703,0.9994555,0.0000030781132,0.000010729213,0.000039200942,0.000017861135,0.000009446517,0.00004415297,0.0000041878266,0.000023431761,0.0003691792],"study_design_scores_gemma":[9.249901e-7,0.000013631003,0.99970585,0.000005044284,0.0000052384225,0.00015352717,0.000035550176,0.000023556193,0.000018962135,0.0000020094747,0.000035256333,4.308156e-7],"about_ca_topic_score_codex":0.014500949,"about_ca_topic_score_gemma":0.027911793,"teacher_disagreement_score":0.014500949,"about_ca_system_score_codex":0.0004401642,"about_ca_system_score_gemma":0.00053901627,"threshold_uncertainty_score":0.028833091},"labels":[],"label_agreement":null},{"id":"W2115657575","doi":"10.1002/hup.933","title":"Orally disintegrating olanzapine and potential differences in treatment‐emergent weight gain","year":2008,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Memorial University of Newfoundland","funders":"","keywords":"Olanzapine; Weight gain; Medicine; Action (physics); Psychology; Randomized controlled trial; Pharmacology; Body weight; Psychiatry; Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.14258962182082963,"score_gpt":0.49568079603468274,"score_spread":0.3530911742138531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115657575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015343366,0.99747986,0.000056166107,0.00011063924,0.000056931505,0.000008319336,0.000019992998,0.000004008607,0.0007298288],"genre_scores_gemma":[0.014729899,0.98415065,0.0002810201,0.00014386183,0.00005848993,0.000020836838,0.000051919673,0.0000014642654,0.0005617621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997607,0.00007631708,0.00005073913,0.00003103612,0.000064700376,0.000016525499],"domain_scores_gemma":[0.99977976,0.00010659348,0.00006894003,0.0000035339513,0.000030725834,0.000010484622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059769076,0.00041865796,0.0011521846,0.0009786129,0.00009518753,0.00048299888,0.0005423261,0.0005353356,0.0023765315],"category_scores_gemma":[0.00083473464,0.00013069065,0.00070050516,0.0010418246,0.00016434334,0.00034785547,0.00023253026,0.0005405165,0.00035533088],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015269662,0.00014938817,0.0008376765,0.024165647,0.00042257938,0.0005504095,0.000056545185,0.0001101845,0.0030941586,0.00078438205,0.0032014828,0.9651006],"study_design_scores_gemma":[0.0032615473,0.006303727,0.06370404,0.025443977,0.006924967,0.02410114,0.0007297623,0.00078236865,0.012289438,0.0043266043,0.85197735,0.00015515368],"about_ca_topic_score_codex":0.0011394667,"about_ca_topic_score_gemma":0.0028410044,"teacher_disagreement_score":0.0023765315,"about_ca_system_score_codex":0.00040159604,"about_ca_system_score_gemma":0.00048481653,"threshold_uncertainty_score":0.007950246},"labels":[],"label_agreement":null},{"id":"W2119461820","doi":"10.1002/hup.766","title":"Patterns of simultaneous polysubstance use in drug using university students","year":2006,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":275,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Dalhousie University","funders":"","keywords":"Polysubstance dependence; Cannabis; Psilocybin; MDMA; Context (archaeology); Amphetamine; Drug; Methylphenidate; Pharmacology; Alcohol; Psychiatry; Psychology; Hallucinogen; Medicine; Substance abuse; Chemistry; Internal medicine; Attention deficit hyperactivity disorder; Dopamine","score_opus":0.07716607449409428,"score_gpt":0.420089419819193,"score_spread":0.3429233453250987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119461820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99976164,0.00005138533,0.00002241218,0.000012494116,0.0000010771962,0.0000036163249,0.000024906827,0.0000017311517,0.00012071736],"genre_scores_gemma":[0.9997546,0.00005988475,0.00003489684,0.000008563222,0.0000018344244,0.0000047327194,0.000035659752,0.0000010844326,0.00009876528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915445,0.00022474777,0.000120778976,0.00013260724,0.00021958399,0.00014778094],"domain_scores_gemma":[0.9973271,0.0005107441,0.0012543417,0.0001315593,0.0002314224,0.00054484844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043650498,0.00023471875,0.0004621593,0.0017871251,0.0006453407,0.00087722536,0.00041368918,0.00054565066,0.0022350939],"category_scores_gemma":[0.0026413552,0.00037886263,0.0003534543,0.0013612527,0.0005498651,0.00046196106,0.0009273867,0.0005259429,0.00034576934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013505678,0.00010528228,0.9887094,0.000025354113,0.000036207835,0.00015804636,0.0022885904,0.000016983258,0.002869673,0.000026286603,0.000037906135,0.005591153],"study_design_scores_gemma":[0.0000017980284,0.00014113843,0.99712604,0.0000073320493,0.000009274538,0.00027899077,0.0020507514,0.0000699985,0.00020610134,0.000011719398,0.00009094437,0.00000586804],"about_ca_topic_score_codex":0.0063207913,"about_ca_topic_score_gemma":0.012940088,"teacher_disagreement_score":0.0063207913,"about_ca_system_score_codex":0.00034470134,"about_ca_system_score_gemma":0.00033517435,"threshold_uncertainty_score":0.012567997},"labels":[],"label_agreement":null},{"id":"W2121605598","doi":"10.1002/1099-1077(200010)15:7<479::aid-hup206>3.0.co;2-5","title":"Quantitative EEG methods and measures in human psychopharmacological research","year":2000,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"EEG and Brain-Computer Interfaces","field":"Neuroscience","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Royal Ottawa Mental Health Centre","funders":"","keywords":"Electroencephalography; Profiling (computer programming); Statistical analysis; Computer science; Psychology; Neuroscience; Statistics; Mathematics","score_opus":0.33804569854435645,"score_gpt":0.6142408501454625,"score_spread":0.276195151601106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121605598","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008626282,0.06553623,0.9055557,0.0025577152,0.0010981241,0.00082586147,0.00079337304,0.00067452044,0.0143321315],"genre_scores_gemma":[0.15834309,0.048086345,0.7784072,0.0017660996,0.0023228186,0.005017977,0.00059449126,0.00040782016,0.0050541465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9864654,0.008002852,0.0010616066,0.0012813591,0.0030195236,0.00016915529],"domain_scores_gemma":[0.9743765,0.017985739,0.0025180425,0.002562447,0.0021789847,0.0003783362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018524393,0.0013193135,0.0010972761,0.003963776,0.00059996144,0.002629106,0.0016527473,0.0017350056,0.0028841293],"category_scores_gemma":[0.043539517,0.00068008364,0.00057703914,0.0042473003,0.004255086,0.0023150777,0.0018131024,0.0024397888,0.0011010871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042980222,0.00035184468,0.0073991213,0.0046766647,0.00026647974,0.00035673438,0.0015859405,0.005229947,0.01854568,0.27509597,0.01217327,0.67388856],"study_design_scores_gemma":[0.00023480412,0.002324726,0.056103986,0.0033240465,0.00023939958,0.003405617,0.0014891695,0.02107673,0.01564357,0.6724821,0.22329527,0.00038058567],"about_ca_topic_score_codex":0.0010565671,"about_ca_topic_score_gemma":0.0007375565,"teacher_disagreement_score":0.018524393,"about_ca_system_score_codex":0.00095967785,"about_ca_system_score_gemma":0.0016124102,"threshold_uncertainty_score":0.097967505},"labels":[],"label_agreement":null},{"id":"W2130846979","doi":"10.1002/hup.595","title":"Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross‐over study","year":2004,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Donepezil; Clinical Global Impression; Placebo; Clozapine; Schizophrenia (object-oriented programming); Internal medicine; Psychosis; Antipsychotic; Psychology; Medicine; Anesthesia; Psychiatry; Dementia","score_opus":0.07556202214836083,"score_gpt":0.49482608847920817,"score_spread":0.41926406633084734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130846979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473625,0.0021045404,0.0004154455,0.00013483032,0.00019909382,0.0014540644,0.00029196183,0.00007872478,0.0005849983],"genre_scores_gemma":[0.9914562,0.0027128006,0.0010191079,0.0004077308,0.00032758998,0.0019897108,0.00052099285,0.000019026209,0.001546808],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998754,0.00044380996,0.00015044547,0.00026869623,0.00016051413,0.00022245386],"domain_scores_gemma":[0.99853563,0.00026772497,0.0003451427,0.00020022359,0.00017549931,0.00047576305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020756805,0.0018777578,0.005666457,0.00088207884,0.00078806194,0.0008460887,0.0009859331,0.0018653834,0.0028144498],"category_scores_gemma":[0.001487176,0.00090931496,0.0020897496,0.00056497403,0.0011326942,0.00093053235,0.00048773809,0.0017419643,0.0008578721],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86942786,0.06059409,0.0022317106,0.0011097568,0.0018900485,0.00021916606,0.0002509269,0.00027026667,0.021250654,0.000051588282,0.00048315333,0.04222081],"study_design_scores_gemma":[0.563557,0.41783658,0.013151221,0.000056382785,0.0012191355,0.00015776069,0.00006687823,0.00047048047,0.0023231388,0.00007006974,0.0010315912,0.00005975194],"about_ca_topic_score_codex":0.0017116804,"about_ca_topic_score_gemma":0.0028743807,"teacher_disagreement_score":0.005666457,"about_ca_system_score_codex":0.0009462901,"about_ca_system_score_gemma":0.0012656335,"threshold_uncertainty_score":0.010977387},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2134860896","doi":"10.1002/hup.1158","title":"Efficacy of reboxetine in adults with attention‐deficit/hyperactivity disorder: A randomized, placebo‐controlled clinical trial","year":2010,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Reboxetine; Placebo; Clinical Global Impression; Rating scale; Psychology; Global Assessment of Functioning; Irritability; Anxiety; Attention deficit hyperactivity disorder; Randomized controlled trial; Clinical trial; Hamilton Anxiety Rating Scale; Psychiatry; Clinical psychology; Medicine; Internal medicine; Reuptake inhibitor; Developmental psychology; Schizophrenia (object-oriented programming)","score_opus":0.043170996251071146,"score_gpt":0.4453527279245991,"score_spread":0.402181731673528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134860896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.947312,0.03238627,0.0009962688,0.0015555689,0.0016153269,0.011454502,0.001544587,0.00023141853,0.0029039027],"genre_scores_gemma":[0.96258956,0.014772835,0.002686181,0.0018510731,0.0014913789,0.011834227,0.0009997778,0.000026232814,0.003748613],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992067,0.00038971697,0.0001126975,0.00014870339,0.000072116214,0.000070102644],"domain_scores_gemma":[0.9992549,0.00024435125,0.00021692527,0.00005002278,0.00006628136,0.0001675607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021983227,0.001057358,0.003366176,0.00041922068,0.0004891297,0.00081593456,0.000814898,0.0026518197,0.007322026],"category_scores_gemma":[0.0021657434,0.0005773767,0.0012480969,0.00035986424,0.00074109616,0.00079634174,0.00025751514,0.0017242327,0.00083247793],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96792597,0.0047038835,0.00042602545,0.0021044926,0.0009823239,0.00005436867,0.000042284177,0.00007949353,0.0030558284,0.00006563363,0.00059034256,0.019969312],"study_design_scores_gemma":[0.97153866,0.026154842,0.0011170589,0.000058539852,0.00036665425,0.000024110228,0.000008674808,0.00008322985,0.00018775284,0.00002845505,0.00042615263,0.0000057699285],"about_ca_topic_score_codex":0.00070404354,"about_ca_topic_score_gemma":0.0019085003,"teacher_disagreement_score":0.007322026,"about_ca_system_score_codex":0.00047750532,"about_ca_system_score_gemma":0.0009320741,"threshold_uncertainty_score":0.024494588},"labels":[],"label_agreement":null},{"id":"W2134906904","doi":"10.1002/hup.1159","title":"The role of nicotine content information in smokers' subjective responses to nicotine and placebo inhalers","year":2010,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Nicotine; Placebo; Craving; Inhaler; Medicine; Abstinence; Smoking cessation; Nicotine withdrawal; Psychology; Addiction; Psychiatry; Internal medicine; Asthma; Alternative medicine","score_opus":0.04181029149686435,"score_gpt":0.40989604821622433,"score_spread":0.36808575671936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134906904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851173,0.0002305188,0.00045170507,0.000039883613,0.0000074150266,0.00004511955,0.000034980192,0.000004818272,0.00067385193],"genre_scores_gemma":[0.999081,0.00009857428,0.0004928973,0.000034889195,0.000015603428,0.000030059819,0.000044519984,0.0000032427718,0.00019930926],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99760723,0.0013859157,0.00014540312,0.00014413722,0.0006360706,0.00008112391],"domain_scores_gemma":[0.9852989,0.010791358,0.0023545579,0.0006107599,0.0005272197,0.00041726022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003429736,0.0002993588,0.00033393202,0.00022819272,0.00013912666,0.00067097397,0.00021472554,0.00045066277,0.0018952596],"category_scores_gemma":[0.0163227,0.00021687071,0.00029830777,0.00011389321,0.00047570353,0.0003719543,0.00035862377,0.00041428788,0.00011632073],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07024429,0.007678869,0.31597635,0.001565152,0.0011448091,0.0002464271,0.005314632,0.0014395971,0.4386862,0.0005030023,0.00020896456,0.15699174],"study_design_scores_gemma":[0.0006007839,0.012950481,0.95893323,0.000080979145,0.00043110587,0.00014503144,0.0005079724,0.0017667689,0.023872942,0.00028806744,0.00038736287,0.000035144465],"about_ca_topic_score_codex":0.00032398457,"about_ca_topic_score_gemma":0.00028711758,"teacher_disagreement_score":0.003429736,"about_ca_system_score_codex":0.00015410366,"about_ca_system_score_gemma":0.00021141274,"threshold_uncertainty_score":0.018138409},"labels":[],"label_agreement":null},{"id":"W2135042408","doi":"10.1002/hup.2431","title":"Olanzapine as the ideal “trip terminator”? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance‐related psychotic symptoms","year":2015,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; Public Health Agency of Canada; World Health Organization","keywords":"Olanzapine; Psychiatry; Medicine; Psychology; Schizophrenia (object-oriented programming)","score_opus":0.11187454134655671,"score_gpt":0.47933637828394826,"score_spread":0.36746183693739154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135042408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484396,0.00076255243,0.00064663927,0.0010326621,0.000021708393,0.00014422253,0.00047742843,0.000005650338,0.002065151],"genre_scores_gemma":[0.99640214,0.0010693258,0.0007921163,0.0004719223,0.000015483221,0.0002352803,0.00023797176,0.000009467718,0.0007663661],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99598193,0.0028880837,0.00028056902,0.00017817445,0.00039505755,0.00027626034],"domain_scores_gemma":[0.9851702,0.009905371,0.0034899325,0.00022378708,0.0009185859,0.00029210592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057967776,0.00014832093,0.00023142062,0.0014216359,0.0009587251,0.0015981718,0.00042364842,0.00047316734,0.0019627512],"category_scores_gemma":[0.018477514,0.00016629008,0.00021284189,0.0014544388,0.0014727532,0.001825088,0.0016932108,0.0005487909,0.0001870829],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000366923,0.000068894275,0.10485849,0.0022541564,0.000028128332,0.0017897317,0.8475549,0.000062409716,0.0020995364,0.0020392027,0.0018739797,0.037003584],"study_design_scores_gemma":[0.000007220968,0.00007527127,0.05329306,0.0007763347,0.000020524223,0.00067545776,0.9374876,0.00011929443,0.00046860205,0.00023974237,0.0068160845,0.000020843794],"about_ca_topic_score_codex":0.00510619,"about_ca_topic_score_gemma":0.008544274,"teacher_disagreement_score":0.0057967776,"about_ca_system_score_codex":0.0019798006,"about_ca_system_score_gemma":0.0021085849,"threshold_uncertainty_score":0.030656636},"labels":[],"label_agreement":null},{"id":"W2140543061","doi":"10.1002/hup.452","title":"Are there gender differences in the prescribing of hypnotic medications for insomnia?","year":2002,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and related disorders","field":"Psychology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; University of Calgary; Saint John Regional Hospital; University of British Columbia Hospital; University Health Network; University of Toronto; Centre for Addiction and Mental Health; Toronto Western Hospital; Lakehead University","funders":"","keywords":"Zopiclone; Insomnia; Pharmacy; Medicine; Medical prescription; Psychiatry; Hypnotic; Marital status; Family medicine; Population; Pharmacology","score_opus":0.17472325250014586,"score_gpt":0.44678380161715897,"score_spread":0.2720605491170131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140543061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754286,0.0007491008,0.000053698346,0.00037413934,0.000015635162,0.0000036234999,0.00018115573,0.0000015257853,0.0010783869],"genre_scores_gemma":[0.999226,0.0002840899,0.000036084035,0.000091588096,0.0000107637625,0.0000018619897,0.00006697368,0.0000012880982,0.00028142545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961865,0.000091456044,0.00003225077,0.00005262126,0.00010366253,0.00010128601],"domain_scores_gemma":[0.9980819,0.0006172858,0.000823822,0.000056946155,0.00016573012,0.00025424737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006156165,0.000087093096,0.00015816181,0.0005246751,0.00025140675,0.00028550514,0.00016850953,0.00026523863,0.003086574],"category_scores_gemma":[0.003914556,0.00017585017,0.00023692333,0.00054092676,0.00037221395,0.00030219162,0.00021952513,0.00020248609,0.00032139305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001689798,0.000027909611,0.99163,0.000018057905,0.000036296962,0.00011508846,0.0010155068,0.000013065712,0.00044453633,0.000068835274,0.00015787822,0.0063037598],"study_design_scores_gemma":[0.000002391465,0.000039307608,0.9989812,0.000005472594,0.0000065054573,0.00014791518,0.00058011746,0.000025379357,0.000030172841,0.000029744344,0.00014989889,0.000001863292],"about_ca_topic_score_codex":0.027180506,"about_ca_topic_score_gemma":0.049193256,"teacher_disagreement_score":0.027180506,"about_ca_system_score_codex":0.00042137885,"about_ca_system_score_gemma":0.00046121443,"threshold_uncertainty_score":0.054044545},"labels":[],"label_agreement":null},{"id":"W2140710408","doi":"10.1002/hup.1069","title":"Is moderate substance use associated with altered executive functioning in a population‐based sample of young adults?","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft","keywords":"Impulsivity; Ecstasy; Psychology; Stroop effect; Cannabis; Cognition; Neuropsychology; Executive functions; Population; Clinical psychology; Cognitive skill; Young adult; Prospective memory; Developmental psychology; Psychiatry; Medicine","score_opus":0.07747693258983618,"score_gpt":0.4045433607698549,"score_spread":0.32706642818001874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140710408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999723,0.00007300706,0.000014905226,0.000016648386,0.0000021660342,0.0000031067364,0.000061581915,9.135975e-7,0.00010468696],"genre_scores_gemma":[0.9997887,0.00004439112,0.000016707809,0.000017661845,0.0000039324955,0.0000033193126,0.00008232095,5.3440306e-7,0.000042470794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997155,0.000059395323,0.000047359677,0.000072102106,0.00005790424,0.000047699275],"domain_scores_gemma":[0.99892247,0.0001835469,0.00053194806,0.00006335654,0.00008534723,0.00021334132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041149982,0.00020853226,0.00044232004,0.0008216614,0.00040311686,0.00067332626,0.00019674782,0.00047049104,0.001682024],"category_scores_gemma":[0.001714409,0.00030572558,0.00030670152,0.0006702141,0.00037042366,0.00031706746,0.00035690243,0.00038494213,0.00025265242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055528522,0.000025202848,0.99912196,0.000004436712,0.000028311202,0.000071586604,0.000066332366,0.0000034194522,0.00018276341,0.0000034215466,0.000016893351,0.0004201761],"study_design_scores_gemma":[0.0000026751939,0.00006125832,0.99951756,0.0000019259273,0.000009402477,0.0002248363,0.00012278443,0.000015503054,0.00001561675,0.0000059299723,0.000021665817,9.156346e-7],"about_ca_topic_score_codex":0.004488327,"about_ca_topic_score_gemma":0.00780713,"teacher_disagreement_score":0.004488327,"about_ca_system_score_codex":0.00017506554,"about_ca_system_score_gemma":0.00022747672,"threshold_uncertainty_score":0.008924365},"labels":[],"label_agreement":null},{"id":"W2141432085","doi":"10.1002/hup.693","title":"A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI‐cycle) to psychiatric disorders—focus on magnetic resonance spectroscopy (MRS) studies","year":2005,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Bipolar disorder; Inositol; Panic disorder; Schizophrenia (object-oriented programming); Psychiatry; Lithium (medication); Phosphatidylinositol; Psychology; Second messenger system; Neuroscience; Medicine; Internal medicine; Signal transduction; Biology; Biochemistry; Anxiety; Receptor","score_opus":0.03522219291729117,"score_gpt":0.43569766055542647,"score_spread":0.4004754676381353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141432085","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022573731,0.99721414,0.00010330711,0.0002192393,0.00027104604,0.000005616091,0.00001924681,0.0000061436303,0.0019356143],"genre_scores_gemma":[0.0006264183,0.99788314,0.00021397205,0.00019245375,0.00021172277,0.000005377487,0.000025853324,0.000001311252,0.00083968125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986255,0.000027573602,0.000028560064,0.000024111694,0.000046242403,0.000010945566],"domain_scores_gemma":[0.99976426,0.00010879569,0.00003793869,0.0000065457007,0.000058711532,0.000023758075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028669112,0.00075522636,0.0012379611,0.0023176477,0.00026525356,0.000768043,0.0007420393,0.00065114873,0.00582848],"category_scores_gemma":[0.0005127146,0.00024354963,0.00031664906,0.0036051443,0.0003122801,0.0013676722,0.0003939414,0.000824274,0.0029854362],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011526187,0.00008667726,0.00033848317,0.03153705,0.0001371531,0.0008114378,0.00015788755,0.00037193508,0.0047227517,0.0030501715,0.061844002,0.89682716],"study_design_scores_gemma":[0.000013877091,0.00008915338,0.002040452,0.005946195,0.00010641036,0.002504428,0.00015160699,0.00006557822,0.0005006463,0.0015020915,0.98706216,0.000017487531],"about_ca_topic_score_codex":0.001053321,"about_ca_topic_score_gemma":0.00217535,"teacher_disagreement_score":0.00582848,"about_ca_system_score_codex":0.00052884925,"about_ca_system_score_gemma":0.00089925196,"threshold_uncertainty_score":0.01949817},"labels":[],"label_agreement":null},{"id":"W2146640192","doi":"10.1002/hup.2351","title":"Abnormal maximal finger tapping in abstinent cannabis users","year":2013,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cannabis; Finger tapping; Tapping; Effects of cannabis; Audiology; Index finger; Psychology; Medicine; Psychiatry","score_opus":0.05107438364688988,"score_gpt":0.40660332734212573,"score_spread":0.35552894369523586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146640192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997342,0.000066046945,0.000033064014,0.0000052649607,0.0000010631492,0.000004203393,0.000027611137,0.0000029144055,0.00012559819],"genre_scores_gemma":[0.9997745,0.00003206307,0.00004822344,0.000005354017,0.0000024242568,0.0000021645928,0.00003641794,8.5937813e-7,0.00009812844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981767,0.000027556538,0.000022184258,0.00004083887,0.00006005187,0.000031734264],"domain_scores_gemma":[0.9991673,0.0001984583,0.0003264189,0.00004007521,0.00008673574,0.0001810694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017613225,0.00032589535,0.00037369464,0.0010028644,0.00034272706,0.0003619444,0.00021577365,0.0003422179,0.0026036706],"category_scores_gemma":[0.0015059328,0.00019484229,0.00014604113,0.0003691442,0.00036291635,0.00022559676,0.00026655284,0.00022830152,0.00022696545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012647451,0.00019374245,0.9677683,0.00005455894,0.00005938951,0.0017551647,0.00044199632,0.00003973618,0.022231815,0.000026785292,0.00005456003,0.006109225],"study_design_scores_gemma":[0.000007977209,0.00033479492,0.99705684,0.0000027951705,0.000010993545,0.0017873744,0.000096642834,0.000068355424,0.0005820013,0.000013003841,0.0000365143,0.0000027766732],"about_ca_topic_score_codex":0.002958097,"about_ca_topic_score_gemma":0.00412168,"teacher_disagreement_score":0.002958097,"about_ca_system_score_codex":0.00016969805,"about_ca_system_score_gemma":0.00012686315,"threshold_uncertainty_score":0.008710206},"labels":[],"label_agreement":null},{"id":"W2147012135","doi":"10.1002/hup.1021","title":"The SNRI venlafaxine improves emotional unawareness in patients with post‐stroke depression","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venlafaxine; Alexithymia; Fluoxetine; Psychology; Depression (economics); Toronto Alexithymia Scale; Stroke (engine); Reuptake inhibitor; Psychiatry; Post-stroke depression; Internal medicine; Medicine; Anesthesia; Serotonin; Antidepressant; Anxiety; Activities of daily living","score_opus":0.016311950886870746,"score_gpt":0.3726536744238983,"score_spread":0.35634172353702753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147012135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842876,0.0010318954,0.00003641074,0.000043707387,0.000012143912,0.000029080156,0.000031412335,0.000007938443,0.00037859572],"genre_scores_gemma":[0.99891984,0.0005670924,0.00013452578,0.000079928126,0.000026666945,0.000018083812,0.0000898357,5.208949e-7,0.00016355391],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9998739,0.000040360428,0.000024312181,0.000014060348,0.000023415918,0.000024000514],"domain_scores_gemma":[0.99973255,0.00007116964,0.000113434566,0.000008789892,0.000019591691,0.00005443948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024827744,0.0002768602,0.0007521889,0.00010491739,0.00018820827,0.00026410082,0.00012414329,0.0002688353,0.0011492376],"category_scores_gemma":[0.000908301,0.00013166656,0.00034901508,0.00010673245,0.000116917785,0.00013400741,0.000083507985,0.00028904318,0.00013543358],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13401267,0.014683634,0.38974014,0.0016569096,0.0044098296,0.0009963312,0.00061625126,0.0018563481,0.045655385,0.00011059762,0.0024016013,0.4038603],"study_design_scores_gemma":[0.012818744,0.061353844,0.9185027,0.000092422444,0.0008887498,0.0012558206,0.00018899111,0.0010119072,0.0025676403,0.000066810055,0.001229903,0.000022434037],"about_ca_topic_score_codex":0.00055535685,"about_ca_topic_score_gemma":0.002123743,"teacher_disagreement_score":0.0011492376,"about_ca_system_score_codex":0.0001461863,"about_ca_system_score_gemma":0.0001454713,"threshold_uncertainty_score":0.0038445592},"labels":[],"label_agreement":null},{"id":"W2147643260","doi":"10.1002/hup.420","title":"Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients","year":2002,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bipolar disorder; Lithium (medication); Mood stabilizer; Internal medicine; Endocrinology; Treatment of bipolar disorder; Mood; Psychology; Sodium; Inositol; Chemistry; Medicine; Psychiatry; Mania; Receptor","score_opus":0.03286246463283928,"score_gpt":0.3658692815645677,"score_spread":0.33300681693172846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147643260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683964,0.00197222,0.00005453594,0.00008211938,0.000014355917,0.000016253787,0.00006559189,0.000018641545,0.0009366901],"genre_scores_gemma":[0.99850297,0.00081176695,0.00016131431,0.00010686994,0.00001612973,0.000014861871,0.00012785742,0.000002298538,0.00025587546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999262,0.000021331236,0.000016535427,0.000009434099,0.000013190334,0.000013260233],"domain_scores_gemma":[0.99985325,0.0000222203,0.000064398686,0.000006269538,0.000016536254,0.00003726211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012582346,0.000174154,0.0003575031,0.0002861076,0.00028351092,0.00025552118,0.000107193366,0.00025359966,0.00095497275],"category_scores_gemma":[0.00046870255,0.000100231315,0.00014285254,0.00023731151,0.00012831371,0.00014379156,0.000097972545,0.00018634512,0.00013644907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015725838,0.0015850186,0.6601462,0.00068039173,0.0005382917,0.0024740775,0.0009644349,0.00030647937,0.08789374,0.00023256605,0.0019073571,0.22754562],"study_design_scores_gemma":[0.00043722772,0.0036092605,0.9898543,0.000056103898,0.00014690428,0.0018950694,0.0002937961,0.0002595854,0.002208004,0.00009632463,0.0011355163,0.000007960442],"about_ca_topic_score_codex":0.0020056188,"about_ca_topic_score_gemma":0.0063112625,"teacher_disagreement_score":0.0020056188,"about_ca_system_score_codex":0.00032661136,"about_ca_system_score_gemma":0.00020675616,"threshold_uncertainty_score":0.0039879084},"labels":[],"label_agreement":null},{"id":"W2149936913","doi":"10.1002/hup.966","title":"Targeted scoring criteria reduce variance in global impressions","year":2008,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Variance (accounting); Psychology; Reliability (semiconductor); Anxiety; Clinical trial; Clinical psychology; Medicine; Psychiatry","score_opus":0.09156338908345499,"score_gpt":0.47542234471080275,"score_spread":0.38385895562734773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149936913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68093765,0.00243109,0.27468494,0.0014086516,0.0011595533,0.018712822,0.0012483266,0.001308937,0.018108029],"genre_scores_gemma":[0.8748764,0.00034264746,0.10845278,0.000618821,0.0004443844,0.0131581705,0.0007807419,0.00027246037,0.0010535534],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.870062,0.090315334,0.014385664,0.0039553945,0.02023214,0.0010494173],"domain_scores_gemma":[0.6943254,0.21060705,0.032533556,0.027628891,0.03329975,0.0016054236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.097487144,0.0010437185,0.002265183,0.0017329571,0.0006795504,0.0011939325,0.000992365,0.00064136565,0.0019878868],"category_scores_gemma":[0.27601793,0.00041834757,0.0014755445,0.0014549555,0.0011325064,0.0012262879,0.002664395,0.0010684106,0.0006518802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014252718,0.0017602075,0.15195699,0.0030167857,0.0023458938,0.00022082462,0.0077078203,0.008785309,0.01768986,0.004928389,0.016547197,0.770788],"study_design_scores_gemma":[0.006662552,0.020116376,0.8479396,0.0012622741,0.0017171348,0.000672795,0.001699966,0.051686466,0.021599652,0.0209936,0.02509536,0.0005541142],"about_ca_topic_score_codex":0.000326797,"about_ca_topic_score_gemma":0.0010257092,"teacher_disagreement_score":0.097487144,"about_ca_system_score_codex":0.0009348472,"about_ca_system_score_gemma":0.0009531461,"threshold_uncertainty_score":0.5155674},"labels":[],"label_agreement":null},{"id":"W2150086017","doi":"10.1002/hup.2288","title":"Exploratory study on association of genetic variation in <i>TBC1D1</i> with antipsychotic‐induced weight gain","year":2013,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Case Western Reserve University; Canadian Institutes of Health Research; Bristol-Myers Squibb","keywords":"Clozapine; Antipsychotic; Allele; Internal medicine; Olanzapine; Weight gain; Genetic association; Endocrinology; Single-nucleotide polymorphism; Biology; Medicine; Schizophrenia (object-oriented programming); Genetics; Genotype; Gene; Body weight; Psychiatry","score_opus":0.027168791714442204,"score_gpt":0.36202328297702846,"score_spread":0.33485449126258626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150086017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986046,0.000060796894,0.0005759157,0.000026481106,0.000003872412,0.000026443555,0.00034801074,0.000009668911,0.00034415038],"genre_scores_gemma":[0.9989053,0.000018681118,0.0004691149,0.000026915694,0.0000049289893,0.00004046177,0.00029966998,0.000006398259,0.00022865864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884903,0.0006216718,0.00005293364,0.00029344027,0.000099993056,0.00008278845],"domain_scores_gemma":[0.9979685,0.00095155626,0.0004937172,0.0002141455,0.00012251316,0.00024956404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001269197,0.0005121766,0.00035976098,0.00059580046,0.000444784,0.00031446107,0.0003566849,0.00043995742,0.0031178216],"category_scores_gemma":[0.0025881908,0.00016792792,0.00094990426,0.0007242482,0.0002775685,0.00014460554,0.0003830496,0.00044732395,0.00032583694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023429934,0.00031609077,0.9817377,0.00004765862,0.0009268999,0.00088124286,0.00048008485,0.00018024415,0.008700786,0.00016797158,0.00027163728,0.0039467565],"study_design_scores_gemma":[0.00008859275,0.0029388843,0.99286216,0.000010700373,0.00033850715,0.0010396534,0.00033059722,0.00088425545,0.0007087833,0.00011736577,0.00066819513,0.000012258379],"about_ca_topic_score_codex":0.0023693398,"about_ca_topic_score_gemma":0.0015101712,"teacher_disagreement_score":0.0031178216,"about_ca_system_score_codex":0.00019262233,"about_ca_system_score_gemma":0.00037184387,"threshold_uncertainty_score":0.010430157},"labels":[],"label_agreement":null},{"id":"W2153999053","doi":"10.1002/hup.434","title":"Dextro‐amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study","year":2002,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Amphetamine; Phosphomonoesters; Dopamine; Endocrinology; Internal medicine; Medicine; Energy metabolism","score_opus":0.10172467838576102,"score_gpt":0.4365998499269413,"score_spread":0.3348751715411803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153999053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925774,0.00022599853,0.00010066291,0.000018674331,0.0000062680515,0.000020308875,0.000041132666,0.000005689806,0.0003235776],"genre_scores_gemma":[0.99906546,0.0001370237,0.00011279875,0.00005516,0.000012201031,0.000020558798,0.00008166834,0.0000025013683,0.00051272946],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990344,0.00002869036,0.0000073652936,0.000022956512,0.000019458279,0.000018114222],"domain_scores_gemma":[0.9998449,0.000023192444,0.000038715887,0.000015475376,0.00002058836,0.000057090994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017580173,0.00036844035,0.00032357004,0.0001934495,0.00041058034,0.00026785795,0.0000826251,0.00038777728,0.0018134933],"category_scores_gemma":[0.0004517025,0.00025429745,0.00012851367,0.00008073734,0.0002837037,0.00015019988,0.00015680089,0.00035701046,0.00040505236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05394842,0.008213621,0.43510616,0.0003871774,0.00028966504,0.004011665,0.0017658952,0.00014865627,0.45023763,0.00016994882,0.0008001685,0.04492089],"study_design_scores_gemma":[0.00083788915,0.043543328,0.92557424,0.00001835646,0.00021614112,0.005871463,0.00053167646,0.00035082534,0.02070452,0.00010366175,0.0022213503,0.00002651546],"about_ca_topic_score_codex":0.000818539,"about_ca_topic_score_gemma":0.0012990433,"teacher_disagreement_score":0.0018134933,"about_ca_system_score_codex":0.00011684712,"about_ca_system_score_gemma":0.00013884634,"threshold_uncertainty_score":0.0060667396},"labels":[],"label_agreement":null},{"id":"W2161905994","doi":"10.1002/hup.612","title":"Comorbidity in bipolar disorder: a framework for rational treatment selection","year":2004,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University of British Columbia; University Health Network","funders":"","keywords":"Bipolar disorder; Schema (genetic algorithms); Bipolar illness; Psychology; Comorbidity; Interim; Psychotherapist; Psychiatry; Mood; Treatment of bipolar disorder; Mood disorders; Clinical psychology; Computer science; Mania; Political science; Information retrieval","score_opus":0.12455225914556964,"score_gpt":0.5153120266579259,"score_spread":0.3907597675123562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161905994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019798921,0.88955164,0.030811675,0.06217493,0.0015910543,0.00040393285,0.00011361337,0.00008778507,0.01328548],"genre_scores_gemma":[0.05700613,0.8545304,0.06546733,0.014786624,0.0042154635,0.0010360876,0.00033498835,0.00003706584,0.0025858295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99501747,0.0031224177,0.00060753606,0.0002493085,0.0008885627,0.00011468591],"domain_scores_gemma":[0.9963903,0.0024369447,0.00040663918,0.00010816414,0.0004654174,0.00019259441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01004358,0.00089482754,0.0031086833,0.003044199,0.00081919134,0.0031214147,0.0019457362,0.002295317,0.0021920581],"category_scores_gemma":[0.0114971595,0.000492374,0.0010052134,0.0024615033,0.0026640124,0.0033124415,0.0019771482,0.0043693134,0.0009317438],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016582139,0.00011325249,0.0022778502,0.0044301446,0.00017253008,0.00049393304,0.00038692864,0.0022621765,0.00021082736,0.121044904,0.029159304,0.8392824],"study_design_scores_gemma":[0.0004581051,0.00047938683,0.007593705,0.026567219,0.0004527071,0.0047142585,0.0017125624,0.0074349004,0.00035634605,0.4918195,0.45823625,0.00017498907],"about_ca_topic_score_codex":0.003037324,"about_ca_topic_score_gemma":0.0044751964,"teacher_disagreement_score":0.01004358,"about_ca_system_score_codex":0.0040025185,"about_ca_system_score_gemma":0.006414829,"threshold_uncertainty_score":0.053116143},"labels":[],"label_agreement":null},{"id":"W2164852716","doi":"10.1002/hup.1077","title":"The association between concurrent psychotropic medications and self‐reported adherence with taking a mood stabilizer in bipolar disorder","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto","funders":"","keywords":"Pill; Mood; Mood stabilizer; Dose; Medicine; Bipolar disorder; Psychiatry; Internal medicine; Pharmacology","score_opus":0.041736593923146104,"score_gpt":0.42737531153427755,"score_spread":0.38563871761113144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164852716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992539,0.0003311497,0.00005092006,0.000048089878,0.000004827145,0.0000048854104,0.00007053798,0.0000022215845,0.00023341144],"genre_scores_gemma":[0.9996013,0.00010457383,0.000081496415,0.000020020412,0.000012109041,0.000004820343,0.00008714603,0.0000010236563,0.00008740663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906343,0.00035453323,0.00017059721,0.00008465236,0.00024799365,0.00007893222],"domain_scores_gemma":[0.9935789,0.002232368,0.0031742195,0.00018053931,0.00042946576,0.0004045542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010397736,0.00015570936,0.00032535673,0.0004317204,0.000251366,0.00042648136,0.00017531293,0.0003724768,0.0020016218],"category_scores_gemma":[0.007790588,0.00021187041,0.00033847275,0.00047701423,0.00019392633,0.00023823896,0.00023504056,0.000589642,0.00016563082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019916183,0.00007241871,0.9967885,0.000012483075,0.000099333876,0.000021796735,0.000044615364,0.00003677892,0.00011157965,0.0000061289493,0.000046674173,0.0025606027],"study_design_scores_gemma":[0.000009164063,0.0001225224,0.9994649,0.0000043786786,0.000024544213,0.00010099604,0.000027863209,0.00018974431,0.000020366137,0.000008925998,0.000025055842,0.0000015143555],"about_ca_topic_score_codex":0.0023344662,"about_ca_topic_score_gemma":0.0040766317,"teacher_disagreement_score":0.0023344662,"about_ca_system_score_codex":0.00023575629,"about_ca_system_score_gemma":0.00016735391,"threshold_uncertainty_score":0.0066960454},"labels":[],"label_agreement":null},{"id":"W2168982155","doi":"10.1002/hup.858","title":"Cerebro‐ and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications","year":2007,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Antipsychotic; Ziprasidone; Aripiprazole; Schizophrenia (object-oriented programming); Internal medicine; Odds ratio; Incidence (geometry); Stroke (engine); Myocardial infarction; Antipsychotic Agent; Cardiology; Retrospective cohort study; Cardiomyopathy; Psychiatry; Pediatrics; Heart failure","score_opus":0.02795511633994579,"score_gpt":0.39755387301401124,"score_spread":0.36959875667406544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168982155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987759,0.00062082114,0.000048419945,0.00004685634,0.000005015322,0.000003712937,0.0002465613,0.0000023239197,0.00025037766],"genre_scores_gemma":[0.99915946,0.00042678794,0.00007961845,0.00002114148,0.000015351856,0.0000037943612,0.00023471637,6.908925e-7,0.000058427806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996044,0.000086694694,0.00006194833,0.000054060125,0.00013801355,0.000054960274],"domain_scores_gemma":[0.9984707,0.00021431172,0.0010286286,0.00004258873,0.00009863995,0.00014506036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040680956,0.00015624375,0.00019172703,0.00075060397,0.00027094554,0.00030565183,0.00010947946,0.00021846106,0.0013033542],"category_scores_gemma":[0.0021141034,0.00014075768,0.00034824436,0.00054461986,0.00016080259,0.00018245148,0.00032412546,0.00032510774,0.00011249201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006341328,0.000007991981,0.9985202,0.0000072972543,0.000040548093,0.000059240352,0.000020233707,0.000014561218,0.00012241265,0.000006280436,0.0000314585,0.0011064241],"study_design_scores_gemma":[0.000005600023,0.00007026493,0.9987251,0.000012342625,0.000042359756,0.0007746383,0.00009119304,0.0000849251,0.00006203803,0.000011459608,0.00011790367,0.000002150861],"about_ca_topic_score_codex":0.004078663,"about_ca_topic_score_gemma":0.007283542,"teacher_disagreement_score":0.004078663,"about_ca_system_score_codex":0.0001826811,"about_ca_system_score_gemma":0.00027500026,"threshold_uncertainty_score":0.008109808},"labels":[],"label_agreement":null},{"id":"W2275368612","doi":"10.1002/hup.2521","title":"Amygdala responses to quetiapine XR and citalopram treatment in major depression: the role of 5‐HTTLPR‐S/Lg polymorphisms","year":2016,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Quetiapine; Citalopram; Amygdala; Major depressive disorder; Antidepressant; Quetiapine Fumarate; Psychology; 5-HTTLPR; Serotonin transporter; Internal medicine; Oncology; Neuroimaging; Medicine; Psychiatry; Serotonin; Schizophrenia (object-oriented programming); Hippocampus; Antipsychotic; Atypical antipsychotic; Receptor","score_opus":0.05734310990205295,"score_gpt":0.4195964379191912,"score_spread":0.3622533280171383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275368612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950457,0.00014554703,0.000068158195,0.00005484029,0.0000020285636,0.0000041624453,0.000030793548,0.0000032271596,0.00018671062],"genre_scores_gemma":[0.9997266,0.000058115602,0.000058835485,0.000032515414,0.000003520742,0.0000029459995,0.000027267888,9.475026e-7,0.00008931491],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989223,0.000051450155,0.0000065335535,0.000017640628,0.000019782885,0.000012340256],"domain_scores_gemma":[0.9998354,0.00004356977,0.000070570146,0.000012484722,0.0000105966565,0.000027392269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026246867,0.000106875326,0.00020214696,0.00008162558,0.000054086184,0.00009847073,0.000093278824,0.00021811352,0.001002876],"category_scores_gemma":[0.00064957194,0.00007066608,0.00015842504,0.000079093,0.000117015035,0.00007041101,0.000058335307,0.00018130708,0.000094893534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032394845,0.001107256,0.3102738,0.00017652784,0.00075364707,0.0007024508,0.00037167128,0.000989297,0.59205383,0.000089044064,0.00056074676,0.06052699],"study_design_scores_gemma":[0.0001220517,0.0017889661,0.9937006,0.0000041485446,0.0000816084,0.0002639381,0.000025306359,0.00037285007,0.0035070628,0.000020363106,0.000110292814,0.0000028069521],"about_ca_topic_score_codex":0.0012037583,"about_ca_topic_score_gemma":0.0024944975,"teacher_disagreement_score":0.0012037583,"about_ca_system_score_codex":0.00020640575,"about_ca_system_score_gemma":0.00009119201,"threshold_uncertainty_score":0.0033549666},"labels":[],"label_agreement":null},{"id":"W2277091616","doi":"10.1002/hup.2519","title":"Genetic association analysis of N‐methyl‐<scp>d</scp>‐aspartate receptor subunit gene<i>GRIN2B</i>and clinical response to clozapine","year":2016,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Genentech; Sunovion; Eisai; Sanofi; National Alliance for Research on Schizophrenia and Depression; GlaxoSmithKline; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Clozapine; Schizophrenia (object-oriented programming); Glutamate receptor; Atypical antipsychotic; Medicine; Internal medicine; Antipsychotic; Pharmacology; Receptor; Psychiatry","score_opus":0.09698878444911962,"score_gpt":0.47350505035859003,"score_spread":0.3765162659094704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277091616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995671,0.000057641446,0.000107098975,0.000028297462,0.0000027998462,0.0000041559383,0.00007529866,0.000003794628,0.0001538491],"genre_scores_gemma":[0.99973565,0.00001812876,0.00010448799,0.000011690081,0.0000032819444,0.0000027402534,0.00006104026,0.0000019154731,0.000061003477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994541,0.00021842052,0.00006402424,0.00013833668,0.000077464385,0.00004772215],"domain_scores_gemma":[0.99850935,0.0005276872,0.00062749855,0.00009373472,0.00007559797,0.0001661189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005902509,0.00037247024,0.00028625687,0.0005260873,0.00021928873,0.00027198004,0.000254558,0.0004755242,0.0028580911],"category_scores_gemma":[0.0023325945,0.000152395,0.00043830997,0.0005013157,0.00033919944,0.00009030562,0.00020505713,0.00031106567,0.00023333088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002524262,0.00010925365,0.97582793,0.000027027712,0.0005375397,0.00086951395,0.0001339545,0.00026433903,0.016518455,0.00007805289,0.00013414778,0.0029754937],"study_design_scores_gemma":[0.000086622524,0.00032680147,0.9952524,0.0000087701255,0.000194965,0.0017921649,0.0000630651,0.0007885289,0.0012905856,0.00006338424,0.00012689918,0.0000057239217],"about_ca_topic_score_codex":0.0032553417,"about_ca_topic_score_gemma":0.0028000122,"teacher_disagreement_score":0.0032553417,"about_ca_system_score_codex":0.00019758155,"about_ca_system_score_gemma":0.0002073239,"threshold_uncertainty_score":0.0095613},"labels":[],"label_agreement":null},{"id":"W2340065564","doi":"10.1002/hup.2532","title":"SSRI‐antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP‐PD study","year":2016,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Centre for Addiction and Mental Health","funders":"National Center for Research Resources; National Institute of Mental Health","keywords":"Sertraline; Olanzapine; Pharmacokinetics; Psychology; Depression (economics); Population; NONMEM; Antipsychotic; Psychiatry; Medicine; Risperidone; Pharmacology; Internal medicine; Schizophrenia (object-oriented programming); Antidepressant","score_opus":0.073962093520956,"score_gpt":0.4661101876067339,"score_spread":0.3921480940857779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340065564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891711,0.007726951,0.0008240108,0.0002946592,0.000047890553,0.00017093899,0.0008621303,0.00006801929,0.00083434006],"genre_scores_gemma":[0.99281585,0.003287884,0.0007685759,0.00031461834,0.00013656542,0.00009270542,0.0017094128,0.00001730442,0.0008570936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999516,0.00015622069,0.00008442315,0.000050512284,0.0001649467,0.00002790402],"domain_scores_gemma":[0.99917823,0.00022419759,0.00028423461,0.00004134968,0.00014492385,0.00012702827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010622831,0.00064659544,0.00092372386,0.0003153608,0.0002153203,0.00050296483,0.00024069496,0.000534949,0.0006740331],"category_scores_gemma":[0.0014490823,0.00029012654,0.00074818265,0.00026424314,0.00015657782,0.00020706431,0.0001654299,0.0004045642,0.00029059607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049150333,0.0026523655,0.73140574,0.0016191383,0.004349584,0.013094697,0.0010750104,0.00071930676,0.039230783,0.000104829174,0.0033402415,0.15325804],"study_design_scores_gemma":[0.0026882852,0.023818083,0.9530305,0.00009371228,0.0021465363,0.0095585305,0.00014820855,0.0011470164,0.0029391844,0.000051078532,0.004314121,0.00006464535],"about_ca_topic_score_codex":0.0013607545,"about_ca_topic_score_gemma":0.0018742933,"teacher_disagreement_score":0.0013607545,"about_ca_system_score_codex":0.00036199478,"about_ca_system_score_gemma":0.00037654562,"threshold_uncertainty_score":0.005617976},"labels":[],"label_agreement":null},{"id":"W2441656824","doi":"10.1002/hup.2537","title":"Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute; University of Saskatchewan","funders":"","keywords":"Randomized controlled trial; Meta-analysis; Cochrane Library; Medicine; Internal medicine; Placebo; Wechsler Adult Intelligence Scale; Psychiatry; Discontinuation; Strictly standardized mean difference; Antipsychotic; Positive and Negative Syndrome Scale; Schizophrenia (object-oriented programming); Psychology; Pediatrics; Psychosis; Cognition","score_opus":0.223928782359479,"score_gpt":0.5341257611764547,"score_spread":0.3101969788169757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2441656824","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031930094,0.99582493,0.00019877945,0.000100779,0.00008278604,0.00026111852,0.0001511427,0.000012316694,0.00017506078],"genre_scores_gemma":[0.077546835,0.91905767,0.0013153766,0.0006005577,0.0001676806,0.0007912068,0.00028026503,0.000010493248,0.00022987321],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963218,0.0014633475,0.0011711956,0.0003700926,0.00051917695,0.00015440988],"domain_scores_gemma":[0.99334705,0.004213093,0.0015268447,0.00016273644,0.00059435295,0.00015597836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072422577,0.0020804657,0.015391717,0.0053454232,0.00056068564,0.0023598953,0.0018916855,0.0018476353,0.0044723144],"category_scores_gemma":[0.013634078,0.0011028018,0.023805538,0.0052899835,0.0006427303,0.0016424748,0.0012491203,0.0014916003,0.00022805504],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036264397,0.00009544542,0.001594307,0.6569366,0.30763197,0.00010972779,0.000099988356,0.00033709727,0.00032642964,0.0001413905,0.0005780029,0.028522683],"study_design_scores_gemma":[0.0019188946,0.00058013666,0.0032633888,0.06250708,0.92832947,0.000113592556,0.00008002073,0.00018306816,0.00017843813,0.00019544586,0.0026189326,0.00003153226],"about_ca_topic_score_codex":0.005148474,"about_ca_topic_score_gemma":0.015562674,"teacher_disagreement_score":0.015391717,"about_ca_system_score_codex":0.0019636108,"about_ca_system_score_gemma":0.0035184212,"threshold_uncertainty_score":0.03830123},"labels":[],"label_agreement":null},{"id":"W2536887084","doi":"10.1002/hup.2548","title":"Captagon: use and trade in the Middle East","year":2016,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency; Public Health Agency of Canada; World Health Organization","keywords":"Middle East; Geography; Archaeology","score_opus":0.519538922703045,"score_gpt":0.5583681680123407,"score_spread":0.03882924530929566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536887084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39269638,0.54057896,0.00057658163,0.005405895,0.00043190172,0.00011079905,0.012317657,0.000043116543,0.047838748],"genre_scores_gemma":[0.70530033,0.2832238,0.0014999604,0.001855933,0.00041802422,0.00008479154,0.0043431176,0.0000238334,0.0032501176],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999514,0.00013674013,0.00011788297,0.000066519766,0.0001221023,0.000042820957],"domain_scores_gemma":[0.9975326,0.0014057873,0.0007458675,0.000043212618,0.00019834195,0.00007419305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007967375,0.00024370664,0.00028134976,0.0057349815,0.00039737427,0.0015638674,0.00023902618,0.00045667318,0.0052184765],"category_scores_gemma":[0.002592217,0.00007076798,0.00036786174,0.00944391,0.00048139616,0.0017631802,0.0006785991,0.00028244147,0.00064349885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008571173,0.00013088461,0.15337057,0.050900076,0.00057504117,0.004406217,0.019142613,0.00020686066,0.003514112,0.012451322,0.024435258,0.73001],"study_design_scores_gemma":[0.000030259816,0.0002952295,0.5402119,0.032267746,0.0010366539,0.009600304,0.034937926,0.00033206932,0.002991607,0.0041436763,0.3740616,0.00009098474],"about_ca_topic_score_codex":0.004068155,"about_ca_topic_score_gemma":0.006071819,"teacher_disagreement_score":0.0057349815,"about_ca_system_score_codex":0.00045819953,"about_ca_system_score_gemma":0.00087467226,"threshold_uncertainty_score":0.017457545},"labels":[],"label_agreement":null},{"id":"W2560733466","doi":"10.1002/hup.2565","title":"Association between overall rate of change in rising breath alcohol concentration and the magnitude of acute tolerance of subjective intoxication via the Mellanby method","year":2016,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"National Institute on Alcohol Abuse and Alcoholism","keywords":"Association (psychology); Alcohol; Alcohol intoxication; Psychology; Medicine; Chemistry; Environmental health; Poison control; Injury prevention; Psychotherapist; Biochemistry","score_opus":0.07614439659618503,"score_gpt":0.457343282927691,"score_spread":0.38119888633150595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560733466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908614,0.00005870193,0.00028318787,0.0000132754,0.0000039649713,0.000016081874,0.00009003482,0.0000062955482,0.00044230663],"genre_scores_gemma":[0.99940133,0.000020836012,0.00017337424,0.0000065441113,0.000003107648,0.000011366805,0.000072966795,0.0000021864867,0.00030821614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994011,0.00022799609,0.000060360257,0.000117891694,0.0001441398,0.00004845312],"domain_scores_gemma":[0.99452895,0.0016219574,0.0025836208,0.0004583164,0.00031570357,0.00049144105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088289817,0.00023731217,0.00017449491,0.00040953094,0.00015268402,0.00037531118,0.00018622949,0.00027435002,0.002981064],"category_scores_gemma":[0.005892219,0.00014074196,0.00019059442,0.00023056693,0.00025617954,0.00028775033,0.00036445906,0.00046131114,0.00026258433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083230407,0.00017751213,0.99375325,0.000010935594,0.00007191288,0.000017876599,0.00008938094,0.000054644825,0.001958226,0.000021618,0.000044873108,0.0029675302],"study_design_scores_gemma":[0.0000033806512,0.00035369914,0.99909496,0.0000015028871,0.000007791438,0.000045291228,0.000040518426,0.0002030277,0.00020219816,0.000008785927,0.00003657087,0.0000022172605],"about_ca_topic_score_codex":0.0012091887,"about_ca_topic_score_gemma":0.0015575183,"teacher_disagreement_score":0.002981064,"about_ca_system_score_codex":0.00013916314,"about_ca_system_score_gemma":0.00011031266,"threshold_uncertainty_score":0.009972632},"labels":[],"label_agreement":null},{"id":"W2582330345","doi":"10.1002/hup.2568","title":"Association study between the neurexin‐1 gene and tardive dyskinesia","year":2017,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Tardive dyskinesia; Neurexin; Association (psychology); Dyskinesia; Medicine; Gene; Psychiatry; Genetics; Psychology; Schizophrenia (object-oriented programming); Internal medicine; Biology; Psychotherapist; Parkinson's disease; Receptor; Postsynaptic potential","score_opus":0.1729668456250712,"score_gpt":0.5169184704713332,"score_spread":0.343951624846262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582330345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996674,0.000106157975,0.000056011577,0.000015679387,0.0000030368149,0.000001990037,0.00006235763,0.0000010144668,0.00008636099],"genre_scores_gemma":[0.9996106,0.0000431397,0.00009811759,0.000009054316,0.0000041357257,0.0000029852504,0.00006981094,0.0000012712941,0.0001608971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977726,0.00007017679,0.000028235097,0.00007861467,0.000024636603,0.00002108591],"domain_scores_gemma":[0.9992899,0.00027916988,0.00020873475,0.000036887675,0.000058194844,0.00012709058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038392917,0.0003082205,0.000254968,0.00044004546,0.0002974093,0.00019421427,0.00017962918,0.00031266082,0.0023859048],"category_scores_gemma":[0.001062023,0.00014294767,0.00026204437,0.00040090657,0.00023700352,0.00012352302,0.00018781138,0.0002956638,0.00017569934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012920884,0.00009042745,0.9897447,0.000024291654,0.0002323646,0.0007360174,0.00012922226,0.000093299794,0.0054928735,0.000053804084,0.000079948426,0.0020309158],"study_design_scores_gemma":[0.000047254514,0.00028359413,0.9975859,0.000009194611,0.00011206695,0.0010078689,0.0000835197,0.00025720824,0.00042668448,0.00004465744,0.0001383098,0.0000037573056],"about_ca_topic_score_codex":0.0014053375,"about_ca_topic_score_gemma":0.0014040472,"teacher_disagreement_score":0.0023859048,"about_ca_system_score_codex":0.00013973251,"about_ca_system_score_gemma":0.00012992449,"threshold_uncertainty_score":0.007981658},"labels":[],"label_agreement":null},{"id":"W2757123312","doi":"10.1002/hup.2633","title":"Does early antipsychotic response predict long‐term treatment outcome?","year":2017,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Health Sciences Centre; McMaster University Medical Centre; McMaster University","funders":"Ontario Mental Health Foundation; McMaster University; Stanley Medical Research Institute","keywords":"Term (time); Antipsychotic; Psychology; Outcome (game theory); Psychiatry; Schizophrenia (object-oriented programming); Medicine; Clinical psychology; Economics","score_opus":0.11239248763713088,"score_gpt":0.5126923681999532,"score_spread":0.40029988056282234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757123312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971501,0.0013975042,0.00023332733,0.0002881686,0.000022510618,0.000014272394,0.00034706836,0.0000069534285,0.0005401438],"genre_scores_gemma":[0.9993248,0.00016584696,0.00011099218,0.000039309616,0.000027406677,0.0000070810943,0.0002226931,0.0000017748462,0.00010024401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991036,0.000370874,0.00014929961,0.00012801915,0.00013667147,0.00011142084],"domain_scores_gemma":[0.98808414,0.0040980596,0.005760426,0.00039535158,0.00053458783,0.0011273334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022903832,0.0003300517,0.00058789167,0.0004322691,0.00028308146,0.0006171392,0.00038274773,0.0008838755,0.0023301179],"category_scores_gemma":[0.0099592665,0.00014843426,0.00072448567,0.00048084994,0.00033831358,0.0006934498,0.00038563434,0.0010290556,0.00035247742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011383564,0.00015829584,0.9907452,0.0000357788,0.00016000621,0.00006572361,0.00005740733,0.00012794064,0.00029377235,0.00002115276,0.00010313187,0.007093201],"study_design_scores_gemma":[0.000035438752,0.0004990176,0.9982419,0.000029945393,0.0000806818,0.00018420018,0.00005699234,0.0005179449,0.0001470419,0.00008998791,0.00010830056,0.000008589536],"about_ca_topic_score_codex":0.0014692512,"about_ca_topic_score_gemma":0.0022075705,"teacher_disagreement_score":0.0023301179,"about_ca_system_score_codex":0.00028089626,"about_ca_system_score_gemma":0.0003879557,"threshold_uncertainty_score":0.012112856},"labels":[],"label_agreement":null},{"id":"W2761909751","doi":"10.1002/hup.2631","title":"Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: An updated meta‐analysis","year":2017,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Regulation of Appetite and Obesity","field":"Neuroscience","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Leptin; Meta-analysis; Schizophrenia (object-oriented programming); Antipsychotic; Medicine; Psychiatry; Medical diagnosis; Internal medicine; Anorexia nervosa; Association (psychology); Psychology; Bipolar disorder; Clinical psychology; Obesity; Cognition; Eating disorders; Psychotherapist","score_opus":0.5028972578192248,"score_gpt":0.5739493626426665,"score_spread":0.07105210482344171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761909751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054660393,0.9934962,0.0002646287,0.000115027615,0.00008185379,0.00006512853,0.0003386461,0.00001381417,0.00015859707],"genre_scores_gemma":[0.15674743,0.83905023,0.0016939348,0.0004911082,0.00021571956,0.00036329744,0.0010813256,0.000025680574,0.00033123212],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996396,0.0016160203,0.000978181,0.00045794641,0.00040370354,0.00014812652],"domain_scores_gemma":[0.99364024,0.004163808,0.0012525995,0.00023248652,0.00060061883,0.00011016523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062011923,0.0021840513,0.010469911,0.0040696934,0.00047066264,0.0021647164,0.0015322653,0.0013756801,0.002887164],"category_scores_gemma":[0.013610442,0.000982982,0.025850208,0.005305822,0.00033521908,0.0008877702,0.0010554238,0.0013436582,0.00023133525],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036311243,0.00005522091,0.011181132,0.2111058,0.7421269,0.00021046594,0.000081836064,0.0006807511,0.0003992936,0.0001303432,0.001201049,0.029196082],"study_design_scores_gemma":[0.00051588146,0.00019378199,0.009531137,0.009677483,0.9772748,0.00016739978,0.00003265023,0.0002010064,0.00012624844,0.00014371377,0.0021147686,0.000021106041],"about_ca_topic_score_codex":0.0055969507,"about_ca_topic_score_gemma":0.0103241475,"teacher_disagreement_score":0.010469911,"about_ca_system_score_codex":0.0014969513,"about_ca_system_score_gemma":0.0018972188,"threshold_uncertainty_score":0.03279543},"labels":[],"label_agreement":null},{"id":"W2783639535","doi":"10.1002/hup.2646","title":"Relative short‐term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder","year":2018,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Treatment of Major Depression","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Servier","keywords":"Vortioxetine; Agomelatine; Tolerability; Major depressive disorder; Placebo; Rating scale; Depression (economics); Medicine; Antidepressant; Psychiatry; Clinical efficacy; Internal medicine; Adverse effect; Psychology; Anxiety; Alternative medicine; Mood","score_opus":0.07839844261861603,"score_gpt":0.47691245931013204,"score_spread":0.398514016691516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783639535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00404974,0.9955509,0.00003823142,0.00008013111,0.000037370835,0.000024323304,0.000035238543,0.0000011498147,0.00018299649],"genre_scores_gemma":[0.061932463,0.9369977,0.0003729078,0.00023288517,0.00012167594,0.000075592616,0.000108313754,0.0000020794541,0.00015625855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820244,0.0008677085,0.000483858,0.00014537225,0.0002650342,0.000035620928],"domain_scores_gemma":[0.9976701,0.0016091322,0.00045538624,0.000025562242,0.00020052565,0.000039216913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028063247,0.00043483873,0.0031917184,0.0010502978,0.00012917662,0.0006362191,0.0006218932,0.00067006465,0.0017040304],"category_scores_gemma":[0.0050010406,0.0002420486,0.0017439122,0.0010579918,0.00022244414,0.00059185276,0.00032464377,0.00069285394,0.00012884226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011658838,0.00024674888,0.002920968,0.36871588,0.022636518,0.00026583835,0.0002324342,0.00025725068,0.0022015928,0.0005605424,0.0016644887,0.58863884],"study_design_scores_gemma":[0.02451026,0.03425021,0.16791093,0.22500113,0.35053158,0.008788342,0.0022757265,0.001985827,0.007710249,0.0030985733,0.1736023,0.00033494126],"about_ca_topic_score_codex":0.00065446517,"about_ca_topic_score_gemma":0.0021542124,"teacher_disagreement_score":0.0031917184,"about_ca_system_score_codex":0.00039915848,"about_ca_system_score_gemma":0.00073242164,"threshold_uncertainty_score":0.014841437},"labels":[],"label_agreement":null},{"id":"W2788553801","doi":"10.1002/hup.2650","title":"Alcohol mixed with energy drink (AMED): A critical review and meta‐analysis","year":2018,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Coffee research and impacts","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Affect (linguistics); Consumption (sociology); Environmental health; Alcohol consumption; Alcohol; Meta-analysis; Alcohol intoxication; Population; Psychology; Medicine; Injury prevention; Poison control","score_opus":0.3011140529374183,"score_gpt":0.5766542435589871,"score_spread":0.2755401906215688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788553801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071111,0.99793327,0.00032604526,0.00025047702,0.00017226678,0.00025027408,0.00019418987,0.000010352047,0.00015195766],"genre_scores_gemma":[0.034798354,0.9596967,0.0019836393,0.0012881778,0.00036359407,0.0012509851,0.00036909818,0.000019305602,0.00023012001],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9882086,0.005033453,0.003860081,0.0010305502,0.001561208,0.00030608728],"domain_scores_gemma":[0.9648189,0.025328921,0.00570369,0.0009056518,0.0029635513,0.0002792083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018973416,0.0023281379,0.012697785,0.007187977,0.00082032755,0.0035133376,0.0022214055,0.0023617,0.0048689116],"category_scores_gemma":[0.053865004,0.0013716952,0.020077482,0.0064051687,0.00096614566,0.0024916006,0.0017174681,0.0017557407,0.0003462003],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008047359,0.000021970545,0.0012229488,0.84129566,0.12953275,0.00010367215,0.00009839906,0.00018672184,0.00019442051,0.00024694102,0.0014685228,0.024823256],"study_design_scores_gemma":[0.0005642923,0.00036702273,0.004075476,0.23825516,0.74339664,0.00026188963,0.00011569701,0.00013602726,0.00027274253,0.0006431999,0.0118656745,0.0000462415],"about_ca_topic_score_codex":0.0060563018,"about_ca_topic_score_gemma":0.014263002,"teacher_disagreement_score":0.018973416,"about_ca_system_score_codex":0.0035299337,"about_ca_system_score_gemma":0.007625954,"threshold_uncertainty_score":0.100342155},"labels":[],"label_agreement":null},{"id":"W2789944740","doi":"10.1002/hup.2652","title":"Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the <scp>PULSAR</scp> study)","year":2018,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcosine; Positive and Negative Syndrome Scale; Placebo; Internal medicine; Schizophrenia (object-oriented programming); Medicine; Tolerability; Psychology; Gastroenterology; Psychosis; Psychiatry; Adverse effect; Glycine; Chemistry","score_opus":0.056462792834141795,"score_gpt":0.3922525650532731,"score_spread":0.3357897722191313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789944740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930024,0.00039893057,0.000049958115,0.00002311277,0.000008215938,0.000036472145,0.000056771292,0.000003861876,0.0001224563],"genre_scores_gemma":[0.9990144,0.00026720195,0.00016993949,0.00006318093,0.000022028673,0.000076353186,0.0002036151,0.0000012988324,0.00018195075],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9997867,0.000100097524,0.000022994276,0.000028795112,0.000029950348,0.00003158805],"domain_scores_gemma":[0.99955434,0.0000792556,0.00015347946,0.000030088117,0.000035772526,0.00014708561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005716008,0.0003997411,0.00068471336,0.00017928403,0.0002536918,0.00029377476,0.00015741779,0.0004902395,0.0007548213],"category_scores_gemma":[0.00047713218,0.00023645324,0.00047086907,0.0001657882,0.00023963864,0.00018082712,0.00017295688,0.0006038242,0.0001668676],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5066317,0.012058147,0.28768626,0.0008141239,0.0013871422,0.0012942529,0.0007250462,0.0006656111,0.12153533,0.00007737781,0.0006918241,0.06643324],"study_design_scores_gemma":[0.029719226,0.25956386,0.69916314,0.000063677726,0.0009913725,0.0012953805,0.0002406552,0.0006741638,0.0069066864,0.00005399169,0.0012812031,0.0000466714],"about_ca_topic_score_codex":0.0004037307,"about_ca_topic_score_gemma":0.0006500485,"teacher_disagreement_score":0.0007548213,"about_ca_system_score_codex":0.00019741998,"about_ca_system_score_gemma":0.00026621707,"threshold_uncertainty_score":0.0030229092},"labels":[],"label_agreement":null},{"id":"W2806664837","doi":"10.1002/hup.2663","title":"Why meta is better: A reply to Linden‐Carmichael et al. (2018)","year":2018,"lang":"en","type":"letter","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Coffee research and impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Psychology; Art","score_opus":0.15986085811209466,"score_gpt":0.5090624449756187,"score_spread":0.34920158686352404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806664837","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057906138,0.018893665,0.0004242443,0.9199421,0.06036409,0.000021887847,0.00009873245,0.000046090252,0.00015125921],"genre_scores_gemma":[0.0010049747,0.008008583,0.0010783382,0.94366616,0.04552125,0.0001124662,0.000037408892,0.00008127046,0.00048957823],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9023286,0.046405982,0.017942078,0.010418647,0.021114066,0.0017905293],"domain_scores_gemma":[0.3949876,0.5061738,0.015791198,0.016163649,0.058457177,0.008426559],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15120015,0.00260361,0.007660417,0.005887853,0.0048189205,0.012267334,0.00948906,0.05076457,0.011850876],"category_scores_gemma":[0.528554,0.0027273744,0.006738332,0.0063826423,0.015166682,0.026105953,0.007550835,0.09410517,0.0076815495],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014001189,0.000030040852,0.00023948633,0.0032052132,0.0003682176,0.00019562268,0.00097196334,0.000103049446,0.00007568232,0.0054760342,0.9718731,0.01732165],"study_design_scores_gemma":[0.0005349564,0.00012913342,0.0008685253,0.01563359,0.00068175065,0.00083361805,0.0012320516,0.00045410942,0.00031825143,0.060647532,0.91831857,0.0003479527],"about_ca_topic_score_codex":0.00719295,"about_ca_topic_score_gemma":0.0074271914,"teacher_disagreement_score":0.8487998,"about_ca_system_score_codex":0.007988573,"about_ca_system_score_gemma":0.01491077,"threshold_uncertainty_score":0.7996324},"labels":[],"label_agreement":null},{"id":"W2810359220","doi":"10.1002/hup.2659","title":"Pharmacogenetic evaluation of a <i>DISP1</i> gene variant in antidepressant treatment of obsessive–compulsive disorder","year":2018,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health; Ontario Ministry of Research, Innovation and Science; Canadian Institutes of Health Research; Ontario Mental Health Foundation; Genome Canada","keywords":"Paroxetine; Fluvoxamine; Genome-wide association study; Sertraline; Antidepressant; Pharmacogenetics; Citalopram; Serotonin reuptake inhibitor; Fluoxetine; Psychiatry; Single-nucleotide polymorphism; Psychology; Genetic association; Medicine; Internal medicine; Oncology; Clinical psychology; Genotype; Genetics; Anxiety; Gene; Biology; Serotonin","score_opus":0.06361174518063484,"score_gpt":0.46323750119478074,"score_spread":0.3996257560141459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810359220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735117,0.00074010494,0.0005423126,0.00026848394,0.000020120266,0.000030770403,0.0003765033,0.000017682312,0.00065279816],"genre_scores_gemma":[0.99896014,0.00010841271,0.00052564364,0.00009844981,0.000021512778,0.000010198334,0.00015453789,0.000005441721,0.000115671595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991641,0.00030732568,0.00011901312,0.00024174569,0.000120762175,0.000047127895],"domain_scores_gemma":[0.9985713,0.0006667977,0.00047826092,0.00009238919,0.000087614426,0.00010357485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092313753,0.0004978205,0.00043116783,0.00049103965,0.000352818,0.0004953036,0.0005341351,0.0008142808,0.00274256],"category_scores_gemma":[0.0026834782,0.00016920008,0.0007233898,0.00088217837,0.00033532872,0.0001527497,0.00019162598,0.00052219915,0.00024423745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068675834,0.00024736198,0.9427349,0.00017801122,0.0018666547,0.0016174515,0.00018525355,0.00070753874,0.025250861,0.000261566,0.00042988083,0.01965302],"study_design_scores_gemma":[0.00044115647,0.00094967417,0.98822206,0.00003879081,0.0015708355,0.0022036338,0.00008305132,0.0029067805,0.0025093635,0.00022870053,0.0008283241,0.000017665605],"about_ca_topic_score_codex":0.0030950368,"about_ca_topic_score_gemma":0.0032535212,"teacher_disagreement_score":0.0030950368,"about_ca_system_score_codex":0.00027103754,"about_ca_system_score_gemma":0.00033224362,"threshold_uncertainty_score":0.009174764},"labels":[],"label_agreement":null},{"id":"W2902851430","doi":"10.1002/hup.2684","title":"Effect of <scp>GAD1</scp> genotype status on auditory attention and acute nicotine administration in healthy volunteers","year":2018,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; University of Ottawa","funders":"Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada","keywords":"P3a; P3b; Nicotine; Psychology; Audiology; Placebo; Event-related potential; Neuroscience; Medicine; Cognition","score_opus":0.014594835185020453,"score_gpt":0.4073445277404722,"score_spread":0.3927496925554517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902851430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99966395,0.0000867652,0.000028696704,0.000008301864,0.0000027947608,0.000008685971,0.000047507463,0.0000020940115,0.00015132003],"genre_scores_gemma":[0.9996282,0.000034680103,0.000049862065,0.000020877225,0.0000043177397,0.000009016227,0.00007500946,0.000002237454,0.00017579172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984,0.000038293198,0.000016452792,0.000059042162,0.000026972242,0.000019275678],"domain_scores_gemma":[0.9995994,0.00010189928,0.00013636307,0.00003134317,0.000032186606,0.000098908095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021166628,0.0002884832,0.0003994792,0.00021618963,0.0002666517,0.0002339863,0.0001253925,0.00039285998,0.0013543365],"category_scores_gemma":[0.0007718131,0.00014280692,0.00019977102,0.00018694736,0.00023348688,0.00013036629,0.00014077472,0.0002801175,0.00022783075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03166294,0.0016143472,0.8741711,0.00012049416,0.00042449837,0.0016647908,0.0005822703,0.00011177595,0.07661915,0.00006054841,0.00025043302,0.012717607],"study_design_scores_gemma":[0.0000636795,0.0020463127,0.9964557,0.0000025125873,0.000055729648,0.00055236294,0.00004805621,0.000071399176,0.00059379486,0.000017514018,0.00008949837,0.0000034120349],"about_ca_topic_score_codex":0.0015793375,"about_ca_topic_score_gemma":0.0024885908,"teacher_disagreement_score":0.0015793375,"about_ca_system_score_codex":0.00015589151,"about_ca_system_score_gemma":0.00010793598,"threshold_uncertainty_score":0.004530728},"labels":[],"label_agreement":null},{"id":"W2945477786","doi":"10.1002/hup.2693","title":"Effects of olanzapine during cognitive and emotional processing in schizophrenia: A review of functional magnetic resonance imaging findings","year":2019,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Olanzapine; Functional magnetic resonance imaging; Psychology; Schizophrenia (object-oriented programming); Cognition; Brain activity and meditation; Neuroscience; Cingulate cortex; Anterior cingulate cortex; Psychosis; Striatum; Neuroimaging; Clinical psychology; Dopamine; Psychiatry; Electroencephalography; Central nervous system","score_opus":0.056630614775938094,"score_gpt":0.4471669234584478,"score_spread":0.39053630868250966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945477786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013686492,0.99961084,0.00001862605,0.000047341087,0.000026632053,0.0000031611705,0.00001985302,0.000002210303,0.00013441048],"genre_scores_gemma":[0.0012919465,0.99847764,0.000070306756,0.000048348,0.000026070697,0.0000053948716,0.000023987397,7.475241e-7,0.0000556055],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996873,0.000061285085,0.00012395806,0.000042874068,0.000066336805,0.000018234949],"domain_scores_gemma":[0.99898046,0.00064403465,0.00020930829,0.000014538646,0.00012495306,0.000026650436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085132016,0.00084032223,0.0019099587,0.0040596593,0.0002050798,0.00067766255,0.0008348683,0.0007920438,0.0021479884],"category_scores_gemma":[0.001753822,0.0002686329,0.0011069772,0.0037785207,0.00031275206,0.00069435016,0.0003923979,0.00049970887,0.00037275674],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002874181,0.000042164305,0.00044454244,0.21890678,0.00076187163,0.0002867126,0.00009503396,0.00023167668,0.001160663,0.0005966917,0.00786996,0.7693165],"study_design_scores_gemma":[0.00027150929,0.0009052368,0.017944682,0.22549185,0.013359133,0.008645544,0.00050493376,0.00043860954,0.0030274678,0.0024032078,0.72685754,0.00015022377],"about_ca_topic_score_codex":0.002812439,"about_ca_topic_score_gemma":0.0056833327,"teacher_disagreement_score":0.0040596593,"about_ca_system_score_codex":0.0007334474,"about_ca_system_score_gemma":0.0015194953,"threshold_uncertainty_score":0.007185757},"labels":[],"label_agreement":null},{"id":"W2968380560","doi":"10.1002/hup.2711","title":"A randomized placebo‐controlled trial examining the effects of escitalopram on neuroticism and state anxiety in a nonclinical sample","year":2019,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Treatment of Major Depression","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Lundbeckfonden; Københavns Universitet","keywords":"Escitalopram; Neuroticism; Psychology; Anxiety; Placebo; Clinical psychology; Psychoticism; Randomized controlled trial; Psychiatry; Sample (material); Medicine; Extraversion and introversion; Big Five personality traits; Personality; Internal medicine; Alternative medicine; Social psychology","score_opus":0.037259737583929746,"score_gpt":0.41616726252952746,"score_spread":0.3789075249455977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968380560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744197,0.010325603,0.00101823,0.0010364483,0.0015167684,0.009156702,0.00061167695,0.00010829315,0.0018064013],"genre_scores_gemma":[0.9819816,0.003888196,0.0020910122,0.0012056872,0.00087886135,0.0076404545,0.00041003467,0.00001471594,0.0018895019],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980129,0.0012326756,0.00021194607,0.00026142062,0.00014052536,0.00014056676],"domain_scores_gemma":[0.9977508,0.0009513482,0.0005461217,0.00016448103,0.00024031314,0.00034694475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033093512,0.0011831524,0.0032091527,0.00057086337,0.0006437089,0.000795959,0.0007808849,0.0020107345,0.008521223],"category_scores_gemma":[0.004839853,0.0006498202,0.0014907598,0.0004747357,0.0013267602,0.000792373,0.00034810675,0.0016760213,0.000681971],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9764737,0.00669917,0.0004266625,0.0010837731,0.0011010914,0.000041472624,0.000033301127,0.00007781985,0.0023697654,0.00008526697,0.00024062803,0.011367299],"study_design_scores_gemma":[0.96045715,0.03812503,0.00066305825,0.00002855133,0.00027904002,0.000011665507,0.000009303543,0.000058024005,0.00015403502,0.00003969116,0.00016991652,0.0000045905203],"about_ca_topic_score_codex":0.0006273602,"about_ca_topic_score_gemma":0.0015029816,"teacher_disagreement_score":0.008521223,"about_ca_system_score_codex":0.0005597939,"about_ca_system_score_gemma":0.0014121837,"threshold_uncertainty_score":0.028506339},"labels":[],"label_agreement":null},{"id":"W2971484309","doi":"10.1002/hup.2712","title":"The effect of baseline antipsychotic status on the 12‐month outcome in initially stabilized patients with schizophrenia","year":2019,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Schizophrenia (object-oriented programming); Extrapyramidal symptoms; Antipsychotic; Brief Psychiatric Rating Scale; Positive and Negative Syndrome Scale; Anxiety; Rating scale; Psychiatry; Depression (economics); Medicine; Clozapine; Internal medicine; Psychology; Psychosis","score_opus":0.03235742957709797,"score_gpt":0.4060553820068312,"score_spread":0.37369795242973325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971484309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938667,0.00031822012,0.000018308443,0.000036933212,0.0000053406166,0.000004165417,0.000069484886,0.0000018355076,0.00015900016],"genre_scores_gemma":[0.9997043,0.0000639286,0.000022606579,0.000010585269,0.000007058104,0.00000381759,0.00013594484,5.601636e-7,0.000051261493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999534,0.00018559449,0.000055385266,0.0000558702,0.000092815964,0.000076308876],"domain_scores_gemma":[0.99724126,0.0006839918,0.0012152614,0.000095641146,0.00021221889,0.00055161986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010965514,0.00023867161,0.00031879972,0.00041772355,0.00037098024,0.00045083032,0.00019175795,0.00050746626,0.0012979654],"category_scores_gemma":[0.003799654,0.00013111491,0.00038523896,0.00026043886,0.00035210146,0.00039743164,0.00026129792,0.00049299793,0.0002580197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031757383,0.00015317624,0.9899985,0.000020764399,0.00009056387,0.00010284119,0.000106317726,0.00008687849,0.0005976464,0.000008376384,0.00008177677,0.005577335],"study_design_scores_gemma":[0.000021214717,0.0009260399,0.99871457,0.000005699929,0.000020561105,0.000088613524,0.000037578586,0.00007013684,0.00006061774,0.000008485801,0.000042471474,0.0000039815377],"about_ca_topic_score_codex":0.0015784679,"about_ca_topic_score_gemma":0.0031749427,"teacher_disagreement_score":0.0015784679,"about_ca_system_score_codex":0.00045330325,"about_ca_system_score_gemma":0.00030193044,"threshold_uncertainty_score":0.0057991743},"labels":[],"label_agreement":null},{"id":"W3005882383","doi":"10.1002/hup.2725","title":"Kava drinking in traditional settings: Towards understanding effects on cognitive function","year":2020,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Medicinal Plant Extracts Effects","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Health Research Council of New Zealand","keywords":"Kava; Test (biology); Cognition; Psychology; Medicine; Psychiatry; Ecology","score_opus":0.15658574671887057,"score_gpt":0.4293378840051202,"score_spread":0.2727521372862496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005882383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954093,0.0028541235,0.00025794262,0.0001109953,0.000008867001,0.000015080546,0.00005044435,0.000003950568,0.0012892933],"genre_scores_gemma":[0.99691916,0.0021338752,0.00045683887,0.00006616453,0.000015309623,0.000015292168,0.000032019896,0.0000010345941,0.00036025184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988496,0.000039598646,0.000006407124,0.000023915123,0.000024286404,0.000020718262],"domain_scores_gemma":[0.9996306,0.00014297293,0.000111190166,0.000026955331,0.000047050176,0.00004123196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044542024,0.00030720924,0.00024359931,0.0004582544,0.00024183291,0.0005647778,0.0003147964,0.0002865709,0.0015545335],"category_scores_gemma":[0.0007045077,0.00008164037,0.0002120988,0.00019015605,0.00063887716,0.00046411436,0.00032516694,0.00032704818,0.000107891836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054988205,0.005098296,0.6580782,0.0027613638,0.0005282317,0.0007757179,0.0073645674,0.00058253383,0.10203901,0.0011684888,0.0004694215,0.21563531],"study_design_scores_gemma":[0.00001720785,0.0025268972,0.98954695,0.000081991566,0.000091471695,0.00021495103,0.0022148103,0.00026421633,0.0033380012,0.00057008275,0.0011247917,0.000008779075],"about_ca_topic_score_codex":0.0028832639,"about_ca_topic_score_gemma":0.0049936553,"teacher_disagreement_score":0.0028832639,"about_ca_system_score_codex":0.0003528533,"about_ca_system_score_gemma":0.00031055158,"threshold_uncertainty_score":0.0057329535},"labels":[],"label_agreement":null},{"id":"W3110473772","doi":"10.1002/hup.2770","title":"Serum levels of neuropeptide Y in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the double‐blind randomized controlled PULSAR study)","year":2020,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcosine; Neuropeptide Y receptor; Positive and Negative Syndrome Scale; Internal medicine; Endocrinology; Psychology; Schizophrenia (object-oriented programming); Placebo; Medicine; Gastroenterology; Psychosis; Psychiatry; Neuropeptide; Chemistry; Receptor","score_opus":0.06532444905830072,"score_gpt":0.37220156706142854,"score_spread":0.30687711800312784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110473772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998329,0.0009509804,0.000119640754,0.00005519745,0.0000479852,0.00022357846,0.00010784125,0.000015071935,0.00015078527],"genre_scores_gemma":[0.99714065,0.0007811113,0.0005416594,0.00017156718,0.000111957655,0.0005550497,0.0002985233,0.0000045590177,0.00039503488],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995436,0.00022013845,0.00004597976,0.00007833215,0.000041761767,0.000070193586],"domain_scores_gemma":[0.9993586,0.00012501741,0.00020151971,0.000067155845,0.00005867702,0.00018889221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097629643,0.00082947663,0.002305982,0.0002992364,0.00033741584,0.00046731488,0.00035655708,0.0010888195,0.0019348237],"category_scores_gemma":[0.00082876073,0.0004748769,0.001110241,0.00026578695,0.00061504764,0.00039526288,0.00025167008,0.00093857467,0.00028416308],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9530121,0.008002402,0.005941336,0.00040648173,0.0007863447,0.00007265844,0.00006831712,0.00014748717,0.012596012,0.000026888601,0.00017114996,0.018768733],"study_design_scores_gemma":[0.6525767,0.2934649,0.049557675,0.00004880334,0.0013009398,0.0001171521,0.00007021277,0.00052026304,0.0017205452,0.000054167198,0.00053272035,0.000035906793],"about_ca_topic_score_codex":0.00083020166,"about_ca_topic_score_gemma":0.001258315,"teacher_disagreement_score":0.002305982,"about_ca_system_score_codex":0.00034733076,"about_ca_system_score_gemma":0.00071538007,"threshold_uncertainty_score":0.006472647},"labels":[],"label_agreement":null},{"id":"W3157303707","doi":"10.1002/hup.2791","title":"Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging study","year":2021,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Forensic Toxicology and Drug Analysis","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Baycrest Hospital; Toronto General Hospital; University Health Network; Centre for Addiction and Mental Health","funders":"","keywords":"Raclopride; Dopamine; Binding potential; Ventral striatum; Psychology; Striatum; Dopamine receptor D2; Medicine; Internal medicine; Narcolepsy; Endocrinology; Neuroscience; Neurology","score_opus":0.1174972655863866,"score_gpt":0.49828855409383455,"score_spread":0.3807912885074479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157303707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804074,0.0011026434,0.0002472441,0.000057428526,0.000005266714,0.000044856264,0.00004344953,0.000003952747,0.00045443504],"genre_scores_gemma":[0.99845207,0.000584647,0.00032503257,0.000109774526,0.000015692647,0.000036369598,0.00009264346,0.0000023857801,0.0003813308],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987483,0.00005604281,0.0000059451795,0.000028866172,0.000019475396,0.000014831961],"domain_scores_gemma":[0.99983335,0.00004231812,0.000060079445,0.000025766196,0.000018783121,0.000019612642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003955535,0.00030588006,0.00029075067,0.000095128285,0.00022265062,0.00024890268,0.00021693297,0.00045496816,0.0012281307],"category_scores_gemma":[0.00057904684,0.00015115748,0.00015664025,0.00007084894,0.00058973354,0.00023926332,0.00014623106,0.0002470512,0.00025538137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068012066,0.0062848586,0.30794272,0.0011908613,0.0009283667,0.0076049515,0.0024335787,0.00047599553,0.5140596,0.0008031724,0.0012511384,0.08901266],"study_design_scores_gemma":[0.001031068,0.10345484,0.8330251,0.0000726826,0.00047847914,0.010058592,0.001673394,0.0012896933,0.039123155,0.0006177194,0.009138612,0.00003662827],"about_ca_topic_score_codex":0.0013165477,"about_ca_topic_score_gemma":0.0023440456,"teacher_disagreement_score":0.0013165477,"about_ca_system_score_codex":0.00021152243,"about_ca_system_score_gemma":0.00023943401,"threshold_uncertainty_score":0.0041084886},"labels":[],"label_agreement":null},{"id":"W3207497475","doi":"10.1002/hup.2821","title":"Melatonin and melatonin‐agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Melatonin; Metabolic syndrome; Internal medicine; Medicine; Antipsychotic; Schizoaffective disorder; Placebo; Endocrinology; Bipolar disorder; Schizophrenia (object-oriented programming); Psychiatry; Psychosis; Obesity","score_opus":0.1323927229962824,"score_gpt":0.4708268889891266,"score_spread":0.3384341659928442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207497475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042955484,0.9945469,0.00025465712,0.00011609656,0.00010509226,0.00026094535,0.00024372428,0.000018644043,0.00015843402],"genre_scores_gemma":[0.14234729,0.85357845,0.0014632585,0.0006364351,0.0002143713,0.0009752401,0.000511529,0.000018510025,0.00025490238],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9947202,0.0023762004,0.0016435945,0.00050507474,0.00057511294,0.00017974747],"domain_scores_gemma":[0.9907266,0.006195599,0.0019782356,0.00025679948,0.0006734941,0.00016925238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008001257,0.0023563146,0.016952157,0.0048064967,0.00055807317,0.0025370219,0.0018579359,0.001884632,0.0031869188],"category_scores_gemma":[0.0177511,0.0012798943,0.0317767,0.005061576,0.0006163882,0.0013308681,0.0011663778,0.0014949569,0.00021941464],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029981548,0.000041906966,0.002051535,0.49646398,0.48486975,0.0001100182,0.00006804793,0.00038613167,0.0002268988,0.00008451435,0.00050657085,0.012192499],"study_design_scores_gemma":[0.0010001666,0.00027228773,0.0026980226,0.02512415,0.9691985,0.000085275955,0.00003897023,0.00014886906,0.000096995194,0.000097653625,0.0012192667,0.000019847845],"about_ca_topic_score_codex":0.006457335,"about_ca_topic_score_gemma":0.015159797,"teacher_disagreement_score":0.016952157,"about_ca_system_score_codex":0.0023912508,"about_ca_system_score_gemma":0.003392731,"threshold_uncertainty_score":0.042315185},"labels":[],"label_agreement":null},{"id":"W3209897178","doi":"10.1002/hup.2824","title":"Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships","year":2021,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"MDMA; Social anxiety; Psychology; Psychotherapist; Context (archaeology); Shame; Anxiety; Clinical psychology; Psychiatry; Social psychology","score_opus":0.3000767527289443,"score_gpt":0.5327557203681698,"score_spread":0.23267896763922546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209897178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015694147,0.9992835,0.000035539695,0.00009783624,0.000028025017,0.0000049479877,0.0000035045723,0.0000017288919,0.00038786975],"genre_scores_gemma":[0.002307825,0.9972734,0.00013304783,0.000094919014,0.00003844383,0.000014568704,0.000006941235,5.8890254e-7,0.00013024532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996631,0.00014570764,0.000054905144,0.000037474816,0.00007980366,0.000018939907],"domain_scores_gemma":[0.9995109,0.00036323458,0.00007064513,0.000009550845,0.00003354896,0.000012042857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086511916,0.0005458096,0.0010818316,0.001567229,0.00024908024,0.0009690865,0.00074240705,0.0011375449,0.0013738216],"category_scores_gemma":[0.0013593665,0.00017952592,0.00057706446,0.0015780982,0.00057170517,0.0008684144,0.0004806579,0.00082137337,0.00036694252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001440235,0.000119185905,0.0002959861,0.07779205,0.00031210826,0.00022873013,0.0003493897,0.00022674829,0.0012839491,0.0042320634,0.0047334456,0.9102824],"study_design_scores_gemma":[0.0001766303,0.0008004743,0.012342037,0.09951992,0.0016399992,0.0062216013,0.0012144718,0.00032150515,0.0026959851,0.0072025866,0.867786,0.00007877895],"about_ca_topic_score_codex":0.0011052671,"about_ca_topic_score_gemma":0.0024255672,"teacher_disagreement_score":0.001567229,"about_ca_system_score_codex":0.0006477134,"about_ca_system_score_gemma":0.0011121718,"threshold_uncertainty_score":0.0046994686},"labels":[],"label_agreement":null},{"id":"W4213037518","doi":"10.1002/hup.2836","title":"Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression","year":2022,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Treatment of Major Depression","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Major depressive disorder; Treatment-resistant depression; Ketamine; Depression (economics); Confidence interval; Medicine; Odds ratio; Antidepressant; Internal medicine; Randomized controlled trial; Logistic regression; Clinical trial; Depressive symptoms; Major depressive episode; Rating scale; Psychiatry; Psychology; Anxiety","score_opus":0.028732841043085884,"score_gpt":0.41228578593714255,"score_spread":0.38355294489405667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213037518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99935466,0.00040464962,0.00004680236,0.000017057395,0.0000041378144,0.000025021296,0.00005452581,0.0000013747624,0.00009178589],"genre_scores_gemma":[0.99961,0.00012963156,0.00006967695,0.000013864139,0.0000070966516,0.000021468486,0.00010565669,4.838566e-7,0.000042129574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995453,0.00024589238,0.00005921047,0.00006077239,0.00005762529,0.00003109253],"domain_scores_gemma":[0.99876946,0.00037635706,0.0005636794,0.000051155563,0.0000807189,0.00015864198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010146841,0.00019860528,0.00049847504,0.00017339709,0.0001374955,0.0002401551,0.00017206238,0.00029351158,0.0009006423],"category_scores_gemma":[0.0018931301,0.00012796462,0.00039475827,0.00019760756,0.00010956227,0.00013458097,0.00011767994,0.00030011978,0.00014741124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046775986,0.0014506419,0.9259374,0.00017572106,0.00054612407,0.00012507838,0.00011630958,0.00022715762,0.0046658036,0.00002200116,0.00024472582,0.019712964],"study_design_scores_gemma":[0.0009784332,0.00600452,0.9915637,0.000019856894,0.00023988687,0.00018537196,0.000042340245,0.0004612573,0.00031622848,0.000019177327,0.00016321184,0.00000603982],"about_ca_topic_score_codex":0.0002549899,"about_ca_topic_score_gemma":0.00044180048,"teacher_disagreement_score":0.0010146841,"about_ca_system_score_codex":0.00012814571,"about_ca_system_score_gemma":0.00012838017,"threshold_uncertainty_score":0.005366206},"labels":[],"label_agreement":null},{"id":"W4239946193","doi":"10.1002/(sici)1099-1077(200004)15:3<199::aid-hup163>3.3.co;2-k","title":"The interaction between cytokines and neurotransmitters in depression and stress: possible mechanism of antidepressant treatments","year":2000,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Nucleus accumbens; Antidepressant; Psychology; Depression (economics); Psychiatry; Neuroscience; Dopamine; Anxiety","score_opus":0.0501237004069989,"score_gpt":0.399544832697158,"score_spread":0.34942113229015914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239946193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5881001,0.38060403,0.007946982,0.007712829,0.0010655789,0.00025590055,0.0003748767,0.000080303435,0.013859403],"genre_scores_gemma":[0.9337614,0.059431184,0.001978537,0.00079704664,0.00073103805,0.00016736907,0.00010171574,0.0000047335993,0.0030270733],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99978834,0.00009834837,0.000018179768,0.000024093606,0.000024971569,0.000045947836],"domain_scores_gemma":[0.99982566,0.00006101421,0.000045607496,0.000014272174,0.000025808471,0.000027552029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005217745,0.0004274586,0.00067993364,0.00045796265,0.00036392195,0.0008150025,0.00044606355,0.00095189014,0.0017604622],"category_scores_gemma":[0.0004669326,0.0002762838,0.0004222963,0.00027204643,0.00067201845,0.00057076383,0.00037575135,0.000762928,0.00018665152],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031573918,0.0022061095,0.041717317,0.003668167,0.00082449894,0.0109736,0.001384378,0.0016390451,0.5140701,0.0382391,0.0054751467,0.34822863],"study_design_scores_gemma":[0.0061992044,0.023789626,0.53211695,0.0011795809,0.0028036137,0.022300605,0.0032672656,0.007974498,0.22868,0.054022636,0.117420696,0.00024527285],"about_ca_topic_score_codex":0.00047567315,"about_ca_topic_score_gemma":0.00069219427,"teacher_disagreement_score":0.0017604622,"about_ca_system_score_codex":0.00039509317,"about_ca_system_score_gemma":0.00039562193,"threshold_uncertainty_score":0.0058892965},"labels":[],"label_agreement":null},{"id":"W4376616454","doi":"10.1002/hup.2871","title":"Can antidepressant use be associated with emotional blunting in a subset of patients with depression? A scoping review of available literature","year":2023,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Feeling; Depression (economics); Antidepressant; Systematic review; Psychology; Adverse effect; Psychiatry; Medicine; Clinical psychology; Psychotherapist; MEDLINE; Anxiety; Internal medicine; Social psychology","score_opus":0.17154310022330413,"score_gpt":0.4849100051008777,"score_spread":0.31336690487757357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376616454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016617738,0.99665654,0.00013641527,0.00045495073,0.00012443576,0.00023745888,0.00035155984,0.000004221571,0.00037250336],"genre_scores_gemma":[0.017948866,0.97994417,0.00043875552,0.00052589935,0.00010948863,0.00060711225,0.00034597196,0.0000031553102,0.00007660249],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99105537,0.0023739468,0.004581441,0.0006946057,0.0011083124,0.00018623621],"domain_scores_gemma":[0.95201415,0.03637704,0.008357725,0.00056180905,0.0024771069,0.0002121401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008507895,0.001064378,0.0045585665,0.019876631,0.00087775296,0.0031399806,0.0015553781,0.0024553088,0.002738077],"category_scores_gemma":[0.05879931,0.0010625123,0.004670444,0.015746117,0.0013566312,0.0026815555,0.0017663757,0.0010536099,0.0002580977],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107267784,0.000019900954,0.0033701605,0.89288116,0.0033241329,0.00036255398,0.0009590389,0.00012256046,0.00014189967,0.00038871446,0.0020060062,0.0963167],"study_design_scores_gemma":[0.00003247486,0.000076499295,0.006042787,0.96537226,0.012988192,0.00092342455,0.000742477,0.000047704052,0.00008335562,0.00034199163,0.013323888,0.000024890054],"about_ca_topic_score_codex":0.008120067,"about_ca_topic_score_gemma":0.0147988675,"teacher_disagreement_score":0.019876631,"about_ca_system_score_codex":0.0029602353,"about_ca_system_score_gemma":0.009373673,"threshold_uncertainty_score":0.044994593},"labels":[],"label_agreement":null},{"id":"W4395689370","doi":"10.1002/hup.2898","title":"Analysis of schizophrenia‐associated genetic markers in the HLA region as risk factors for tardive dyskinesia","year":2024,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation; Brain and Behavior Research Foundation","keywords":"Tardive dyskinesia; Single-nucleotide polymorphism; SNP; Schizophrenia (object-oriented programming); Genotype; Human leukocyte antigen; Dyskinesia; Medicine; Psychiatry; Psychology; Internal medicine; Clinical psychology; Genetics; Biology; Gene; Immunology; Disease","score_opus":0.05832295645562774,"score_gpt":0.41232138129574136,"score_spread":0.3539984248401136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395689370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995684,0.00009821419,0.00010192761,0.000020553147,0.0000018394921,0.0000033493109,0.000070684975,0.000002195468,0.00013282828],"genre_scores_gemma":[0.99968886,0.000032101998,0.000137974,0.000008546106,0.0000017825813,0.0000025452025,0.000056241177,0.0000012851408,0.00007068116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968505,0.0001062879,0.00003821496,0.00006490263,0.000055666424,0.00004988003],"domain_scores_gemma":[0.9990644,0.00031012748,0.00034410023,0.000044128617,0.00007236234,0.0001648934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046413188,0.00028880133,0.00021709976,0.0007203786,0.00036122845,0.0003020977,0.00024328135,0.00030604197,0.0025862874],"category_scores_gemma":[0.0013614284,0.000110442656,0.00036077865,0.0008550859,0.00027035672,0.0000952233,0.00024518542,0.00028673376,0.0001484153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008037739,0.000040635947,0.9859891,0.000016642658,0.000224202,0.00038720164,0.00009604573,0.00016024293,0.009356421,0.000059667324,0.000054697764,0.0028114903],"study_design_scores_gemma":[0.00002491633,0.00013149114,0.99798125,0.000008024208,0.000115350034,0.0004396935,0.00012248795,0.00045928828,0.0005565275,0.0000530316,0.000104119776,0.0000038571025],"about_ca_topic_score_codex":0.01526127,"about_ca_topic_score_gemma":0.016299495,"teacher_disagreement_score":0.01526127,"about_ca_system_score_codex":0.00030343304,"about_ca_system_score_gemma":0.0007303335,"threshold_uncertainty_score":0.030344844},"labels":[],"label_agreement":null},{"id":"W4410564375","doi":"10.1002/hup.70006","title":"Clozapine Once‐Versus Multiple‐Daily Dosing Regimen: A Single‐Center, Retrospective, Cross‐Sectional Study","year":2025,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dosing; Medicine; Clozapine; Regimen; Adverse effect; Retrospective cohort study; Population; Internal medicine; Single Center; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.09763144311708988,"score_gpt":0.49327081293386876,"score_spread":0.3956393698167789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410564375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99937904,0.00024739015,0.00007029276,0.000012622788,0.0000042100264,0.000026732916,0.00012184108,0.0000020890352,0.00013578194],"genre_scores_gemma":[0.9994192,0.00012613747,0.000081571605,0.00005311135,0.0000123112195,0.00002564078,0.00021822468,0.0000016717321,0.00006216563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991358,0.00020491528,0.00013164036,0.00027402083,0.00014948365,0.00010423923],"domain_scores_gemma":[0.99838936,0.00024595545,0.00076454633,0.0001620629,0.0002092435,0.00022880614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001001055,0.00044852548,0.00067608093,0.00074294064,0.000565197,0.0005976073,0.00035113853,0.00054022577,0.0010102898],"category_scores_gemma":[0.0015947677,0.00057826476,0.0005951832,0.0011851324,0.0004049099,0.0007136828,0.0003192091,0.0005026665,0.000255585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036985724,0.000115162344,0.9982558,0.000018945664,0.00012729669,0.00009538475,0.000092833245,0.000015459302,0.00020905894,0.000008569527,0.000048539354,0.00064315024],"study_design_scores_gemma":[0.00007778008,0.00073679304,0.9978461,0.0000092278215,0.0001764572,0.0004340646,0.0002435302,0.00021500238,0.00008616412,0.000010120447,0.00015602246,0.000008689429],"about_ca_topic_score_codex":0.0046905633,"about_ca_topic_score_gemma":0.004707671,"teacher_disagreement_score":0.0046905633,"about_ca_system_score_codex":0.00052534667,"about_ca_system_score_gemma":0.0005731933,"threshold_uncertainty_score":0.009326518},"labels":[],"label_agreement":null},{"id":"W7117739282","doi":"10.1002/hup.70031","title":"Anxiolytic Medication Use in Low‐ Middle‐ and High‐Income Countries: A World Mental Health Surveys Report","year":2025,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and related disorders","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Executive Agency for Health and Consumers; Pfizer Foundation; U.S. Public Health Service; Bristol-Myers Squibb; Eli Lilly and Company; Ministerio de Salud de la Nación; Pan American Health Organization; Fundação de Amparo à Pesquisa do Estado de São Paulo; Universidad CES; European Commission; World Health Organization; GlaxoSmithKline; Fogarty International Center; National Institute of Mental Health; Pfizer","keywords":"Anxiolytic; Anxiety; Medical prescription; Anti-Anxiety Agents; Mental health; Pharmacotherapy; Intervention (counseling); Antidepressant","score_opus":0.04443655691560618,"score_gpt":0.44293738271774574,"score_spread":0.3985008258021396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117739282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898453,0.00126879,0.00009657873,0.00030698424,0.000018408131,0.000038195423,0.0063946,0.000009755938,0.0020213223],"genre_scores_gemma":[0.9965964,0.00075294747,0.000117987765,0.00013727488,0.000014682365,0.000037100162,0.0021881294,0.0000016651275,0.00015375993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994091,0.00022665768,0.00010793745,0.00006169353,0.000093342256,0.00010133153],"domain_scores_gemma":[0.99829096,0.0002138016,0.0009226,0.000070669616,0.00025678196,0.0002451523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087986985,0.00022446025,0.00023040277,0.0010418553,0.00022701651,0.0005272892,0.0002330563,0.00025618053,0.0012582876],"category_scores_gemma":[0.0017981216,0.00018953714,0.00041113436,0.0019024913,0.00026737954,0.0005251832,0.000759181,0.0003464656,0.0002763117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018685309,0.000020761878,0.99626726,0.000073415795,0.00006718911,0.00002880229,0.0002902405,0.000021802256,0.00007138091,0.000016706934,0.00070524414,0.0024185278],"study_design_scores_gemma":[0.0000019300255,0.000017860708,0.9990609,0.000016353872,0.000012417034,0.00004146945,0.00053830066,0.00002017776,0.00002416784,0.0000039012507,0.0002603623,0.0000022240615],"about_ca_topic_score_codex":0.010067607,"about_ca_topic_score_gemma":0.011063565,"teacher_disagreement_score":0.010067607,"about_ca_system_score_codex":0.00021710679,"about_ca_system_score_gemma":0.000281822,"threshold_uncertainty_score":0.020018041},"labels":[],"label_agreement":null},{"id":"W865674970","doi":"10.1002/hup.1189","title":"Add‐on mirtazapine improves depressive symptoms in schizophrenia: a double‐blind randomized placebo‐controlled study with an open‐label extension phase","year":2011,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mirtazapine; Placebo; Schizophrenia (object-oriented programming); Positive and Negative Syndrome Scale; Psychology; Randomized controlled trial; Depression (economics); Psychiatry; Major depressive disorder; Psychosis; Internal medicine; Antidepressant; Medicine","score_opus":0.12834789893637277,"score_gpt":0.4855986779447769,"score_spread":0.35725077900840413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W865674970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98749197,0.003868903,0.0008701372,0.00028091614,0.0006009738,0.0053327326,0.0006854895,0.00014915488,0.0007197367],"genre_scores_gemma":[0.9791311,0.0048826113,0.0035927433,0.00082233053,0.0009914897,0.007151765,0.0010819918,0.000040898383,0.0023051132],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984433,0.0008070774,0.00017789126,0.00023017086,0.0001551755,0.0001863744],"domain_scores_gemma":[0.9981559,0.00046989686,0.00040825838,0.0002797846,0.00019383442,0.00049231737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003367006,0.0020395818,0.0045057507,0.0009509741,0.00058927987,0.0009705204,0.00115149,0.0022795808,0.0046428903],"category_scores_gemma":[0.002400871,0.0011875434,0.0032554453,0.0007358855,0.0017105556,0.0011099211,0.0005168947,0.0021645662,0.0008160539],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97203356,0.012855761,0.00031222787,0.0006297023,0.00084152084,0.000025838515,0.00003329735,0.00010200374,0.0047679497,0.00003847274,0.00015258841,0.008207033],"study_design_scores_gemma":[0.9205588,0.07686892,0.0012389538,0.00001820223,0.00047762142,0.000014908327,0.000010203808,0.00015320996,0.0004374755,0.000034753197,0.0001736007,0.000013234639],"about_ca_topic_score_codex":0.001205573,"about_ca_topic_score_gemma":0.002814637,"teacher_disagreement_score":0.0046428903,"about_ca_system_score_codex":0.00075988274,"about_ca_system_score_gemma":0.0012079001,"threshold_uncertainty_score":0.01780665},"labels":[],"label_agreement":null}]}